{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T13:19:56Z","timestamp":1761311996614,"version":"3.40.5"},"publisher-location":"Cham","reference-count":539,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783031667756"},{"type":"electronic","value":"9783031667763"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/164_2023_679","type":"book-chapter","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T17:03:24Z","timestamp":1694711004000},"page":"369-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Asthma and COPD: A Focus on \u03b2-Agonists \u2013 Past, Present and Future"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2371-8202","authenticated-orcid":false,"given":"Jillian G.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4106-8469","authenticated-orcid":false,"given":"Dominick E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"679_CR1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1113\/jphysiol.1901.sp000869","volume":"27","author":"JJ Abel","year":"1901","unstructured":"Abel JJ (1901) On epinephrine, the active constituent of the suprarenal capsule and its compounds. J Physiol 27:237","journal-title":"J Physiol"},{"key":"679_CR2","first-page":"151","volume":"8","author":"JJ Abel","year":"1897","unstructured":"Abel JJ, Crawford AC (1897) On the blood-pressure raising constituent of the suprarenal capsule. Bull Johns Hopkins Hosp 8:151\u2013157","journal-title":"Bull Johns Hopkins Hosp"},{"key":"679_CR3","doi-asserted-by":"publisher","first-page":"CD001186","DOI":"10.1002\/14651858.CD001186.pub2","volume":"8","author":"MJ Abramson","year":"2010","unstructured":"Abramson MJ, Puy RM, Weiner JM (2010) Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev 8:CD001186. https:\/\/doi.org\/10.1002\/14651858.CD001186.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"679_CR4","first-page":"27","volume-title":"Asthma and its radical treatment","author":"J Adam","year":"1913","unstructured":"Adam J (1913) Asthma and its radical treatment. Henry Kimpton, p 27. as referenced in Melland, 1910"},{"issue":"3","key":"679_CR5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1152\/ajplegacy.1948.153.3.586","volume":"153","author":"RP Ahlquist","year":"1948","unstructured":"Ahlquist RP (1948) A study of the adrenotropic receptors. Am J Physiol 153(3):586\u2013600. https:\/\/doi.org\/10.1152\/ajplegacy.1948.153.3.586","journal-title":"Am J Physiol"},{"issue":"8","key":"679_CR6","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1056\/NEJMoa1104623","volume":"365","author":"RK Albert","year":"2011","unstructured":"Albert RK, Connett J, Bailey WC, Casaburi R, Cooper JA Jr, Criner GJ, Curtis JL, Dransfield MT, Han MK, Lazarus SC, Make B, Marchetti N, Martinez FJ, Madinger NE, McEvoy C, Niewoehner DE, Porsasz J, Price CS, Reilly J, Scanlon PD, Sciurba FC, Scharf SM, Washko GR, Woodruff PG, Anthonisen NR, COPD Clinical Research Network (2011) Azithromycin for prevention of exacerbations of COPD. N Engl J Med 365(8):689\u2013698. https:\/\/doi.org\/10.1056\/NEJMoa1104623","journal-title":"N Engl J Med"},{"issue":"Suppl","key":"679_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/BF02718131","volume":"168","author":"PM Aldons","year":"1990","unstructured":"Aldons PM (1990) Can a new beta 2-agonist reduce the mortality of asthma? Lung 168(Suppl):186\u2013191. https:\/\/doi.org\/10.1007\/BF02718131","journal-title":"Lung"},{"key":"679_CR8","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1152\/ajplegacy.1901.5.7.457","volume":"5","author":"TB Aldrich","year":"1901","unstructured":"Aldrich TB (1901) A preliminary report on the active principle of the suprarenal gland. Am J Physiol 5:457\u2013461","journal-title":"Am J Physiol"},{"issue":"4","key":"679_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.pupt.2004.04.001","volume":"17","author":"M Alvarez-Guerra","year":"2004","unstructured":"Alvarez-Guerra M, Libertus H, Garay RP (2004) Inhibition by reproterol of cAMP PDE in intact mastocytoma P-815 cells. Pulm Pharmacol Ther 17(4):213\u2013218. https:\/\/doi.org\/10.1016\/j.pupt.2004.04.001","journal-title":"Pulm Pharmacol Ther"},{"key":"679_CR10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/978-3-0348-7324-6_22","volume":"43","author":"GP Anderson","year":"1993","unstructured":"Anderson GP (1993a) Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol. Agents Actions Suppl 43:253\u2013269. https:\/\/doi.org\/10.1007\/978-3-0348-7324-6_22","journal-title":"Agents Actions Suppl"},{"issue":"26","key":"679_CR11","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1016\/0024-3205(93)90729-m","volume":"52","author":"GP Anderson","year":"1993","unstructured":"Anderson GP (1993b) Formoterol: pharmacology, molecular basis of agonism, and mechanism of long duration of a highly potent and selective beta 2-adrenoceptor agonist bronchodilator. Life Sci 52(26):2145\u20132160. https:\/\/doi.org\/10.1016\/0024-3205(93)90729-m","journal-title":"Life Sci"},{"issue":"9","key":"679_CR12","first-page":"1139","volume":"50","author":"PJ Anderson","year":"2005","unstructured":"Anderson PJ (2005) History of aerosol therapy: liquid nebulization to MDIs to DPIs. Respir Care 50(9):1139\u20131150","journal-title":"Respir Care"},{"issue":"2-3","key":"679_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1385\/CRIAI:31:2:119","volume":"31","author":"GP Anderson","year":"2006","unstructured":"Anderson GP (2006) Current issues with beta2-adrenoceptor agonists: pharmacology and molecular and cellular mechanisms. Clin Rev Allergy Immunol 31(2-3):119\u2013130. https:\/\/doi.org\/10.1385\/CRIAI:31:2:119","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"679_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/thx.32.6.717","volume":"32","author":"G Anderson","year":"1977","unstructured":"Anderson G, Wilkins E (1977) A trial of clenbuterol in bronchial asthma. Thorax 32(6):717\u2013719. https:\/\/doi.org\/10.1136\/thx.32.6.717","journal-title":"Thorax"},{"issue":"3","key":"679_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1183\/09031936.94.07030569","volume":"7","author":"GP Anderson","year":"1994","unstructured":"Anderson GP, Lind\u00e9n A, Rabe KF (1994) Why are long-acting beta-adrenoceptor agonists long-acting? Eur Respir J 7(3):569\u2013578. https:\/\/doi.org\/10.1183\/09031936.94.07030569","journal-title":"Eur Respir J"},{"issue":"7483","key":"679_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1136\/bmj.38316.729907.8F","volume":"330","author":"HR Anderson","year":"2005","unstructured":"Anderson HR, Ayres JG, Sturdy PM, Bland JM, Butland BK, Peckitt C, Taylor JC, Victor CR (2005) Bronchodilator treatment and deaths from asthma: case-control study. BMJ 330(7483):117. https:\/\/doi.org\/10.1136\/bmj.38316.729907.8F","journal-title":"BMJ"},{"key":"679_CR17","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.2147\/COPD.S246353","volume":"15","author":"S Andreas","year":"2020","unstructured":"Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P (2020) A post hoc holter ECG analysis of olodaterol and formoterol in moderate-to-very-severe COPD. Int J Chron Obstruct Pulmon Dis 15:1955\u20131965. https:\/\/doi.org\/10.2147\/COPD.S246353","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"2","key":"679_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1124\/jpet.112.193284","volume":"342","author":"M Aparici","year":"2012","unstructured":"Aparici M, G\u00f3mez-Angelats M, Vilella D, Otal R, Carcasona C, Vi\u00f1als M, Ramos I, Gavald\u00e0 A, De Alba J, Gras J, Cortijo J, Morcillo E, Puig C, Ryder H, Beleta J, Miralpeix M (2012) Pharmacological characterization of abediterol, a novel inhaled \u03b2(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models. J Pharmacol Exp Ther 342(2):497\u2013509. https:\/\/doi.org\/10.1124\/jpet.112.193284","journal-title":"J Pharmacol Exp Ther"},{"key":"679_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2015.11.053","volume":"770","author":"M Aparici","year":"2016","unstructured":"Aparici M, Gavald\u00e0 A, Ramos I, Carcasona C, Otal R, Fern\u00e1ndez-Blanco JA, Montero JL, Garc\u00eda VM, L\u00f3pez R, De Alba J, Doe C, Puig C, Vilella D, Miralpeix M (2016) In vitro and in vivo preclinical profile of abediterol (LAS100977), an inhaled long-acting \u03b22-adrenoceptor agonist, compared with indacaterol, olodaterol and vilanterol. Eur J Pharmacol 770:61\u201369. https:\/\/doi.org\/10.1016\/j.ejphar.2015.11.053","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"679_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/j.1476-5381.1976.tb07473.x","volume":"57","author":"GH Apperley","year":"1976","unstructured":"Apperley GH, Daly MJ, Levy GP (1976) Selectivity of beta-adrenoceptor agonists and antagonists on bronchial, skeletal, vascular and cardiac muscle in the anaesthetized cat. Br J Pharmacol 57(2):235\u2013246. https:\/\/doi.org\/10.1111\/j.1476-5381.1976.tb07473.x","journal-title":"Br J Pharmacol"},{"key":"679_CR21","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.0954-6820.1970.tb05289.x","volume":"512","author":"B Arner","year":"1970","unstructured":"Arner B (1970) A comparative clinical trial of different subcutaneous doses of terbutaline and orciprenaline in bronchial asthma. Acta Med Scand Suppl 512:45\u201348. https:\/\/doi.org\/10.1111\/j.0954-6820.1970.tb05289.x","journal-title":"Acta Med Scand Suppl"},{"key":"679_CR22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.0954-6820.1970.tb05288.x","volume":"512","author":"B Arner","year":"1970","unstructured":"Arner B, Bertler A, Karlefors T, Westling H (1970) Bronchodilator effect of a new sympathomimetic beta-receptor-stimulating agent, terbutaline, given subcutaneously to asthmatic patients. Acta Med Scand Suppl 512:41\u201343. https:\/\/doi.org\/10.1111\/j.0954-6820.1970.tb05288.x","journal-title":"Acta Med Scand Suppl"},{"issue":"7233","key":"679_CR23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/bmj.320.7233.506","volume":"320","author":"JK Aronson","year":"2000","unstructured":"Aronson JK (2000) \u201cWhere name and image meet\u201d \u2013 the argument for \u201cadrenaline\u201d. BMJ 320(7233):506\u2013509. https:\/\/doi.org\/10.1136\/bmj.320.7233.506","journal-title":"BMJ"},{"issue":"5","key":"679_CR24","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S2213-2600(15)00087-9","volume":"3","author":"G Arthur","year":"2015","unstructured":"Arthur G (2015) Epinephrine: a short history. Lancet Respir Med 3(5):350\u2013351. https:\/\/doi.org\/10.1016\/S2213-2600(15)00087-9","journal-title":"Lancet Respir Med"},{"issue":"4","key":"679_CR25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1183\/09031936.93.02040325","volume":"2","author":"P Arvidsson","year":"1989","unstructured":"Arvidsson P, Larsson S, L\u00f6fdahl CG, Melander B, W\u00e5hlander L, Svedmyr N (1989) Formoterol, a new long-acting bronchodilator for inhalation. Eur Respir J 2(4):325\u2013330","journal-title":"Eur Respir J"},{"issue":"5223","key":"679_CR26","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/2241028a0","volume":"224","author":"ES Assem","year":"1969","unstructured":"Assem ES, Schild HO (1969) Inhibition by sympathomimetic amines of histamine release by antigen in passively sensitized human lung. Nature 224(5223):1028\u20131029. https:\/\/doi.org\/10.1038\/2241028a0","journal-title":"Nature"},{"issue":"3 Pt 1","key":"679_CR27","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1164\/ajrccm.161.3.9904006","volume":"161","author":"DH Au","year":"2000","unstructured":"Au DH, Lemaitre RN, Curtis JR, Smith NL, Psaty BM (2000) The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists. Am J Respir Crit Care Med 161(3 Pt 1):827\u2013830","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"679_CR28","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1378\/chest.121.3.846","volume":"121","author":"DH Au","year":"2002","unstructured":"Au DH, Curtis JR, Every NR, McDonell MB, Fihn SD (2002) Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest 121(3):846\u2013851","journal-title":"Chest"},{"issue":"4","key":"679_CR29","first-page":"284","volume":"49","author":"L B\u00e4cklund","year":"1968","unstructured":"B\u00e4cklund L, Fagerberg E (1968) Ventilatory capacity after bronchodilatation with a new beta-sympathomimetic substance. Scand J Respir Dis 49(4):284\u2013290","journal-title":"Scand J Respir Dis"},{"issue":"6","key":"679_CR30","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/thoraxjnl-2021-217124","volume":"77","author":"C Baggott","year":"2022","unstructured":"Baggott C, Hardy JK, Sparks J, Sabbagh D, Beasley R, Weatherall M, Fingleton J (2022) Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis. Thorax 77(6):563\u2013572. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217124","journal-title":"Thorax"},{"key":"679_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1476-5381.2010.00754.x","volume":"160","author":"JG Baker","year":"2010","unstructured":"Baker JG (2010) The selectivity of \u03b2-adrenoceptor agonists at the human \u03b21, \u03b22 and \u03b23 adrenoceptors. Br J Pharmacol 160:148\u2013161","journal-title":"Br J Pharmacol"},{"key":"679_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1136\/thoraxjnl-2016-208412","volume":"72","author":"JG Baker","year":"2017","unstructured":"Baker JG, Wilcox RG (2017) \u03b2-Blockers, heart disease and COPD: current controversies and uncertainties. Thorax 72:271\u2013276","journal-title":"Thorax"},{"key":"679_CR34","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/mol.64.3.679","volume":"64","author":"JG Baker","year":"2003","unstructured":"Baker JG, Hall IP, Hill SJ (2003) Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses. Mol Pharmacol 64:679\u2013688","journal-title":"Mol Pharmacol"},{"key":"679_CR35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1124\/mol.114.095364","volume":"87","author":"JG Baker","year":"2015","unstructured":"Baker JG, Proudman RGW, Hill SJ (2015) Salmeterol\u2019s extreme \u03b22-selectivity is due to residues in both extracellular loops and transmembrane domains. Mol Pharmacol 87:103\u2013120","journal-title":"Mol Pharmacol"},{"key":"679_CR36","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1096\/fj.201601305R","volume":"31","author":"JG Baker","year":"2017","unstructured":"Baker JG, Gardiner SM, Woolard J, Fromont C, Jadhav GP, Mistry SN, Thompson KSJ, Kellam B, Hill SJ, Fischer PM (2017) Novel selective \u03b21-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease. FASEB J 31:3150\u20133166","journal-title":"FASEB J"},{"key":"679_CR37","unstructured":"Baker J, Fromont C, Proudman R, Kellam B, Fischer P (2020a) Development of long-acting \u03b22-selective antagonists as a potential treatment to reduce tumour growth and metastasis. BJP:2645\u20132647. https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/abs\/10.1111\/bph.15035"},{"issue":"4","key":"679_CR38","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1021\/acsptsci.0c00051","volume":"3","author":"JG Baker","year":"2020","unstructured":"Baker JG, Fromont C, Bruder M, Thompson KSJ, Kellam B, Hill SJ, Fischer PM (2020b) Using esterase selectivity to determine the in vivo duration of systemic availability and abolish systemic side-effects of topical \u03b2-blockers. ACS Pharmacol Transl Sci 3(4):737\u2013748. https:\/\/doi.org\/10.1021\/acsptsci.0c00051","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"2","key":"679_CR33","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.2527\/jas1984.5951256x","volume":"59","author":"PK Baker","year":"1984","unstructured":"Baker PK, Dalrymple RH, Ingle DL, Ricks CA (1984) Use of a \u03b2-adrenergic agonist to alter muscle and fat deposition in lambs. J Anim Sci 59(2):1256\u20131261. https:\/\/doi.org\/10.2527\/jas1984.5951256x","journal-title":"J Anim Sci"},{"issue":"3","key":"679_CR39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1177\/0310057X1704500301","volume":"45","author":"CM Ball","year":"2017","unstructured":"Ball CM, Featherstone PJ (2017) The early history of adrenaline. Anaesth Intensive Care 45(3):279\u2013281. https:\/\/doi.org\/10.1177\/0310057X1704500301","journal-title":"Anaesth Intensive Care"},{"issue":"3","key":"679_CR40","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1476-5381.1991.tb12486.x","volume":"104","author":"DI Ball","year":"1991","unstructured":"Ball DI, Brittain RT, Coleman RA, Denyer LH, Jack D, Johnson M, Lunts LH, Nials AT, Sheldrick KE, Skidmore IF (1991) Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol 104(3):665\u2013671. https:\/\/doi.org\/10.1111\/j.1476-5381.1991.tb12486.x","journal-title":"Br J Pharmacol"},{"issue":"9","key":"679_CR41","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1042\/CS20191309","volume":"134","author":"A Banno","year":"2020","unstructured":"Banno A, Reddy AT, Lakshmi SP, Reddy RC (2020) Bidirectional interaction of airway epithelial remodeling and inflammation in asthma. Clin Sci (Lond) 134(9):1063\u20131079. https:\/\/doi.org\/10.1042\/CS20191309","journal-title":"Clin Sci (Lond)"},{"key":"679_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/pgmj.44.507.6","volume":"44","author":"H Barcroft","year":"1968","unstructured":"Barcroft H, Talbot JF (1968) Oliver and Sch\u00e4fer\u2019s discovery of the cardiovascular action of suprarenal extract. Postgrad Med J 44:6\u20138. https:\/\/doi.org\/10.1136\/pgmj.44.507.6","journal-title":"Postgrad Med J"},{"issue":"1\u20132","key":"679_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1113\/jphysiol.1910.sp001392","volume":"41","author":"G Barger","year":"1910","unstructured":"Barger G, Dale HH (1910) Chemical structure and sympathomimetic action of amines. J Physiol 41(1\u20132):19\u201359. https:\/\/doi.org\/10.1113\/jphysiol.1910.sp001392","journal-title":"J Physiol"},{"issue":"5\u20136","key":"679_CR44","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/0024-3205(93)90310-y","volume":"52","author":"PJ Barnes","year":"1993","unstructured":"Barnes PJ (1993) Muscarinic receptor subtypes in airways. Life Sci 52(5\u20136):521\u2013527. https:\/\/doi.org\/10.1016\/0024-3205(93)90310-y","journal-title":"Life Sci"},{"issue":"8","key":"679_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1164\/rccm.201302-0388PP","volume":"188","author":"PJ Barnes","year":"2013","unstructured":"Barnes PJ (2013) Theophylline. Am J Respir Crit Care Med 188(8):901\u2013906. https:\/\/doi.org\/10.1164\/rccm.201302-0388PP","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"679_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jccase.2013.07.004","volume":"8","author":"AR Barry","year":"2013","unstructured":"Barry AR, Graham MM (2013) Case report and review of clenbuterol cardiac toxicity. J Cardiol Cases 8(4):131\u2013133. https:\/\/doi.org\/10.1016\/j.jccase.2013.07.004","journal-title":"J Cardiol Cases"},{"key":"679_CR47","doi-asserted-by":"publisher","first-page":"CD010344","DOI":"10.1002\/14651858.CD010344.pub2","volume":"10","author":"J Batterink","year":"2015","unstructured":"Batterink J, Cessford TA, Taylor RA (2015) Pharmacological interventions for the acute management of hyperkalaemia in adults. Cochrane Database Syst Rev 10:CD010344. https:\/\/doi.org\/10.1002\/14651858.CD010344.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"679_CR48","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1124\/jpet.105.098251","volume":"317","author":"C Battram","year":"2006","unstructured":"Battram C, Charlton SJ, Cuenoud B, Dowling MR, Fairhurst RA, Farr D, Fozard JR, Leighton-Davies JR, Lewis CA, McEvoy L, Turner RJ, Trifilieff A (2006) In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther 317(2):762\u2013770. https:\/\/doi.org\/10.1124\/jpet.105.098251","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"679_CR49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.65.5.507","volume":"65","author":"J Beardshaw","year":"1974","unstructured":"Beardshaw J, MacLean L, Chan-Yeung M (1974) Comparison of the bronchodilator and cardiac effects of hydroxyphenylorciprenaline and orciprenaline. Chest 65(5):507\u2013511. https:\/\/doi.org\/10.1378\/chest.65.5.507","journal-title":"Chest"},{"issue":"2 Pt 2","key":"679_CR50","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/s0091-6749(99)70270-8","volume":"104","author":"R Beasley","year":"1999","unstructured":"Beasley R, Pearce N, Crane J, Burgess C (1999) Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 104(2 Pt 2):S18\u2013S30. https:\/\/doi.org\/10.1016\/s0091-6749(99)70270-8","journal-title":"J Allergy Clin Immunol"},{"issue":"6 Pt 1","key":"679_CR51","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/0091-6749(89)90385-0","volume":"84","author":"AB Becker","year":"1989","unstructured":"Becker AB, Simons FE (1989) Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma. J Allergy Clin Immunol 84(6 Pt 1):891\u2013895. https:\/\/doi.org\/10.1016\/0091-6749(89)90385-0","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"679_CR52","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s12325-009-0044-3","volume":"26","author":"KM Beeh","year":"2009","unstructured":"Beeh KM, Beier J (2009) Indacaterol, a novel inhaled, once-daily, long-acting beta2-agonist for the treatment of obstructive airways diseases. Adv Ther 26(7):691\u2013699. https:\/\/doi.org\/10.1007\/s12325-009-0044-3","journal-title":"Adv Ther"},{"issue":"6","key":"679_CR53","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.pupt.2006.09.001","volume":"20","author":"J Beier","year":"2007","unstructured":"Beier J, Chanez P, Martinot JB, Schreurs AJ, Tk\u00e1cov\u00e1 R, Bao W, Jack D, Higgins M (2007) Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial. Pulm Pharmacol Ther 20(6):740\u2013749. https:\/\/doi.org\/10.1016\/j.pupt.2006.09.001","journal-title":"Pulm Pharmacol Ther"},{"issue":"6","key":"679_CR54","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.pupt.2009.05.001","volume":"22","author":"J Beier","year":"2009","unstructured":"Beier J, Beeh KM, Brookman L, Peachey G, Hmissi A, Pascoe S (2009) Bronchodilator effects of indacaterol and formoterol in patients with COPD. Pulm Pharmacol Ther 22(6):492\u2013496. https:\/\/doi.org\/10.1016\/j.pupt.2009.05.001","journal-title":"Pulm Pharmacol Ther"},{"issue":"1","key":"679_CR55","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12890-016-0266-5","volume":"16","author":"J Beier","year":"2016","unstructured":"Beier J, Pujol H, Seoane B, Jimenez E, Astbury C, Massana E, Ruiz S, de Miquel G (2016) Abediterol, a novel long-acting \u03b22-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD. BMC Pulm Med 16(1):102. https:\/\/doi.org\/10.1186\/s12890-016-0266-5","journal-title":"BMC Pulm Med"},{"key":"679_CR56","doi-asserted-by":"publisher","first-page":"e00356","DOI":"10.1002\/prp2.356","volume":"5","author":"J Beier","year":"2017","unstructured":"Beier J, Fuhr R, Seoane B, Massana E, de Miquel G, Pujol H, Ruiz S (2017) Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a phase II, randomized, 7-day, crossover study. Pharmacol Res Perspect 5:e00356. https:\/\/doi.org\/10.1002\/prp2.356","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"679_CR57","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1164\/ajrccm.153.3.8630581","volume":"153","author":"MJ Belman","year":"1996","unstructured":"Belman MJ, Botnick WC, Shin JW (1996) Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153(3):967\u2013975. https:\/\/doi.org\/10.1164\/ajrccm.153.3.8630581","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"679_CR58","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1136\/thx.49.8.771","volume":"49","author":"JA Bennett","year":"1994","unstructured":"Bennett JA, Smyth ET, Pavord ID, Wilding PJ, Tattersfield AE (1994) Systemic effects of salbutamol and salmeterol in patients with asthma. Thorax 49(8):771\u2013774. https:\/\/doi.org\/10.1136\/thx.49.8.771","journal-title":"Thorax"},{"issue":"2","key":"679_CR59","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1183\/09031936.99.13244599","volume":"13","author":"JA Bennett","year":"1999","unstructured":"Bennett JA, Harrison TW, Tattersfield AE (1999) The contribution of the swallowed fraction of an inhaled dose of salmeterol to it systemic effects. Eur Respir J 13(2):445\u2013448. https:\/\/doi.org\/10.1183\/09031936.99.13244599","journal-title":"Eur Respir J"},{"issue":"2","key":"679_CR60","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0021-8707(48)90101-4","volume":"19","author":"RL Benson","year":"1948","unstructured":"Benson RL, Perlman F (1948) Clinical effects of epinephrine by inhalation; a survey. J Allergy 19(2):129\u2013140. https:\/\/doi.org\/10.1016\/0021-8707(48)90101-4","journal-title":"J Allergy"},{"issue":"9","key":"679_CR61","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/BF01898049","volume":"25","author":"J Bergman","year":"1969","unstructured":"Bergman J, Persson H, Wetterlin K (1969) 2 New groups of selective stimulants of adrenergic beta-receptors. Experientia 25(9):899\u2013901. https:\/\/doi.org\/10.1007\/BF01898049","journal-title":"Experientia"},{"issue":"1","key":"679_CR62","first-page":"18","volume":"17","author":"HM Beumer","year":"1979","unstructured":"Beumer HM (1979a) Pirbuterol in the treatment of bronchial asthma. Int J Clin Pharmacol Biopharm 17(1):18\u201325","journal-title":"Int J Clin Pharmacol Biopharm"},{"issue":"6","key":"679_CR63","first-page":"237","volume":"17","author":"HM Beumer","year":"1979","unstructured":"Beumer HM (1979b) Comparative investigations on pirbuterol, salbutamol and placebo aerosols in bronchial asthma. Int J Clin Pharmacol Biopharm 17(6):237\u2013239","journal-title":"Int J Clin Pharmacol Biopharm"},{"issue":"3","key":"679_CR64","first-page":"147","volume":"21","author":"HM Beumer","year":"1983","unstructured":"Beumer HM (1983) Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma. Int J Clin Pharmacol Ther Toxicol 21(3):147\u2013166","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"issue":"4","key":"679_CR65","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000193882","volume":"35","author":"HM Beumer","year":"1978","unstructured":"Beumer HM, Mills JG, Sharpe PC (1978) Comparative study of carbuterol and salbutamol from metered aerosols in bronchial asthma. Respiration 35(4):220\u2013223. https:\/\/doi.org\/10.1159\/000193882","journal-title":"Respiration"},{"issue":"Suppl 2","key":"679_CR66","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000195766","volume":"55","author":"S Bianco","year":"1989","unstructured":"Bianco S (1989) Role of broxaterol in bronchial hyperresponsiveness. Respiration 55(Suppl 2):20\u201327. https:\/\/doi.org\/10.1159\/000195766","journal-title":"Respiration"},{"issue":"1","key":"679_CR67","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1185\/03007997509113642","volume":"3","author":"S Bianco","year":"1975","unstructured":"Bianco S, Kamburoff PL, Prime FJ (1975) Comparison between the bronchodilator and cardiovascular effects of inhaling 0.5 mg. rimiterol (\u2018Pulmadil\u2019) and 0.2 mg. salbutamol. Curr Med Res Opin 3(1):30\u201335. https:\/\/doi.org\/10.1185\/03007997509113642","journal-title":"Curr Med Res Opin"},{"key":"679_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/164_2016_64","volume":"237","author":"CK Billington","year":"2017","unstructured":"Billington CK, Penn RB, Hall IP (2017) \u03b22 Agonists. Handb Exp Pharmacol 237:23\u201340. https:\/\/doi.org\/10.1007\/164_2016_64","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"679_CR69","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.chest.2016.03.032","volume":"150","author":"L Bjermer","year":"2016","unstructured":"Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M (2016) Reslizumab for inadequately controlled asthma with elevated blood eosinophil levels: a randomized phase 3 study. Chest 150(4):789\u2013798. https:\/\/doi.org\/10.1016\/j.chest.2016.03.032","journal-title":"Chest"},{"issue":"6","key":"679_CR70","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s40265-021-01518-w","volume":"81","author":"HA Blair","year":"2021","unstructured":"Blair HA (2021) Indacaterol\/glycopyrronium\/mometasone: a review in asthma. Drugs 81(6):709\u2013719. https:\/\/doi.org\/10.1007\/s40265-021-01518-w","journal-title":"Drugs"},{"issue":"5","key":"679_CR71","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/j.jaci.2020.12.643","volume":"147","author":"CI Bloom","year":"2021","unstructured":"Bloom CI, Franklin C, Bush A, Saglani S, Quint JK (2021) Burden of preschool wheeze and progression to asthma in the UK: population-based cohort 2007 to 2017. J Allergy Clin Immunol 147(5):1949\u20131958. https:\/\/doi.org\/10.1016\/j.jaci.2020.12.643","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"679_CR72","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1136\/thx.51.11.1100","volume":"51","author":"H Booth","year":"1996","unstructured":"Booth H, Bish R, Walters J, Whitehead F, Walters EH (1996) Salmeterol tachyphylaxis in steroid treated asthmatic subjects. Thorax 51(11):1100\u20131104. https:\/\/doi.org\/10.1136\/thx.51.11.1100","journal-title":"Thorax"},{"issue":"12","key":"679_CR73","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/eurjhf\/hfp148","volume":"11","author":"LCM Boudestein","year":"2009","unstructured":"Boudestein LCM, Rutten FH, Cramer MJ, Lammers JWJ, Hoes AW (2009) The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail 11(12):1182\u20131188. https:\/\/doi.org\/10.1093\/eurjhf\/hfp148","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"679_CR74","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.bmcl.2009.12.087","volume":"20","author":"T Bouyssou","year":"2010","unstructured":"Bouyssou T, Hoenke C, Rudolf K, Lustenberger P, Pestel S, Sieger P, Lotz R, Heine C, B\u00fcttner FH, Schnapp A, Konetzki I (2010a) Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy. Bioorg Med Chem Lett 20(4):1410\u20131414. https:\/\/doi.org\/10.1016\/j.bmcl.2009.12.087","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"679_CR75","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1124\/jpet.110.167007","volume":"334","author":"T Bouyssou","year":"2010","unstructured":"Bouyssou T, Casarosa P, Naline E, Pestel S, Konetzki I, Devillier P, Schnapp A (2010b) Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models. J Pharmacol Exp Ther 334(1):53\u201362. https:\/\/doi.org\/10.1124\/jpet.110.167007","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"679_CR76","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1476-5381.1970.tb10334.x","volume":"38","author":"WC Bowman","year":"1970","unstructured":"Bowman WC, Nott MW (1970) Actions of some sympathomimetic bronchodilator and beta-adrenoceptor blocking drugs on contractions of the cat soleus muscle. Br J Pharmacol 38(1):37\u201349. https:\/\/doi.org\/10.1111\/j.1476-5381.1970.tb10334.x","journal-title":"Br J Pharmacol"},{"key":"679_CR77","doi-asserted-by":"publisher","first-page":"225S","DOI":"10.1111\/j.2042-7158.1971.tb08807.x","volume":"23","author":"WC Bowman","year":"1971","unstructured":"Bowman WC, Nott MW (1971) Muscle tremor produced by sympathomimetic bronchodilators. J Pharm Pharmacol 23:225S. https:\/\/doi.org\/10.1111\/j.2042-7158.1971.tb08807.x","journal-title":"J Pharm Pharmacol"},{"issue":"1\u20133","key":"679_CR78","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.resp.2008.05.010","volume":"163","author":"A Braiman","year":"2008","unstructured":"Braiman A, Priel Z (2008) Efficient mucociliary transport relies on efficient regulation of ciliary beating. Respir Physiol Neurobiol 163(1\u20133):202\u2013207. https:\/\/doi.org\/10.1016\/j.resp.2008.05.010","journal-title":"Respir Physiol Neurobiol"},{"issue":"5","key":"679_CR79","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/s0954-6111(06)80009-0","volume":"186","author":"P Bremner","year":"1992","unstructured":"Bremner P, Burgess C, Beasley R, Woodman K, Marshall S, Crane J, Pearce N (1992a) Nebulized fenoterol causes greater cardiovascular and hypokalaemic effects than equivalent bronchodilator doses of salbutamol in asthmatics. Respir Med 186(5):419\u2013423. https:\/\/doi.org\/10.1016\/s0954-6111(06)80009-0","journal-title":"Respir Med"},{"issue":"10","key":"679_CR80","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1136\/thx.47.10.814","volume":"47","author":"P Bremner","year":"1992","unstructured":"Bremner P, Burgess CD, Crane J, McHaffie D, Galletly D, Pearce N, Woodman K, Beasley R (1992b) Cardiovascular effects of fenoterol under conditions of hypoxaemia. Thorax 47(10):814\u2013817. https:\/\/doi.org\/10.1136\/thx.47.10.814","journal-title":"Thorax"},{"issue":"2","key":"679_CR81","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1183\/09031936.93.06020204","volume":"6","author":"P Bremner","year":"1993","unstructured":"Bremner P, Woodman K, Burgess C, Crane J, Purdie G, Pearce N, Beasley R (1993) A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol. Eur Respir J 6(2):204\u2013210","journal-title":"Eur Respir J"},{"issue":"4","key":"679_CR82","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1378\/chest.109.4.957","volume":"109","author":"P Bremner","year":"1996","unstructured":"Bremner P, Siebers R, Crane J, Beasley R, Burgess C (1996) Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol. Chest 109(4):957\u2013962. https:\/\/doi.org\/10.1378\/chest.109.4.957","journal-title":"Chest"},{"key":"679_CR83","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/01.RES.59.3.297","volume":"59","author":"MR Bristow","year":"1986","unstructured":"Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB (1986) \u03b21- and \u03b2 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective \u03b2 1-receptor down-regulation in heart failure. Circ Res 59:297\u2013309","journal-title":"Circ Res"},{"issue":"5156","key":"679_CR84","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/219862a0","volume":"219","author":"RT Brittain","year":"1968","unstructured":"Brittain RT, Farmer JB, Jack D, Martin LE, Simpson WT (1968) Alpha-[(t-butylamino)methyl]-4-hydroxy-m-xylene-alpha 1,alpha 3-diol (AH.3365): a selective beta-adrenergic stimulant. Nature 219(5156):862\u2013863. https:\/\/doi.org\/10.1038\/219862a0","journal-title":"Nature"},{"issue":"3","key":"679_CR85","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0306-039x(76)90001-5","volume":"2","author":"RT Brittain","year":"1976","unstructured":"Brittain RT, Dean CM, Jack D (1976) Sympathomimetic bronchodilator drugs. Pharmacol Ther B 2(3):423\u2013462. https:\/\/doi.org\/10.1016\/0306-039x(76)90001-5","journal-title":"Pharmacol Ther B"},{"issue":"6","key":"679_CR86","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s12325-021-02025-w","volume":"39","author":"D Brittain","year":"2022","unstructured":"Brittain D, D\u2019Andrea P, Gruen E, Hosoe M, Jain D, Jauernig J, Pethe A, Scosyrev E, Tanase AM, Tillmann HC (2022) A review of the unique drug development strategy of indacaterol acetate\/glycopyrronium bromide\/mometasone furoate: a first-in-class, once-daily, single-inhaler, fixed-dose combination treatment for asthma. Adv Ther 39(6):2365\u20132378. https:\/\/doi.org\/10.1007\/s12325-021-02025-w","journal-title":"Adv Ther"},{"issue":"5800","key":"679_CR87","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1136\/bmj.1.5800.585","volume":"1","author":"HM Brown","year":"1972","unstructured":"Brown HM, Storey G, George WH (1972) Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma. Br Med J 1(5800):585\u2013590. https:\/\/doi.org\/10.1136\/bmj.1.5800.585","journal-title":"Br Med J"},{"key":"679_CR88","first-page":"787","volume":"83","author":"J Bullowa","year":"1903","unstructured":"Bullowa J, Kaplan D (1903) Treatment of asthmatic attacks: on the hypodermatic use of adrenalin chloride in the treatment of asthmatic attacks. Med News 83:787\u2013790","journal-title":"Med News"},{"issue":"1","key":"679_CR89","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1002\/cpt197824184","volume":"24","author":"NK Burki","year":"1978","unstructured":"Burki NK, Diamond L (1978) Long-term oral bronchodilator therapy of asthma with pirbuterol. Clin Pharmacol Ther 24(1):84\u201389. https:\/\/doi.org\/10.1002\/cpt197824184","journal-title":"Clin Pharmacol Ther"},{"key":"679_CR90","first-page":"385","volume-title":"Adrenalin: a short account of its therapeutic applications","author":"J Burnett","year":"1903","unstructured":"Burnett J (1903) Adrenalin: a short account of its therapeutic applications. The Medical Times and Hopsital Gazette. 20th June, pp 385\u2013387"},{"issue":"8353","key":"679_CR91","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/s0140-6736(83)92335-8","volume":"2","author":"C Bushe","year":"1983","unstructured":"Bushe C (1983) Salbutamol for hyperkalaemia. Lancet 2(8353):797. https:\/\/doi.org\/10.1016\/s0140-6736(83)92335-8","journal-title":"Lancet"},{"issue":"3","key":"679_CR92","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1476-5381.1991.tb12487.x","volume":"104","author":"PR Butchers","year":"1991","unstructured":"Butchers PR, Vardey CJ, Johnson M (1991) Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 104(3):672\u2013676. https:\/\/doi.org\/10.1111\/j.1476-5381.1991.tb12487.x","journal-title":"Br J Pharmacol"},{"key":"679_CR93","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1476-5381.1987.tb11324.x","volume":"92","author":"BF Buxton","year":"1987","unstructured":"Buxton BF, Jones CR, Molenaar P, Summers RJ (1987) Characterization and autoradiographic localization of \u03b2-beta-adrenoceptor subtypes in human cardiac tissues. Br J Pharmacol 92:299\u2013310","journal-title":"Br J Pharmacol"},{"issue":"6","key":"679_CR94","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1016\/j.jaci.2021.03.035","volume":"147","author":"B Camoretti-Mercado","year":"2021","unstructured":"Camoretti-Mercado B, Lockey RF (2021) Airway smooth muscle pathophysiology in asthma. J Allergy Clin Immunol 147(6):1983\u20131995. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.035","journal-title":"J Allergy Clin Immunol"},{"key":"679_CR95","first-page":"496","volume":"79","author":"PWL Camps","year":"1929","unstructured":"Camps PWL (1929) A note on the inhalations treatment of asthma. Guy\u2019s Hospital Rep 79:496\u2013498","journal-title":"Guy\u2019s Hospital Rep"},{"issue":"6884","key":"679_CR96","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1136\/bmj.306.6884.1034","volume":"306","author":"W Castle","year":"1993","unstructured":"Castle W, Fuller R, Hall J, Palmer J (1993) Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 306(6884):1034\u20131037. https:\/\/doi.org\/10.1136\/bmj.306.6884.1034","journal-title":"BMJ"},{"issue":"26","key":"679_CR97","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","volume":"378","author":"M Castro","year":"2018","unstructured":"Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A (2018) Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma. N Engl J Med 378(26):2486\u20132496. https:\/\/doi.org\/10.1056\/NEJMoa1804092","journal-title":"N Engl J Med"},{"key":"679_CR98","doi-asserted-by":"publisher","first-page":"CD006363","DOI":"10.1002\/14651858.CD006363.pub2","volume":"3","author":"CJ Cates","year":"2008","unstructured":"Cates CJ, Cates MJ (2008) Regular treatment with salmeterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev 3:CD006363. https:\/\/doi.org\/10.1002\/14651858.CD006363.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"679_CR99","doi-asserted-by":"publisher","first-page":"CD006923","DOI":"10.1002\/14651858.CD006923.pub2","volume":"8","author":"CJ Cates","year":"2008","unstructured":"Cates CJ, Cates MJ, Lasserson TJ (2008) Regular treatment with formoterol for chronic asthma: serious adverse events. Cochrane Database Syst Rev 8(4):CD006923. https:\/\/doi.org\/10.1002\/14651858.CD006923.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"679_CR100","doi-asserted-by":"publisher","first-page":"CD006922","DOI":"10.1002\/14651858.CD006922.pub4","volume":"12","author":"CJ Cates","year":"2018","unstructured":"Cates CJ, Schmidt S, Ferrer M, Sayer B, Waterson S (2018) Inhaled steroids with and without regular salmeterol for asthma: serious adverse events. Cochrane Database Syst Rev 12(12):CD006922. https:\/\/doi.org\/10.1002\/14651858.CD006922.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"679_CR101","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s002280050561","volume":"54","author":"M Cazzola","year":"1999","unstructured":"Cazzola M, Calderaro F, Califano C, Di Pema F, Vinciguerra A, Donner CF, Matera MG (1999) Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease. Eur J Clin Pharmacol 54(11):829\u2013833. https:\/\/doi.org\/10.1007\/s002280050561","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"679_CR102","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.2165\/00003495-200565120-00001","volume":"65","author":"M Cazzola","year":"2005","unstructured":"Cazzola M, Matera MG, Donner CF (2005) Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease. Drugs 65(12):1595\u20131610. https:\/\/doi.org\/10.2165\/00003495-200565120-00001","journal-title":"Drugs"},{"key":"679_CR103","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.rmed.2019.08.005","volume":"156","author":"M Cazzola","year":"2019","unstructured":"Cazzola M, Rogliani P, Matera MG (2019) Ultra-LABAs for the treatment of asthma. Respir Med 156:47\u201352. https:\/\/doi.org\/10.1016\/j.rmed.2019.08.005","journal-title":"Respir Med"},{"key":"679_CR104","doi-asserted-by":"publisher","unstructured":"Cazzola M, Matera MG, Rogliani P, Calzetta L (2021) Comparative studies of dual bronchodilation in COPD. Monaldi Arch Chest Dis 91(1). https:\/\/doi.org\/10.4081\/monaldi.2021.1625","DOI":"10.4081\/monaldi.2021.1625"},{"issue":"3","key":"679_CR105","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1476-5381.1968.tb00504.x","volume":"33","author":"LA Chahl","year":"1968","unstructured":"Chahl LA, O\u2019Donnell SR (1968) The actions of orciprenaline and protokylol on guinea-pig trachea. Br J Pharmacol Chemother 33(3):552\u2013559. https:\/\/doi.org\/10.1111\/j.1476-5381.1968.tb00504.x","journal-title":"Br J Pharmacol Chemother"},{"issue":"1","key":"679_CR106","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/thoraxjnl-2020-215664","volume":"76","author":"CV Chalitsios","year":"2021","unstructured":"Chalitsios CV, Shaw DE, McKeever TM (2021) Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies. Thorax 76(1):21\u201328. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215664","journal-title":"Thorax"},{"issue":"Suppl","key":"679_CR107","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/BF02718133","volume":"168","author":"D Charpin","year":"1990","unstructured":"Charpin D (1990) Acute and long-term effectiveness of tulobuterol inhaler, a new beta 2-agonist, in the treatment of asthma. Lung 168(Suppl):194\u2013201. https:\/\/doi.org\/10.1007\/BF02718133","journal-title":"Lung"},{"issue":"5","key":"679_CR108","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S2213-2600(20)30408-2","volume":"9","author":"R Chaudhuri","year":"2021","unstructured":"Chaudhuri R, Rubin A, Sumino K, Lapa E, Silva JR, Niven R, Siddiqui S, Klooster K, McEvoy C, Shah PL, Simoff M, Khatri S, Barbers R, Mark Grubb G, McMullen EA, Olson JL, Laviolette M, BT10+ Study Group (2021) Safety and effectiveness of bronchial thermoplasty after 10 years in patients with persistent asthma (BT10+): a follow-up of three randomised controlled trials. Lancet Respir Med 9(5):457\u2013466. https:\/\/doi.org\/10.1016\/S2213-2600(20)30408-2","journal-title":"Lancet Respir Med"},{"issue":"4","key":"679_CR109","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000195423","volume":"53","author":"A Chetta","year":"1988","unstructured":"Chetta A, Garavaldi G, Cuomo A, Gurrieri G, Olivieri D (1988) Early bronchodilating effect of a new oral beta-2-receptor agonist (broxaterol) in bronchial asthma. Respiration 53(4):220\u2013224. https:\/\/doi.org\/10.1159\/000195423","journal-title":"Respiration"},{"issue":"17","key":"679_CR110","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJM199210223271703","volume":"327","author":"D Cheung","year":"1992","unstructured":"Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ (1992) Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med 327(17):1198\u20131203. https:\/\/doi.org\/10.1056\/NEJM199210223271703","journal-title":"N Engl J Med"},{"issue":"6","key":"679_CR111","first-page":"440","volume":"41","author":"D Chiarino","year":"1986","unstructured":"Chiarino D, Fantucci M, Carenzi A, Della Bella D, Frigeni V, Sala R (1986) New isoxazole derivatives with a potent and selective beta 2-adrenergic activity. Farmaco Sci 41(6):440\u2013453","journal-title":"Farmaco Sci"},{"issue":"5","key":"679_CR112","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.japh.2020.02.010","volume":"60","author":"B Chongmelaxme","year":"2020","unstructured":"Chongmelaxme B, Chaiyakunapruk N, Dilokthornsakul P (2020) Association between adherence and severe asthma exacerbation: a systematic review and meta-analysis. J Am Pharm Assoc 60(5):669\u2013685.e2","journal-title":"J Am Pharm Assoc"},{"issue":"5652","key":"679_CR113","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/bmj.2.5652.287","volume":"2","author":"YF Choo-Kang","year":"1969","unstructured":"Choo-Kang YF, Simpson WT, Grant IW (1969) Controlled comparison of the bronchodilator effects of three beta-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br Med J 2(5652):287\u2013289. https:\/\/doi.org\/10.1136\/bmj.2.5652.287","journal-title":"Br Med J"},{"issue":"11","key":"679_CR114","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1164\/rccm.200502-257OE","volume":"171","author":"EK Chu","year":"2005","unstructured":"Chu EK, Drazen JM (2005) Asthma: one hundred years of treatment and onward. Am J Respir Crit Care Med 171(11):1202\u20131208. https:\/\/doi.org\/10.1164\/rccm.200502-257OE","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"679_CR115","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.rmed.2007.06.002","volume":"101","author":"AG Chuchalin","year":"2007","unstructured":"Chuchalin AG, Tsoi AN, Richter K, Krug N, Dahl R, Luursema PB, Cameron R, Bao W, Higgins M, Woessner R, van As A (2007) Safety and tolerability of indacaterol in asthma: a randomized, placebo-controlled 28-day study. Respir Med 101(10):2065\u20132075. https:\/\/doi.org\/10.1016\/j.rmed.2007.06.002. Epub 2007 Jul 20","journal-title":"Respir Med"},{"issue":"2","key":"679_CR116","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1183\/09031936.00202013","volume":"43","author":"KF Chung","year":"2014","unstructured":"Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, Adcock IM, Bateman ED, Bel EH, Bleecker ER, Boulet LP, Brightling C, Chanez P, Dahlen SE, Djukanovic R, Frey U, Gaga M, Gibson P, Hamid Q, Jajour NN, Mauad T, Sorkness RL, Teague WG (2014) International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 43(2):343\u2013373. https:\/\/doi.org\/10.1183\/09031936.00202013","journal-title":"Eur Respir J"},{"issue":"1","key":"679_CR117","first-page":"182","volume":"49","author":"RB Clark","year":"1996","unstructured":"Clark RB, Allal C, Friedman J, Johnson M, Barber R (1996) Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite. Mol Pharmacol 49(1):182\u2013189","journal-title":"Mol Pharmacol"},{"key":"679_CR118","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0165-6147(97)01138-3","volume":"19","author":"WP Clarke","year":"1998","unstructured":"Clarke WP, Bond RA (1998) The elusive nature of intrinsic efficacy. Trends Pharmacol Sci 19:270\u2013276","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"679_CR119","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/009127009903900302","volume":"39","author":"DW Cockcroft","year":"1999","unstructured":"Cockcroft DW (1999) Pharmacologic therapy for asthma: overview and historical perspective. J Clin Pharmacol 39(3):216\u2013222","journal-title":"J Clin Pharmacol"},{"issue":"8875","key":"679_CR120","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0140-6736(93)92695-p","volume":"342","author":"DW Cockcroft","year":"1993","unstructured":"Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC (1993) Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342(8875):833\u2013837. https:\/\/doi.org\/10.1016\/0140-6736(93)92695-p","journal-title":"Lancet"},{"issue":"6 Suppl","key":"679_CR121","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1378\/chest.73.6_supplement.992","volume":"73","author":"BM Cohen","year":"1978","unstructured":"Cohen BM (1978) Comparison of the broncholytic and cardiovascular responses of asthmatic patients to aerosol dose of isoproterenol and fenoterol. Chest 73(6 Suppl):992\u2013993. https:\/\/doi.org\/10.1378\/chest.73.6_supplement.992","journal-title":"Chest"},{"issue":"3","key":"679_CR122","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0014-2999(77)90338-7","volume":"46","author":"DF Colella","year":"1977","unstructured":"Colella DF, Chakrin LW, Shetzline A, Wardell JR Jr (1977) Characterization of the adrenergic activity of carbuterol (SK&F 40383-A). Eur J Pharmacol 46(3):229\u2013241. https:\/\/doi.org\/10.1016\/0014-2999(77)90338-7","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"679_CR123","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2125.1980.tb04837.x","volume":"9","author":"JG Collier","year":"1980","unstructured":"Collier JG, Dobbs RJ, Williams I (1980) Salbutamol aerosol causes a tachycardia due to the inhaled rather than the swallowed fraction. Br J Clin Pharmacol 9(3):273\u2013274. https:\/\/doi.org\/10.1111\/j.1365-2125.1980.tb04837.x","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"679_CR124","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1476-5381.1969.tb08301.x","volume":"36","author":"JM Collins","year":"1969","unstructured":"Collins JM, McDevitt DG, Shanks RG, Swanton JG (1969) The cardio-toxicity of isoprenaline during hypoxia. Br J Pharmacol 36(1):35\u201345. https:\/\/doi.org\/10.1111\/j.1476-5381.1969.tb08301.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"679_CR125","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1476-5381.1971.tb08070.x","volume":"43","author":"ME Conolly","year":"1971","unstructured":"Conolly ME, Davies DS, Dollery CT, George CF (1971) Resistance to \u03b2-adrenoceptor stimulants (a possible explanation for the rise in ashtma deaths). Br J Pharmacol 43(2):389\u2013402","journal-title":"Br J Pharmacol"},{"issue":"2","key":"679_CR126","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/s0196-0644(94)70146-6","volume":"24","author":"P Cook","year":"1994","unstructured":"Cook P, Scarfone RJ, Cook RT (1994) Adenosine in the termination of albuterol-induced supraventricular tachycardia. Ann Emerg Med 24(2):316\u2013319. https:\/\/doi.org\/10.1016\/s0196-0644(94)70146-6","journal-title":"Ann Emerg Med"},{"issue":"10","key":"679_CR127","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1056\/NEJMoa1704064","volume":"377","author":"J Corren","year":"2017","unstructured":"Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, van der Merwe R (2017) Tezepelumab in adults with uncontrolled asthma. N Engl J Med 377(10):936\u2013946. https:\/\/doi.org\/10.1056\/NEJMoa1704064","journal-title":"N Engl J Med"},{"issue":"6","key":"679_CR128","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/all.15197","volume":"77","author":"J Corren","year":"2022","unstructured":"Corren J, Pham TH, Garcia Gil E, Sa\u0142apa K, Ren P, Parnes JR, Colice G, Griffiths JM (2022) Baseline type 2 biomarker levels and response to tezepelumab in severe asthma. Allergy 77(6):1786\u20131796. https:\/\/doi.org\/10.1111\/all.15197","journal-title":"Allergy"},{"issue":"1","key":"679_CR129","doi-asserted-by":"publisher","first-page":"00570","DOI":"10.1183\/23120541.00570-2021","volume":"8","author":"S Couillard","year":"2021","unstructured":"Couillard S, Do WIH, Beasley R, Hinks TSC, Pavord ID (2021) Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE). ERJ Open Res 8(1):00570\u201302021. https:\/\/doi.org\/10.1183\/23120541.00570-2021","journal-title":"ERJ Open Res"},{"issue":"8644","key":"679_CR130","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/s0140-6736(89)92505-1","volume":"1","author":"J Crane","year":"1989","unstructured":"Crane J, Pearce N, Flatt A, Burgess C, Jackson R, Kwong T, Ball M, Beasley R (1989a) Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study. Lancet 1(8644):917\u2013922. https:\/\/doi.org\/10.1016\/s0140-6736(89)92505-1","journal-title":"Lancet"},{"issue":"2","key":"679_CR131","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/thx.44.2.136","volume":"44","author":"J Crane","year":"1989","unstructured":"Crane J, Burgess C, Beasley R (1989b) Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax 44(2):136\u2013140. https:\/\/doi.org\/10.1136\/thx.44.2.136","journal-title":"Thorax"},{"issue":"6","key":"679_CR132","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.pcrj.2006.09.002","volume":"15","author":"G Crompton","year":"2006","unstructured":"Crompton G (2006) A brief history of inhaled asthma therapy over the last fifty years. Prim Care Respir J 15(6):326\u2013331. https:\/\/doi.org\/10.1016\/j.pcrj.2006.09.002","journal-title":"Prim Care Respir J"},{"issue":"3","key":"679_CR133","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1164\/ajrccm.159.3.9806117","volume":"159","author":"GK Crompton","year":"1999","unstructured":"Crompton GK, Ayres JG, Basran G, Schiraldi G, Brusasco V, Eivindson A, Jamieson AH, Olsson H (1999) Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids. Am J Respir Crit Care Med 159(3):824\u2013828. https:\/\/doi.org\/10.1164\/ajrccm.159.3.9806117","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"679_CR134","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1365-2125.1985.tb02715.x","volume":"19","author":"MJ Crowe","year":"1985","unstructured":"Crowe MJ, Counihan HE, O'Malley K (1985) A comparative study of a new selective beta 2-adrenoceptor agonist, procaterol and salbutamol in asthma. Br J Clin Pharmacol 19(6):787\u2013791. https:\/\/doi.org\/10.1111\/j.1365-2125.1985.tb02715.x","journal-title":"Br J Clin Pharmacol"},{"key":"679_CR135","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijcard.2007.01.069","volume":"120","author":"JM Cruickshank","year":"2007","unstructured":"Cruickshank JM (2007) Are we misunderstanding beta-blockers. Int J Cardiol 120:10\u201327. https:\/\/doi.org\/10.1016\/j.ijcard.2007.01.069","journal-title":"Int J Cardiol"},{"issue":"10","key":"679_CR136","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1016\/j.jaip.2020.06.031","volume":"8","author":"P Cullinan","year":"2020","unstructured":"Cullinan P, Vandenplas O, Bernstein D (2020) Assessment and management of occupational asthma. J Allergy Clin Immunol Pract 8(10):3264\u20133275. https:\/\/doi.org\/10.1016\/j.jaip.2020.06.031","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"679_CR137","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1476-5381.1969.tb07975.x","volume":"35","author":"VA Cullum","year":"1969","unstructured":"Cullum VA, Farmer JB, Jack D, Levy GP (1969) Salbutamol: a new, selective beta-adrenoceptive receptor stimulant. Br J Pharmacol 35(1):141\u2013151. https:\/\/doi.org\/10.1111\/j.1476-5381.1969.tb07975.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"679_CR138","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1113\/jphysiol.1934.sp003190","volume":"82","author":"JL D\u2019Silva","year":"1934","unstructured":"D\u2019Silva JL (1934) The action of adrenaline on serum potassium. J Physiol 82(4):393\u2013398. https:\/\/doi.org\/10.1113\/jphysiol.1934.sp003190","journal-title":"J Physiol"},{"issue":"12","key":"679_CR139","doi-asserted-by":"publisher","first-page":"588","DOI":"10.5694\/j.1326-5377.1973.tb129672.x","volume":"2","author":"JL Da Costa","year":"1973","unstructured":"Da Costa JL, Goh BK (1973) A comparative trial of subcutaneous terbutaline, Th1165a and adrenaline in bronchial asthma. Med J Aust 2(12):588\u2013591. https:\/\/doi.org\/10.5694\/j.1326-5377.1973.tb129672.x","journal-title":"Med J Aust"},{"issue":"7","key":"679_CR140","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1398-9995.1985.tb00257.x","volume":"40","author":"R Dahl","year":"1985","unstructured":"Dahl R, Harving H, Henriksen J, R\u00f8nne K, Sch\u00f8ler P (1985) Procaterol and terbutaline in bronchial asthma. A double-blind, placebo-controlled, cross-over study. Allergy 40(7):501\u2013505. https:\/\/doi.org\/10.1111\/j.1398-9995.1985.tb00257.x","journal-title":"Allergy"},{"key":"679_CR141","first-page":"491","volume":"76","author":"HD Dakin","year":"1905","unstructured":"Dakin HD (1905) The synthesis of a substance allied to adrenalin. Proc R Soc Med 76:491\u2013497","journal-title":"Proc R Soc Med"},{"issue":"3","key":"679_CR142","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1113\/jphysiol.1906.sp001148","volume":"34","author":"HH Dale","year":"1906","unstructured":"Dale HH (1906) On some physiological actions of ergot. J Physiol 34(3):163\u2013206. https:\/\/doi.org\/10.1113\/jphysiol.1906.sp001148","journal-title":"J Physiol"},{"issue":"2","key":"679_CR143","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1378\/chest.107.2.406","volume":"107","author":"GE D'Alonzo","year":"1995","unstructured":"D'Alonzo GE, Smolensky MH, Feldman S, Gnosspelius Y, Karlsson K (1995) Bambuterol in the treatment of asthma. A placebo-controlled comparison of once-daily morning vs evening administration. Chest 107(2):406\u2013412. https:\/\/doi.org\/10.1378\/chest.107.2.406","journal-title":"Chest"},{"issue":"5","key":"679_CR144","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1365-2125.1980.tb01782.x","volume":"10","author":"C Davis","year":"1980","unstructured":"Davis C, Conolly ME (1980) Tachyphylaxis to beta-adrenoceptor agonists in human bronchial smooth muscle: studies in vitro. Br J Clin Pharmacol 10(5):417\u2013423. https:\/\/doi.org\/10.1111\/j.1365-2125.1980.tb01782.x","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"679_CR145","first-page":"403","volume":"6","author":"G De Candussio","year":"1986","unstructured":"De Candussio G, Franchi D, Manini G, Arossa W, Castello D (1986) Duration of oral procaterol protection from methacholine-induced bronchial obstruction. Int J Clin Pharmacol Res 6(5):403\u2013407","journal-title":"Int J Clin Pharmacol Res"},{"issue":"12","key":"679_CR146","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/0006-2952(83)90046-1","volume":"32","author":"M Delhaye","year":"1983","unstructured":"Delhaye M, Taton G, Camus JC, Chatelain P, Robberecht P, Waelbroeck M, Christophe J (1983) Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase. Biochem Pharmacol 32(12):1831\u20131835. https:\/\/doi.org\/10.1016\/0006-2952(83)90046-1","journal-title":"Biochem Pharmacol"},{"key":"679_CR147","unstructured":"Department of Health (UK) (2011) An outcomes strategy for chronic obstructive pulmonary disease (COPD) and asthma in England"},{"issue":"4","key":"679_CR148","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0952-0600(92)90068-r","volume":"5","author":"JL Devalia","year":"1992","unstructured":"Devalia JL, Sapsford RJ, Rusznak C, Toumbis MJ, Davies RJ (1992) The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro. Pulm Pharmacol 5(4):257\u2013263. https:\/\/doi.org\/10.1016\/0952-0600(92)90068-r","journal-title":"Pulm Pharmacol"},{"issue":"3","key":"679_CR149","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.rmed.2006.12.004","volume":"101","author":"Z Diamant","year":"2007","unstructured":"Diamant Z, Boot JD, Virchow JC (2007) Summing up 100 years of asthma. Respir Med 101(3):378\u2013388. https:\/\/doi.org\/10.1016\/j.rmed.2006.12.004","journal-title":"Respir Med"},{"issue":"12","key":"679_CR150","first-page":"66","volume":"27","author":"M Diewitz","year":"1977","unstructured":"Diewitz M (1977) The influence of the broncholytic reproterol in persons with bradycardic arrhythmia upon impulse and conduction as well as irritability of the human ventricle. Arzneimittelforschung 27(12):66\u201372","journal-title":"Arzneimittelforschung"},{"issue":"11\u201312","key":"679_CR151","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1002\/j.1552-4604.1977.tb01549.x","volume":"17","author":"DH Drachler","year":"1977","unstructured":"Drachler DH, Bower JS, Miller DA, Rotman HH (1977) Long-term evaluation of a new aerosol bronchodilator, carbuterol, and comparison with isoproterenol. J Clin Pharmacol 17(11\u201312):734\u2013739. https:\/\/doi.org\/10.1002\/j.1552-4604.1977.tb01549.x","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"679_CR152","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s40733-021-00078-w","volume":"7","author":"S Dragonieri","year":"2021","unstructured":"Dragonieri S, Carpagnano GE (2021) Biological therapy for severe asthma. Asthma Res Pract 7(1):12. https:\/\/doi.org\/10.1186\/s40733-021-00078-w","journal-title":"Asthma Res Pract"},{"issue":"12","key":"679_CR153","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1056\/NEJM199609193351202","volume":"335","author":"JM Drazen","year":"1996","unstructured":"Drazen JM, Israel E, Boushey HA, Chinchilli VM, Fahy JV, Fish JE, Lazarus SC, Lemanske RF, Martin RJ, Peters SP, Sorkness C, Szefler SJ (1996) Comparison of regularly scheduled with as-needed use of albuterol in mild asthma. Asthma Clinical Research Network. N Engl J Med 335(12):841\u2013847. https:\/\/doi.org\/10.1056\/NEJM199609193351202","journal-title":"N Engl J Med"},{"issue":"1","key":"679_CR154","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2010.11.032","volume":"127","author":"SR Durham","year":"2010","unstructured":"Durham SR, Leung DY (2010) One hundred years of allergen immunotherapy: time to ring the changes. J Allergy Clin Immunol 127(1):3\u20137. https:\/\/doi.org\/10.1016\/j.jaci.2010.11.032","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"679_CR155","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/0007-0971(80)90010-8","volume":"74","author":"AJ Dyson","year":"1980","unstructured":"Dyson AJ, Mackay AD (1980) Two oral beta-adrenergic stimulant drugs, pirbuterol and salbutamol, in reversible airway obstruction. Br J Dis Chest 74(1):70\u201377","journal-title":"Br J Dis Chest"},{"issue":"5","key":"679_CR156","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1111\/j.1476-5381.1995.tb15103.x","volume":"116","author":"KE Ellis","year":"1995","unstructured":"Ellis KE, Mistry R, Boyle JP, Challiss RA (1995) Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutamol in bovine tracheal smooth muscle. Br J Pharmacol 116(5):2510\u20132516. https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb15103.x","journal-title":"Br J Pharmacol"},{"issue":"4","key":"679_CR157","first-page":"229","volume":"43","author":"TJ Ence","year":"1979","unstructured":"Ence TJ, Tashkin DP, Ho D, Child JS (1979) Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol. Ann Allergy 43(4):229\u2013236","journal-title":"Ann Allergy"},{"key":"679_CR158","first-page":"869","volume":"22","author":"G Engelhardt","year":"1972","unstructured":"Engelhardt G (1972) Structure-activity studies in a series of new amino-halogen substituted phenyl-aminoethanoles. Arzneimittel-Forsch 22:869\u2013876","journal-title":"Arzneimittel-Forsch"},{"issue":"7a","key":"679_CR159","first-page":"1404","volume":"26","author":"G Engelhardt","year":"1976","unstructured":"Engelhardt G (1976) Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors. Arzneimittelforschung 26(7a):1404\u20131420","journal-title":"Arzneimittelforschung"},{"issue":"11A","key":"679_CR160","first-page":"1625","volume":"34","author":"G Engelhardt","year":"1984","unstructured":"Engelhardt G (1984) Structure-activity relationships in further series of amino-halogen substituted phenyl-aminoethanols. Arzneimittelforschung 34(11A):1625\u20131632","journal-title":"Arzneimittelforschung"},{"key":"679_CR161","first-page":"521","volume":"11","author":"A Engelhardt","year":"1961","unstructured":"Engelhardt A, Hoefke W, Wick H (1961) Zur pharmakologie des sympathomimeticums 1-(3,5-dihydroxyphenyl)-l-hydroxy-2-isopropylaminoathan. Arzneimittel-Forsch 11:521\u2013525","journal-title":"Arzneimittel-Forsch"},{"key":"679_CR162","doi-asserted-by":"publisher","unstructured":"Enilari O, Sinha S (2019) The global impact of asthma in adult populations. Ann Glob Health 85(1). https:\/\/doi.org\/10.5334\/aogh.2412","DOI":"10.5334\/aogh.2412"},{"issue":"1","key":"679_CR163","first-page":"30","volume":"59","author":"NE Eriksson","year":"1978","unstructured":"Eriksson NE, Lindgren SB (1978) The rapidity of bronchodilatation. A comparison of isoprenaline, terbutaline and rimiterol. Scand. J Respir Dis 59(1):30\u201336","journal-title":"J Respir Dis"},{"issue":"3","key":"679_CR164","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archinte.1987.00370030147029","volume":"147","author":"JM Esdaile","year":"1987","unstructured":"Esdaile JM, Feinstein AR, Horwitz RI (1987) A reappraisal of the United Kingdom epidemic of fatal asthma. Can general mortality data implicate a therapeutic agent? Arch Intern Med 147(3):543\u2013549","journal-title":"Arch Intern Med"},{"issue":"5545","key":"679_CR165","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1136\/bmj.2.5545.178","volume":"2","author":"PD Exon","year":"1967","unstructured":"Exon PD (1967) Pressurized aerosols in asthma. Br Med J 2(5545):178. https:\/\/doi.org\/10.1136\/bmj.2.5545.178","journal-title":"Br Med J"},{"issue":"1","key":"679_CR166","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2165\/00003495-199142010-00007","volume":"42","author":"D Faulds","year":"1991","unstructured":"Faulds D, Hollingshead LM, Goa KL (1991) Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs 42(1):115\u2013137. https:\/\/doi.org\/10.2165\/00003495-199142010-00007","journal-title":"Drugs"},{"issue":"11","key":"679_CR167","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1136\/thx.2009.128082","volume":"65","author":"JR Feary","year":"2010","unstructured":"Feary JR, Rodrigues LC, Smith CJ, Hubbard RB, Gibson JE (2010) Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 65(11):956\u2013962. https:\/\/doi.org\/10.1136\/thx.2009.128082","journal-title":"Thorax"},{"issue":"6","key":"679_CR168","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1007\/s12325-020-01311-3","volume":"37","author":"GT Ferguson","year":"2020","unstructured":"Ferguson GT, Darken P, Ballal S, Siddiqui MK, Singh B, Attri S, Holmgren U, de Nigris E (2020) Efficacy of budesonide\/glycopyrronium\/formoterol fumarate metered dose inhaler (BGF MDI) versus other inhaled corticosteroid\/long-acting muscarinic antagonist\/long-acting \u03b22-Agonist (ICS\/LAMA\/LABA) triple combinations in COPD: a systematic literature review and network meta-analysis. Adv Ther 37(6):2956\u20132975. https:\/\/doi.org\/10.1007\/s12325-020-01311-3","journal-title":"Adv Ther"},{"key":"679_CR169","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/3527608001","volume-title":"Analogue-based drug discovery","author":"J Fischer","year":"2006","unstructured":"Fischer J, Ganellin CR (2006) Analogue-based drug discovery. Wiley, pp 542\u2013543. ISBN 9783527607495"},{"key":"679_CR170","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1183\/20734735.004116","volume":"12","author":"K Fitch","year":"2016","unstructured":"Fitch K (2016) The world anti-doping code: can you have asthma and still be an elite athlete? Breathe 12:148\u2013158","journal-title":"Breathe"},{"issue":"10210","key":"679_CR171","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/S0140-6736(19)32216-0","volume":"394","author":"JM FitzGerald","year":"2019","unstructured":"FitzGerald JM, Sadatsafavi M (2019) Triple therapy in a single inhaler: a new option for uncontrolled asthma. Lancet 394(10210):1690\u20131692. https:\/\/doi.org\/10.1016\/S0140-6736(19)32216-0","journal-title":"Lancet"},{"issue":"1","key":"679_CR172","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","volume":"6","author":"JM FitzGerald","year":"2018","unstructured":"FitzGerald JM, Bleecker ER, Menzies-Gow A, Zangrilli JG, Hirsch I, Metcalfe P, Newbold P, Goldman M (2018) Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies. Lancet Respir Med 6(1):51\u201364. https:\/\/doi.org\/10.1016\/S2213-2600(17)30344-2. Epub 2017 Sep 11","journal-title":"Lancet Respir Med"},{"issue":"1","key":"679_CR173","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1378\/chest.75.1.8","volume":"75","author":"MR Flick","year":"1979","unstructured":"Flick MR, Block AJ (1979) Nocturnal vs diurnal cardiac arrhythmias in patients with chronic obstructive pulmonary disease. Chest 75(1):8\u201311. https:\/\/doi.org\/10.1378\/chest.75.1.8","journal-title":"Chest"},{"issue":"11","key":"679_CR174","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","volume":"176","author":"P Flood-Page","year":"2007","unstructured":"Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC, International Mepolizumab Study Group (2007) A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma. Am J Respir Crit Care Med 176(11):1062\u20131071. https:\/\/doi.org\/10.1164\/rccm.200701-085OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"679_CR175","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2125.1991.tb05561.x","volume":"31","author":"RW Foster","year":"1991","unstructured":"Foster RW, Atanga GK, Carpenter JR, Evans DE, Rakshi K, Small RC (1991) A method for bioassay of potency and effectiveness of inhaled bronchodilators in normal subjects. Br J Clin Pharmacol 31(4):445\u2013455. https:\/\/doi.org\/10.1111\/j.1365-2125.1991.tb05561.x","journal-title":"Br J Clin Pharmacol"},{"key":"679_CR176","first-page":"63","volume":"72","author":"S Fr\u00e4nkel","year":"1897","unstructured":"Fr\u00e4nkel S (1897) Physiological action of the suprarenal capsules. J Chem Soc 72:63\u201364. Abstracts. From Wien Med Bl\u00e4tter 1896;14, 15, 16","journal-title":"J Chem Soc"},{"key":"679_CR177","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1080\/00325481.1956.11691366","volume":"20","author":"T Freedman","year":"1956","unstructured":"Freedman T (1956) Medihaler therapy for bronchial asthma. Postgrad Med 20:667\u2013673","journal-title":"Postgrad Med"},{"issue":"1","key":"679_CR178","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2165\/00003495-198835010-00002","volume":"35","author":"HA Friedel","year":"1988","unstructured":"Friedel HA, Brogden RN (1988) Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease. Drugs 35(1):22\u201341. https:\/\/doi.org\/10.2165\/00003495-198835010-00002","journal-title":"Drugs"},{"issue":"7","key":"679_CR179","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/02770900600758432","volume":"43","author":"K Fujimoto","year":"2006","unstructured":"Fujimoto K, Komatsu Y, Yasuo M, Urushihata K, Kubo K (2006) Comparison of the clinical efficacy of salmeterol and sustained-release tulobuterol (patch) on inadequately controlled asthma patients on inhaled corticosteroids. J Asthma 43(7):501\u2013507. https:\/\/doi.org\/10.1080\/02770900600758432","journal-title":"J Asthma"},{"issue":"6","key":"679_CR180","doi-asserted-by":"publisher","first-page":"447","DOI":"10.2165\/00151829-200504060-00008","volume":"4","author":"Y Fukuchi","year":"2005","unstructured":"Fukuchi Y, Nagai A, Seyama K, Nishimura M, Hirata K, Kubo K, Ichinose M, Aizawa H, Research Group TB (2005) Clinical efficacy and safety of transdermal tulobuterol in the treatment of stable COPD: an open-label comparison with inhaled salmeterol. Treat Respir Med 4(6):447\u2013455. https:\/\/doi.org\/10.2165\/00151829-200504060-00008","journal-title":"Treat Respir Med"},{"key":"679_CR181","first-page":"21","volume-title":"Advances in drug research","author":"RF Furchgott","year":"1966","unstructured":"Furchgott RF (1966) In: Harper NJ, Simmonds AB (eds) Advances in drug research, vol 3. Academic Press, pp 21\u201355"},{"key":"679_CR182","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2147\/JAA.S223093","volume":"12","author":"K Furuhashi","year":"2019","unstructured":"Furuhashi K, Fujisawa T, Hashimoto D, Kamiya Y, Yasui H, Karayama M, Suzuki Y, Hozumi H, Enomoto N, Nakamura Y, Inui N, Suda T (2019) Once-daily fluticasone furoate\/vilanterol combination versus twice-daily budesonide\/formoterol combination in the treatment of controlled stable asthma: a randomized crossover trial. J Asthma Allergy 12:253\u2013261. https:\/\/doi.org\/10.2147\/JAA.S223093","journal-title":"J Asthma Allergy"},{"issue":"17","key":"679_CR183","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1056\/NEJM197810262991707","volume":"299","author":"SP Galant","year":"1978","unstructured":"Galant SP, Duriseti L, Underwood S, Insel PA (1978) Decreased beta-adrenergic receptors on polymorphonuclear leukocytes after adrenergic therapy. N Engl J Med 299(17):933\u2013936. https:\/\/doi.org\/10.1056\/NEJM197810262991707","journal-title":"N Engl J Med"},{"issue":"3","key":"679_CR184","doi-asserted-by":"publisher","first-page":"2102866","DOI":"10.1183\/13993003.02866-2021","volume":"60","author":"L Garc\u00eda-Marcos","year":"2022","unstructured":"Garc\u00eda-Marcos L, Asher MI, Pearce N, Ellwood E, Bissell K, Chiang CY, El Sony A, Ellwood P, Marks GB, Mortimer K, Mart\u00ednez-Torres AE, Morales E, Perez-Fernandez V, Robertson S, Rutter CE, Silverwood RJ, Strachan DP, Global Asthma Network Phase I Study Group (2022) The burden of asthma, hay fever and eczema in children in 25 countries: GAN phase I study. Eur Respir J 60(3):2102866. https:\/\/doi.org\/10.1183\/13993003.02866-2021","journal-title":"Eur Respir J"},{"issue":"11","key":"679_CR185","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/thx.51.11.1093","volume":"51","author":"JE Garrett","year":"1996","unstructured":"Garrett JE, Lanes SF, Kolbe J, Rea HH (1996) Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity. Thorax 51(11):1093\u20131099. https:\/\/doi.org\/10.1136\/thx.51.11.1093","journal-title":"Thorax"},{"issue":"7","key":"679_CR186","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1001\/jama.1949.72900240003008","volume":"39","author":"LN Gay","year":"1949","unstructured":"Gay LN, Long JW (1949) Clinical evaluation of isopropyl-epinephrine in management of bronchial asthma. JAMA 39(7):452\u2013457. https:\/\/doi.org\/10.1001\/jama.1949.72900240003008","journal-title":"JAMA"},{"key":"679_CR187","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S2213-2600(17)30293-X","volume":"9","author":"GBD 2015 Chronic Respiratory Disease Collaborators","year":"2017","unstructured":"GBD 2015 Chronic Respiratory Disease Collaborators (2017) Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med 9:691\u2013706. https:\/\/doi.org\/10.1016\/S2213-2600(17)30293-X","journal-title":"Lancet Respir Med"},{"issue":"1","key":"679_CR188","doi-asserted-by":"publisher","first-page":"CD010139","DOI":"10.1002\/14651858.CD010139.pub2","volume":"1","author":"JB Geake","year":"2015","unstructured":"Geake JB, Dabscheck EJ, Wood-Baker R, Cates CJ (2015) Indacaterol, a once-daily beta2-agonist, versus twice-daily beta2-agonists or placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 1(1):CD010139. https:\/\/doi.org\/10.1002\/14651858.CD010139.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"679_CR189","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1136\/bjsports-2014-093526","volume":"48","author":"H Geyer","year":"2014","unstructured":"Geyer H, Sch\u00e4nzer W, Thevis M (2014) Anabolic agents: recent strategies for their detection and protection from inadvertent doping. Br J Sports Med 48(10):820\u2013826. https:\/\/doi.org\/10.1136\/bjsports-2014-093526","journal-title":"Br J Sports Med"},{"issue":"10095","key":"679_CR190","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(17)31281-3","volume":"390","author":"PG Gibson","year":"2017","unstructured":"Gibson PG, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, Peters MJ, Marks GB, Baraket M, Powell H, Taylor SL, Leong LEX, Rogers GB, Simpson JL (2017) Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet 390(10095):659\u2013668. https:\/\/doi.org\/10.1016\/S0140-6736(17)31281-3","journal-title":"Lancet"},{"key":"679_CR191","unstructured":"GINA \u2013 Global Initiative for Asthma (2022) GINA report, global strategy for asthma management and prevention. https:\/\/ginasthma.org\/gina-reports\/"},{"issue":"592","key":"679_CR192","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/pgmj.51.592.53","volume":"51","author":"R Goldberg","year":"1975","unstructured":"Goldberg R, van As M, Joffe BI, Krut L, Bersohn I, Seftel HC (1975) Metabolic responses to selective beta-adrenergic stimulation in man. Postgrad Med J 51(592):53\u201358. https:\/\/doi.org\/10.1136\/pgmj.51.592.53","journal-title":"Postgrad Med J"},{"key":"679_CR193","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1353\/book.3231","volume-title":"Adrenaline and the inner world: an introduction to scientific integrative medicine","author":"DS Goldstein","year":"2006","unstructured":"Goldstein DS (2006) Adrenaline and the inner world: an introduction to scientific integrative medicine. The Johns Hopkins University Press, p 60. ISBN: 9780801882883"},{"key":"679_CR194","doi-asserted-by":"publisher","unstructured":"Gonem S, Cumella A, Richardson M (2019) Asthma admission rates and patterns of salbutamol and inhaled corticosteroid prescribing in England from 2013 to 2017. Thorax. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212723","DOI":"10.1136\/thoraxjnl-2018-212723"},{"issue":"4","key":"679_CR195","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S2213-2600(13)70070-5","volume":"1","author":"S Goodacre","year":"2013","unstructured":"Goodacre S, Cohen J, Bradburn M, Gray A, Benger J, Coats T, 3Mg Research Team (2013) Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial. Lancet Respir Med 1(4):293\u2013300. https:\/\/doi.org\/10.1016\/S2213-2600(13)70070-5","journal-title":"Lancet Respir Med"},{"issue":"8","key":"679_CR196","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1177\/003693306801300","volume":"13","author":"GS Graham","year":"1968","unstructured":"Graham GS (1968) Two sudden unexplained deaths in asthmatics. Scott Med J 13(8):282\u2013283. https:\/\/doi.org\/10.1177\/003693306801300","journal-title":"Scott Med J"},{"issue":"2","key":"679_CR197","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1136\/thx.46.2.105","volume":"46","author":"J Grainger","year":"1991","unstructured":"Grainger J, Woodman K, Pearce N, Crane J, Burgess C, Keane A, Beasley R (1991) Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax 46(2):105\u2013111. https:\/\/doi.org\/10.1136\/thx.46.2.105","journal-title":"Thorax"},{"issue":"9273","key":"679_CR198","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1016\/S0140-6736(00)05132-1","volume":"357","author":"RH Green","year":"2001","unstructured":"Green RH, Pavord ID (2001) Leukotriene antagonists and symptom control in chronic persistent asthma. Lancet 357(9273):1991\u20131992. https:\/\/doi.org\/10.1016\/S0140-6736(00)05132-1","journal-title":"Lancet"},{"key":"679_CR199","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0140-6736(65)90796-8","volume":"286","author":"MJ Greenberg","year":"1965","unstructured":"Greenberg MJ (1965) Isoprenaline in myocardial failure. Lancet 286:442\u2013443. https:\/\/doi.org\/10.1016\/S0140-6736(65)90796-8","journal-title":"Lancet"},{"key":"679_CR200","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1136\/bmj.1.5539.563","volume":"1","author":"MJ Greenberg","year":"1967","unstructured":"Greenberg MJ, Pines A (1967) Pressurized aerosols in asthma. Br Med J 1:563. https:\/\/doi.org\/10.1136\/bmj.1.5539.563","journal-title":"Br Med J"},{"issue":"4","key":"679_CR201","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1177\/009127007101100406","volume":"11","author":"JP Griffin","year":"1971","unstructured":"Griffin JP, Turner P (1971) Preliminary studies of a new bronchodilator (WG 253) in man. J Clin Pharmacol New Drugs 11(4):280\u2013287","journal-title":"J Clin Pharmacol New Drugs"},{"issue":"8","key":"679_CR202","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/thorax.55.8.650","volume":"55","author":"AR Guhan","year":"2000","unstructured":"Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE (2000) Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax 55(8):650\u2013656. https:\/\/doi.org\/10.1136\/thorax.55.8.650","journal-title":"Thorax"},{"issue":"1","key":"679_CR203","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF00202167","volume":"48","author":"SD Gunn","year":"1995","unstructured":"Gunn SD, Ayres JG, McConchie SM (1995) Comparison of the efficacy, tolerability and patient acceptability of once-daily bambuterol tablets against twice-daily controlled release salbutamol in nocturnal asthma. ACROBATICS Research Group. Eur J Clin Pharmacol 48(1):23\u201328. https:\/\/doi.org\/10.1007\/BF00202167","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"679_CR204","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00063110-200309000-00012","volume":"10","author":"D Habashy","year":"2003","unstructured":"Habashy D, Lam LT, Browne GJ (2003) The administration of beta2-agonists for paediatric asthma and its adverse reaction in Australian and New Zealand emergency departments: a cross-sectional survey. Eur J Emerg Med 10(3):219\u2013224. https:\/\/doi.org\/10.1097\/00063110-200309000-00012","journal-title":"Eur J Emerg Med"},{"issue":"12","key":"679_CR205","first-page":"22","volume":"27","author":"S Habersang","year":"1977","unstructured":"Habersang S, Leuschner F, Stroman F, Domenico A, Schlichtegroll A (1977) Compound with bronchospasmolytical activity from the chemical class of beta-phenylethyl-aminoalkyl-xanthines. Arzneimittelforschung 27(12):22\u201335","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"679_CR206","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1365-2710.1992.tb01285.x","volume":"17","author":"CA Haffner","year":"1992","unstructured":"Haffner CA, Kendall MJ (1992) Metabolic effects of beta 2-agonists. J Clin Pharm Ther 17(3):155\u2013164. https:\/\/doi.org\/10.1111\/j.1365-2710.1992.tb01285.x","journal-title":"J Clin Pharm Ther"},{"issue":"3","key":"679_CR207","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"P Haldar","year":"2008","unstructured":"Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH (2008) Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178(3):218\u2013224. https:\/\/doi.org\/10.1164\/rccm.200711-1754OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"679_CR208","doi-asserted-by":"publisher","first-page":"1801033","DOI":"10.1183\/13993003.01033-2018","volume":"52","author":"TS Hallstrand","year":"2018","unstructured":"Hallstrand TS, Leuppi JD, Joos G, Hall GL, Carlsen KH, Kaminsky DA, Coates AL, Cockcroft DW, Culver BH, Diamant Z, Gauvreau GM, Horvath I, de Jongh FHC, Laube BL, Sterk PJ, Wanger J, American Thoracic Society (ATS)\/European Respiratory Society (ERS) Bronchoprovocation Testing Task Force (2018) ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing. Eur Respir J 52(5):1801033. https:\/\/doi.org\/10.1183\/13993003.01033-2018","journal-title":"Eur Respir J"},{"issue":"1","key":"679_CR209","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1378\/chest.11-2231","volume":"142","author":"NA Hanania","year":"2012","unstructured":"Hanania NA, Feldman G, Zachgo W, Shim JJ, Crim C, Sanford L, Lettis S, Barnhart F, Haumann B (2012) The efficacy and safety of the novel long-acting \u03b22 agonist vilanterol in patients with COPD: a randomized placebo-controlled trial. Chest 142(1):119\u2013127. https:\/\/doi.org\/10.1378\/chest.11-2231","journal-title":"Chest"},{"issue":"1","key":"679_CR210","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","volume":"9","author":"LG Heaney","year":"2021","unstructured":"Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, Hardman TC, Arron JR, Choy DF, Bradding P, Brightling CE, Chaudhuri R, Cowan DC, Mansur AH, Fowler SJ, Niven RM, Howarth PH, Lordan JL, Menzies-Gow A, Harrison TW, Robinson DS, Holweg CTJ, Matthews JG, Pavord ID, Investigators for the MRC Refractory Asthma Stratification Programme (2021) Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Lancet Respir Med 9(1):57\u201368. https:\/\/doi.org\/10.1016\/S2213-2600(20)30397-0","journal-title":"Lancet Respir Med"},{"issue":"4","key":"679_CR211","first-page":"716","volume":"31","author":"H Hesse","year":"1981","unstructured":"Hesse H, Kasparek R, Mizera W, Unterholzner C, Konietzko N (1981) Influence of reproterol on ciliary beat frequency of human bronchial epithelium in vitro. Arzneimittelforschung 31(4):716\u2013718","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"679_CR212","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jemermed.2016.05.047","volume":"51","author":"MA Hieger","year":"2016","unstructured":"Hieger MA, Emswiler MP, Maskell KF, Sentz JT, Miller KB, Wolf CE, Cumpston KL, Wills BK (2016) A case series of clenbuterol toxicity caused by adulterated heroin. J Emerg Med 51(3):259\u2013261. https:\/\/doi.org\/10.1016\/j.jemermed.2016.05.047","journal-title":"J Emerg Med"},{"issue":"8563","key":"679_CR213","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/s0140-6736(87)91057-9","volume":"2","author":"RM Higgins","year":"1987","unstructured":"Higgins RM, Cookson WO, Lane DJ, John SM, McCarthy GL, McCarthy ST (1987) Cardiac arrhythmias caused by nebulised beta-agonist therapy. Lancet 2(8563):863\u2013864. https:\/\/doi.org\/10.1016\/s0140-6736(87)91057-9","journal-title":"Lancet"},{"issue":"1","key":"679_CR214","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1476-5381.1977.tb09734.x","volume":"61","author":"N Himori","year":"1977","unstructured":"Himori N, Taira N (1977) Assessment of the selectivity of OPC-2009, a new beta2-adrenoceptor stimulatn, by the use of the blood-perfused trachea in situ and of the isolated blood-perfused papillary muscle of the dog. Br J Pharmacol 61(1):9\u201317. https:\/\/doi.org\/10.1111\/j.1476-5381.1977.tb09734.x","journal-title":"Br J Pharmacol"},{"issue":"5","key":"679_CR215","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.annemergmed.2008.04.026","volume":"52","author":"RS Hoffman","year":"2008","unstructured":"Hoffman RS, Kirrane BM, Marcus SM, Clenbuterol Study Investigators (2008) A descriptive study of an outbreak of clenbuterol-containing heroin. Ann Emerg Med 52(5):548\u2013553. https:\/\/doi.org\/10.1016\/j.annemergmed.2008.04.026","journal-title":"Ann Emerg Med"},{"issue":"2","key":"679_CR216","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","volume":"369","author":"C Hoffmann","year":"2004","unstructured":"Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN (2004) Comparative pharmacology of human beta-adrenergic receptor subtypes \u2013 characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch Pharmacol 369(2):151\u2013159. https:\/\/doi.org\/10.1007\/s00210-003-0860-y","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"679_CR217","doi-asserted-by":"publisher","first-page":"967","DOI":"10.2147\/COPD.S353799","volume":"17","author":"MJ Hsieh","year":"2022","unstructured":"Hsieh MJ, Chen NH, Cheng SL, Tao CW, Wei YF, Wu YK, Chan MC, Liu SF, Hsu WH, Yang TM, Lin MS, Liu CL, Kuo PH, Tsai YH (2022) Comparing clinical outcomes of tiotropium\/olodaterol, umeclidinium\/vilanterol, and indacaterol\/glycopyrronium fixed-dose combination therapy in patients with chronic obstructive pulmonary disease in taiwan: a multicenter cohort study. Int J Chron Obstruct Pulmon Dis 17:967\u2013976. https:\/\/doi.org\/10.2147\/COPD.S353799","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"5","key":"679_CR218","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1378\/chest.63.5.661","volume":"63","author":"LD Hudson","year":"1973","unstructured":"Hudson LD, Kurt TL, Petty TL, Genton E (1973) Arrhythmias associated with acute respiratory failure in patients with chronic airway obstruction. Chest 63(5):661\u2013665. https:\/\/doi.org\/10.1378\/chest.63.5.661","journal-title":"Chest"},{"issue":"7","key":"679_CR219","first-page":"1337","volume":"26","author":"H Ida","year":"1976","unstructured":"Ida H (1976a) Cardiorespiratory activitirs of 3-formylamino-4-hydroxy-alpha-(n-1-methyl-2-p-methoxyphenethylaminomethyl)-benzylalcohol-hemifumarate(BD 40A) and some other beta-adrenoceptor stimulants in conscious guinea pigs. Arzneimittelforschung 26(7):1337\u20131340","journal-title":"Arzneimittelforschung"},{"issue":"5","key":"679_CR220","first-page":"839","volume":"26","author":"H Ida","year":"1976","unstructured":"Ida H (1976b) Comparison of the action of BD 40 A and some other beta-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig. Arzneimittelforschung 26(5):839\u2013842","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"679_CR221","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00408-013-9525-x","volume":"192","author":"IH Iftikhar","year":"2014","unstructured":"Iftikhar IH, Imtiaz M, Brett AS, Amrol DJ (2014) Cardiovascular safety of long acting beta agonist-inhaled corticosteroid combination products in adult patients with asthma: a systematic review. Lung 192(1):47\u201354. https:\/\/doi.org\/10.1007\/s00408-013-9525-x","journal-title":"Lung"},{"issue":"7615","key":"679_CR222","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/s0140-6736(69)90051-8","volume":"2","author":"WH Inman","year":"1969","unstructured":"Inman WH, Adelstein AM (1969) Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet 2(7615):279\u2013285. https:\/\/doi.org\/10.1016\/s0140-6736(69)90051-8","journal-title":"Lancet"},{"issue":"1","key":"679_CR223","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/1440-1681.12683","volume":"44","author":"H Inoue","year":"2017","unstructured":"Inoue H, Niimi A, Matsumoto H, Ito I, Oguma T, Otsuka K, Takeda T, Nakaji H, Tajiri T, Iwata T, Nagasaki T, Mishima M (2017) A 12-week, randomized, parallel-group, proof-of-concept study of tulobuterol patch and salmeterol inhaler as add-on therapy in adult-onset mild-to-moderate asthma. Clin Exp Pharmacol Physiol 44(1):21\u201329. https:\/\/doi.org\/10.1111\/1440-1681.12683","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"679_CR224","first-page":"389","volume":"6","author":"F Ioli","year":"1986","unstructured":"Ioli F, Donner CF, Fracchia C, Manini G, Patessio A, Spada EL, Vecchio C (1986) A new bronchodilating agent, procaterol, in preventing exercise-induced asthma. Int J Clin Pharmacol Res 6(5):389\u2013396","journal-title":"Int J Clin Pharmacol Res"},{"issue":"4","key":"679_CR225","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/0014-2999(79)90459-x","volume":"53","author":"Y Irie","year":"1979","unstructured":"Irie Y, Igawa T, Hosokawa T, Saitoh Y (1979) Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist. Eur J Pharmacol 53(4):351\u2013358. https:\/\/doi.org\/10.1016\/0014-2999(79)90459-x","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"679_CR226","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1017\/s0025727300000235","volume":"54","author":"M Jackson","year":"2010","unstructured":"Jackson M (2010) \u201cDivine stramonium\u201d: the rise and fall of smoking for asthma. Med Hist 54(2):171\u2013194. https:\/\/doi.org\/10.1017\/s0025727300000235","journal-title":"Med Hist"},{"issue":"9","key":"679_CR227","doi-asserted-by":"publisher","first-page":"CD006924","DOI":"10.1002\/14651858.CD006924.pub4","volume":"9","author":"S Janjua","year":"2019","unstructured":"Janjua S, Schmidt S, Ferrer M, Cates CJ (2019) Inhaled steroids with and without regular formoterol for asthma: serious adverse events. Cochrane Database Syst Rev 9(9):CD006924. https:\/\/doi.org\/10.1002\/14651858.CD006924.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"38","key":"679_CR228","doi-asserted-by":"publisher","first-page":"23871","DOI":"10.1074\/jbc.272.38.23871","volume":"272","author":"B January","year":"1997","unstructured":"January B, Seibold A, Whaley B, Hipkin RW, Lin D, Schonbrunn A, Barber R, Clark RB (1997) Beta2-adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem 272(38):23871\u201323879. https:\/\/doi.org\/10.1074\/jbc.272.38.23871","journal-title":"J Biol Chem"},{"issue":"4","key":"679_CR229","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/sj.bjp.0701658","volume":"123","author":"B January","year":"1998","unstructured":"January B, Seibold A, Allal C, Whaley BS, Knoll BJ, Moore RH, Dickey BF, Barber R, Clark RB (1998) Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor. Br J Pharmacol 123(4):701\u2013711. https:\/\/doi.org\/10.1038\/sj.bjp.0701658","journal-title":"Br J Pharmacol"},{"issue":"2","key":"679_CR230","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0952-0600(89)90028-8","volume":"2","author":"AB Jeppsson","year":"1989","unstructured":"Jeppsson AB, L\u00f6fdahl CG, Waldeck B, Widmark E (1989) On the predictive value of experiments in vitro in the evaluation of the effect duration of bronchodilator drugs for local administration. Pulm Pharmacol 2(2):81\u201385. https:\/\/doi.org\/10.1016\/0952-0600(89)90028-8","journal-title":"Pulm Pharmacol"},{"issue":"4","key":"679_CR231","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/j.1600-0773.1992.tb00982.x","volume":"71","author":"AB Jeppsson","year":"1992","unstructured":"Jeppsson AB, K\u00e4llstr\u00f6m BL, Waldeck B (1992) Studies on the interaction between formoterol and salmeterol in guinea-pig trachea in vitro. Pharmacol Toxicol 71(4):272\u2013277. https:\/\/doi.org\/10.1111\/j.1600-0773.1992.tb00982.x","journal-title":"Pharmacol Toxicol"},{"issue":"1","key":"679_CR232","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1053\/prrv.2000.0102","volume":"2","author":"M Johnson","year":"2001","unstructured":"Johnson M (2001) Beta2-adrenoceptors: mechanisms of action of beta2-agonists. Paediatr Respir Rev 2(1):57\u201362. https:\/\/doi.org\/10.1053\/prrv.2000.0102","journal-title":"Paediatr Respir Rev"},{"issue":"26","key":"679_CR233","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1016\/0024-3205(93)90728-l","volume":"52","author":"M Johnson","year":"1993","unstructured":"Johnson M, Butchers PR, Coleman RA, Nials AT, Strong P, Sumner MJ, Vardey CJ, Whelan CJ (1993) The pharmacology of salmeterol. Life Sci 52(26):2131\u20132143. https:\/\/doi.org\/10.1016\/0024-3205(93)90728-l","journal-title":"Life Sci"},{"issue":"4","key":"679_CR234","doi-asserted-by":"publisher","first-page":"380","DOI":"10.4104\/pcrj.2011.00066","volume":"20","author":"PW Jones","year":"2011","unstructured":"Jones PW, Barnes N, Vogelmeier C, Lawrence D, Kramer B (2011) Efficacy of indacaterol in the treatment of patients with COPD. Prim Care Respir J 20(4):380\u2013388. https:\/\/doi.org\/10.4104\/pcrj.2011.00066","journal-title":"Prim Care Respir J"},{"issue":"3","key":"679_CR235","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000029381","volume":"66","author":"UR Juergens","year":"1999","unstructured":"Juergens UR, St\u00f6ber M, Vetter H (1999) Reproterol \u2013 a monomolecular combination of orciprenaline and theophylline: novel aspects of its mode of action in asthma. Respiration 66(3):220\u2013224. https:\/\/doi.org\/10.1159\/000029381","journal-title":"Respiration"},{"issue":"7","key":"679_CR236","first-page":"365","volume":"9","author":"UR Juergens","year":"2004","unstructured":"Juergens UR, St\u00f6ber M, Libertus H, Darlath W, Gillissen A, Vetter H (2004) Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro. Eur J Med Res 9(7):365\u2013370","journal-title":"Eur J Med Res"},{"key":"679_CR237","unstructured":"Kahn RH (1907) Zur physiologie der trachea. Arch Physiol:398\u2013426"},{"issue":"6","key":"679_CR238","doi-asserted-by":"publisher","first-page":"e20154496","DOI":"10.1542\/peds.2015-4496","volume":"137","author":"SV Kaiser","year":"2016","unstructured":"Kaiser SV, Huynh T, Bacharier LB, Rosenthal JL, Bakel LA, Parkin PC, Cabana MD (2016) Preventing exacerbations in preschoolers with recurrent wheeze: a meta-analysis. Pediatrics 137(6):e20154496. https:\/\/doi.org\/10.1542\/peds.2015-4496","journal-title":"Pediatrics"},{"issue":"6","key":"679_CR239","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1378\/chest.127.6.2057","volume":"127","author":"EM Kallergis","year":"2005","unstructured":"Kallergis EM, Manios EG, Kanoupakis EM, Schiza SE, Mavrakis HE, Klapsinos NK, Vardas PE (2005) Acute electrophysiologic effects of inhaled salbutamol in humans. Chest 127(6):2057\u20132063. https:\/\/doi.org\/10.1378\/chest.127.6.2057","journal-title":"Chest"},{"issue":"4","key":"679_CR240","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1378\/chest.109.4.953","volume":"109","author":"S Kalra","year":"1996","unstructured":"Kalra S, Swystun VA, Bhagat R, Cockcroft DW (1996) Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol. Chest 109(4):953\u2013956. https:\/\/doi.org\/10.1378\/chest.109.4.953","journal-title":"Chest"},{"issue":"1","key":"679_CR241","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1365-2125.1977.tb00669.x","volume":"4","author":"PL Kamburoff","year":"1977","unstructured":"Kamburoff PL, Prime FJ, Schmidt OP (1977) The bronchodilator effect of NAB 365. Br J Clin Pharmacol 4(1):67\u201371. https:\/\/doi.org\/10.1111\/j.1365-2125.1977.tb00669.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"679_CR242","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1111\/j.1476-5381.1994.tb13100.x","volume":"112","author":"K Kanthakumar","year":"1994","unstructured":"Kanthakumar K, Cundell DR, Johnson M, Wills PJ, Taylor GW, Cole PJ, Wilson R (1994) Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin. Br J Pharmacol 112(2):493\u2013498. https:\/\/doi.org\/10.1111\/j.1476-5381.1994.tb13100.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"679_CR243","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1378\/chest.78.2.283","volume":"78","author":"I Kass","year":"1980","unstructured":"Kass I, Mingo TS (1980) Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects. Chest 78(2):283\u2013287. https:\/\/doi.org\/10.1378\/chest.78.2.283","journal-title":"Chest"},{"issue":"11A","key":"679_CR244","first-page":"1699","volume":"34","author":"Y Kawakami","year":"1984","unstructured":"Kawakami Y (1984) First clinical studies on mabuterol. A summarizing report. Arzneimittelforschung 34(11A):1699\u20131700","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"679_CR245","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.tvjl.2008.08.021","volume":"182","author":"CF Kearns","year":"2009","unstructured":"Kearns CF, McKeever KH (2009) Clenbuterol and the horse revisited. Vet J 182(3):384\u2013391. https:\/\/doi.org\/10.1016\/j.tvjl.2008.08.021","journal-title":"Vet J"},{"issue":"5187","key":"679_CR246","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/2211251a0","volume":"221","author":"GR Kelman","year":"1969","unstructured":"Kelman GR, Palmer KN, Cross MR (1969) Cardiovascular effects of AH.3365 (salbutamol). Nature 221(5187):1251. https:\/\/doi.org\/10.1038\/2211251a0","journal-title":"Nature"},{"key":"679_CR247","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0165-6147(99)01361-9","volume":"20","author":"T Kenakin","year":"1999","unstructured":"Kenakin T (1999a) Efficacy in drug receptor theory: outdated concept or under-valued tool? Trends Pharmacol Sci 20:400\u2013405","journal-title":"Trends Pharmacol Sci"},{"key":"679_CR248","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1056-8719(00)00070-8","volume":"42","author":"T Kenakin","year":"1999","unstructured":"Kenakin T (1999b) The measurement of efficacy in the drug discovery agonist selection process. J Pharmacol Toxicol Methods 42:177\u2013187","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"2","key":"679_CR249","first-page":"340","volume":"229","author":"TP Kenakin","year":"1984","unstructured":"Kenakin TP, Beek D (1984) Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number. J Pharmacol Exp Ther 229(2):340\u2013345","journal-title":"J Pharmacol Exp Ther"},{"issue":"5371","key":"679_CR250","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/bmj.2.5371.1506","volume":"2","author":"MC Kennedy","year":"1963","unstructured":"Kennedy MC, Jackson SL (1963) Oral sympathomimetics in treatment of asthma. Br Med J 2(5371):1506\u20131509. https:\/\/doi.org\/10.1136\/bmj.2.5371.1506","journal-title":"Br Med J"},{"issue":"5545","key":"679_CR251","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/bmj.2.5545.177-c","volume":"2","author":"JW Kerr","year":"1967","unstructured":"Kerr JW (1967) Deaths from asthma. Br Med J 2(5545):177\u2013178. https:\/\/doi.org\/10.1136\/bmj.2.5545.177-c","journal-title":"Br Med J"},{"issue":"10","key":"679_CR252","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1136\/thx.50.10.1062","volume":"50","author":"DG Kiely","year":"1995","unstructured":"Kiely DG, Cargill RI, Grove A, Struthers AD, Lipworth BJ (1995) Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol. Thorax 50(10):1062\u20131066. https:\/\/doi.org\/10.1136\/thx.50.10.1062","journal-title":"Thorax"},{"issue":"2","key":"679_CR253","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1254\/jjp.57.175","volume":"57","author":"H Kikkawa","year":"1991","unstructured":"Kikkawa H, Naito K, Ikezawa K (1991) Tracheal relaxing effects and beta 2-selectivity of TA-2005, a newly developed bronchodilating agent, in isolated guinea pig tissues. Jpn J Pharmacol 57(2):175\u2013185. https:\/\/doi.org\/10.1254\/jjp.57.175","journal-title":"Jpn J Pharmacol"},{"issue":"8","key":"679_CR254","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1248\/bpb.17.1047","volume":"17","author":"H Kikkawa","year":"1994","unstructured":"Kikkawa H, Kanno K, Ikezawa K (1994) TA-2005, a novel, long-acting, and selective beta 2-adrenoceptor agonist: characterization of its in vivo bronchodilating action in guinea pigs and cats in comparison with other beta 2-agonists. Biol Pharm Bull 17(8):1047\u20131052. https:\/\/doi.org\/10.1248\/bpb.17.1047","journal-title":"Biol Pharm Bull"},{"issue":"24","key":"679_CR255","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1001\/jama.2021.7872","volume":"325","author":"LHY Kim","year":"2021","unstructured":"Kim LHY, Saleh C, Whalen-Browne A, O'Byrne PM, Chu DK (2021) Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma: a systematic review and meta-analysis. JAMA 325(24):2466\u20132479. https:\/\/doi.org\/10.1001\/jama.2021.7872","journal-title":"JAMA"},{"issue":"5","key":"679_CR256","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1378\/chest.65.5.483","volume":"65","author":"RE Kleiger","year":"1974","unstructured":"Kleiger RE, Senior RM (1974) Longterm electrocardiographic monitoring of ambulatory patients with chronic airway obstruction. Chest 65(5):483\u2013487. https:\/\/doi.org\/10.1378\/chest.65.5.483","journal-title":"Chest"},{"issue":"12","key":"679_CR257","first-page":"4","volume":"27","author":"KH Klingler","year":"1977","unstructured":"Klingler KH (1977) Synthesis of bronchospasmolytically effective beta phenylethyl-aminoalkyl-xanthines. Arzneimittelforschung 27(12):4\u201314","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"679_CR258","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1080\/02770900601180321","volume":"44","author":"Y Kobayashi","year":"2007","unstructured":"Kobayashi Y, Yasuba H, Kudou M, Kita H (2007) Addition of transdermal or inhaled long-acting Beta2-agonists in adult asthmatic patients treated with inhaled corticosteroids: switchover study from tulobuterol patch to salmeterol dry powder inhaler. J Asthma 44(2):77\u201381. https:\/\/doi.org\/10.1080\/02770900601180321","journal-title":"J Asthma"},{"key":"679_CR259","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/BF01936304","volume":"197","author":"H Konzett","year":"1940","unstructured":"Konzett H (1940a) Neue broncholytisch hochwirksame K\u00f6rper der Adrenalinreihe. Arch Exp Path Pharm 197:27\u201340. https:\/\/doi.org\/10.1007\/BF01936304","journal-title":"Arch Exp Path Pharm"},{"key":"679_CR260","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/BF01936305","volume":"197","author":"H Konzett","year":"1940","unstructured":"Konzett H (1940b) Zur Pharmakologie neuer adrenalinverwandter K\u00f6rper. Arch Exp Path Pharm 197:41\u201356. https:\/\/doi.org\/10.1007\/BF01936305","journal-title":"Arch Exp Path Pharm"},{"key":"679_CR261","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-6147(81)90259-5","volume":"2","author":"H Konzett","year":"1981","unstructured":"Konzett H (1981) On the discovery of isoprenaline. Trends Pharmacol Sci 2:47\u201349","journal-title":"Trends Pharmacol Sci"},{"key":"679_CR262","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF01861842","volume":"195","author":"H Konzett","year":"1940","unstructured":"Konzett H, R\u00f6ssler R (1940) Versuchsanordnung zu Untersuchungen an der Bronchialmuskulatur. Naunyn Schmiedebergs Arch Pharmakol Exp Pathol 195:71\u201374. https:\/\/doi.org\/10.1007\/BF01861842","journal-title":"Naunyn Schmiedebergs Arch Pharmakol Exp Pathol"},{"issue":"6","key":"679_CR263","doi-asserted-by":"publisher","first-page":"2100413","DOI":"10.1183\/13993003.00413-2021","volume":"58","author":"M Kraft","year":"2021","unstructured":"Kraft M, Brusselle G, FitzGerald JM, Pavord ID, Keith M, Fager\u00e5s M, Garcia Gil E, Hirsch I, Goldman M, Colice G (2021) Patient characteristics, biomarkers and exacerbation risk in severe, uncontrolled asthma. Eur Respir J 58(6):2100413. https:\/\/doi.org\/10.1183\/13993003.00413-2021","journal-title":"Eur Respir J"},{"issue":"16","key":"679_CR264","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1056\/NEJMp0810561","volume":"360","author":"JM Kramer","year":"2009","unstructured":"Kramer JM (2009) Balancing the benefits and risks of inhaled long-acting beta-agonists \u2013 the influence of values. N Engl J Med 360(16):1592\u20131595. https:\/\/doi.org\/10.1056\/NEJMp0810561","journal-title":"N Engl J Med"},{"issue":"11A","key":"679_CR265","first-page":"1612","volume":"34","author":"G Kr\u00fcger","year":"1984","unstructured":"Kr\u00fcger G, Keck J, Noll K, Pieper H (1984) Synthesis of further amino-halogen-substituted phenyl-aminoethanols. Arzneimittelforschung 34(11A):1612\u20131624","journal-title":"Arzneimittelforschung"},{"issue":"7","key":"679_CR266","first-page":"1028","volume":"25","author":"S Kubo","year":"1975","unstructured":"Kubo S, Kas\u00e9 Y, Miyata T, Kito G, Uesaka I (1975) Pharmacological studies of 1-(o-chlorophenyl)-2-tert.-butylaminoethanol (C-78), a new bronchodilator. Arzneimittelforschung 25(7):1028\u20131037","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"679_CR267","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2527\/1998.761195x","volume":"76","author":"HA Kuiper","year":"1998","unstructured":"Kuiper HA, Noordam MY, van Dooren-Flipsen MM, Schilt R, Roos AH (1998) Illegal use of beta-adrenergic agonists: European Community. J Anim Sci 76(1):195\u2013207. https:\/\/doi.org\/10.2527\/1998.761195x","journal-title":"J Anim Sci"},{"issue":"12","key":"679_CR268","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1046\/j.1440-1681.2002.03777.x","volume":"29","author":"H Kume","year":"2002","unstructured":"Kume H, Kondo M, Ito Y, Suzuki R, Yamaki K, Takagi K (2002) Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function. Clin Exp Pharmacol Physiol 29(12):1076\u20131083. https:\/\/doi.org\/10.1046\/j.1440-1681.2002.03777.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"679_CR269","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1378\/chest.91.3.382","volume":"91","author":"M K\u00fcng","year":"1987","unstructured":"K\u00fcng M, Croley SW, Phillips BA (1987) Systemic cardiovascular and metabolic effects associated with the inhalation of an increased dose of albuterol. Influence of mouth rinsing and gargling. Chest 91(3):382\u2013387. https:\/\/doi.org\/10.1378\/chest.91.3.382","journal-title":"Chest"},{"issue":"2","key":"679_CR270","first-page":"301","volume":"202","author":"SH Kuo","year":"1977","unstructured":"Kuo SH, Kamaka JK, Lum BK (1977) Adrenergic receptor mechanisms involved in the hyperglycemia and hyperlactic-acidemia produced by sympathomimetic amines in the cat. J Pharmacol Exp Ther 202(2):301\u2013309","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"679_CR271","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1248\/bpb.17.1023","volume":"17","author":"T Kusayama","year":"1994","unstructured":"Kusayama T, Oka J, Yabana H, Adachi-Akahane S, Nagao T (1994) Binding of a catechol derivative of denopamine (T-0509) and N-tert-butylnoradrenaline (Colterol) to beta 1- and beta 2-adrenoceptors. Biol Pharm Bull 17(8):1023\u20131027. https:\/\/doi.org\/10.1248\/bpb.17.1023","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"679_CR272","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nm.2737","volume":"18","author":"BN Lambrecht","year":"2012","unstructured":"Lambrecht BN, Hammad H (2012) The airway epithelium in asthma. Nat Med 18(5):684\u2013692. https:\/\/doi.org\/10.1038\/nm.2737","journal-title":"Nat Med"},{"issue":"4","key":"679_CR273","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.immuni.2019.03.018","volume":"50","author":"BN Lambrecht","year":"2019","unstructured":"Lambrecht BN, Hammad H, Fahy JV (2019) The cytokines of asthma. Immunity 50(4):975\u2013991. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.018","journal-title":"Immunity"},{"key":"679_CR274","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3181\/00379727-116-29239","volume":"116","author":"AM Lands","year":"1964","unstructured":"Lands AM, Brown TG Jr (1964) A comparison of the cardiac stimulating and bronchodilator actions of selected sympathomimetic amines. Proc Soc Exp Biol 116:331\u2013333. https:\/\/doi.org\/10.3181\/00379727-116-29239","journal-title":"Proc Soc Exp Biol"},{"issue":"5088","key":"679_CR275","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/214597a0","volume":"214","author":"AM Lands","year":"1967","unstructured":"Lands AM, Arnold A, McAuliff JP, Luduena FP, Brown TG Jr (1967a) Differentiation of receptor systems activated by sympathomimetic amines. Nature 214(5088):597\u2013598. https:\/\/doi.org\/10.1038\/214597a0","journal-title":"Nature"},{"issue":"21","key":"679_CR276","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/0024-3205(67)90031-8","volume":"6","author":"AM Lands","year":"1967","unstructured":"Lands AM, Luduena FP, Buzzo HJ (1967b) Differentiation of receptors responsive to isoproterenol. Life Sci 6(21):2241\u20132249. https:\/\/doi.org\/10.1016\/0024-3205(67)90031-8","journal-title":"Life Sci"},{"issue":"3","key":"679_CR277","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/s0895-4356(96)00375-7","volume":"50","author":"SF Lanes","year":"1997","unstructured":"Lanes SF, Birmann B, Raiford D, Walker AM (1997) International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992. J Clin Epidemiol 50(3):321\u2013328. https:\/\/doi.org\/10.1016\/s0895-4356(96)00375-7","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"679_CR278","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0091-6749(77)90209-3","volume":"59","author":"S Larsson","year":"1977","unstructured":"Larsson S, Svedmyr N, Thiringer G (1977) Lack of bronchial beta adrenoceptor resistance in asthmatics during long-term treatment with terbutaline. J Allergy Clin Immunol 59(2):93\u2013100. https:\/\/doi.org\/10.1016\/0091-6749(77)90209-3","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"679_CR279","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41533-020-0182-2","volume":"30","author":"K Larsson","year":"2020","unstructured":"Larsson K, Kankaanranta H, Janson C, Lehtim\u00e4ki L, St\u00e4llberg B, L\u00f8kke A, H\u00f8ines K, Roslind K, Ulrik CS (2020) Bringing asthma care into the twenty-first century. NPJ Prim Care Respir Med 30(1):25. https:\/\/doi.org\/10.1038\/s41533-020-0182-2","journal-title":"NPJ Prim Care Respir Med"},{"key":"679_CR280","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s00424-007-0324-1","volume":"455","author":"S Lee","year":"2008","unstructured":"Lee S, Schwinger RH, Brixius K (2008) Genetically changed mice with chronic deficiency or overexpression of the \u03b2-beta-adrenoceptors \u2013 what can we learn for the therapy of heart failure? Pflugers Arch 455:767\u2013774","journal-title":"Pflugers Arch"},{"issue":"6","key":"679_CR281","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1111\/bcp.13210","volume":"83","author":"WH Lee","year":"2017","unstructured":"Lee WH, Kim H-J, Lee C-H (2017) The impact of olodaterol on the risk of mortality and serious adverse events: a systematic review and meta-analysis. Br J Clin Pharmacol 83(6):1166\u20131175. https:\/\/doi.org\/10.1111\/bcp.13210","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"679_CR282","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","volume":"9","author":"LA Lee","year":"2020","unstructured":"Lee LA, Bailes Z, Barnes N, Boulet LP, Edwards D, Fowler A, Hanania NA, Kerstjens HAM, Kerwin E, Nathan R, Oppenheimer J, Papi A, Pascoe S, Brusselle G, Peachey G, Sule N, Tabberer M, Pavord ID (2020a) Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial. Lancet Respir Med 9(1):69\u201384. https:\/\/doi.org\/10.1016\/S2213-2600(20)30389-1","journal-title":"Lancet Respir Med"},{"issue":"1","key":"679_CR283","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12931-020-01540-8","volume":"21","author":"HW Lee","year":"2020","unstructured":"Lee HW, Park J, Jang EJ, Lee CH (2020b) Comparisons of exacerbations and mortality among LAMA\/LABA combinations in stable chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis. Respir Res 21(1):310. https:\/\/doi.org\/10.1186\/s12931-020-01540-8","journal-title":"Respir Res"},{"issue":"7","key":"679_CR284","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1159\/000515133","volume":"100","author":"HW Lee","year":"2021","unstructured":"Lee HW, Kim HJ, Jang EJ, Lee CH (2021) Comparisons of efficacy and safety between triple (inhaled corticosteroid\/long-acting muscarinic antagonist\/long-acting beta-agonist) therapies in chronic obstructive pulmonary disease: Systematic review and Bayesian network meta-analysis. Respiration 100(7):631\u2013643. https:\/\/doi.org\/10.1159\/000515133","journal-title":"Respiration"},{"issue":"5750","key":"679_CR285","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/bmj.1.5750.637","volume":"1","author":"JS Legge","year":"1971","unstructured":"Legge JS, Gaddie J, Palmer KN (1971) Comparison of two oral selective beta2-adrenergic stimulant drugs in bronchial asthma. Br Med J 1(5750):637\u2013639. https:\/\/doi.org\/10.1136\/bmj.1.5750.637","journal-title":"Br Med J"},{"issue":"5828","key":"679_CR286","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/293103a0","volume":"293","author":"RA Lewis","year":"1981","unstructured":"Lewis RA, Austen KF (1981) Mediation of local homeostasis and inflammation by leukotrienes and other mast cell-dependent compounds. Nature 293(5828):103\u2013108. https:\/\/doi.org\/10.1038\/293103a0","journal-title":"Nature"},{"issue":"1","key":"679_CR287","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/jcm9010071","volume":"9","author":"AG Liedtke","year":"2019","unstructured":"Liedtke AG, Lava SAG, Milani GP, Agostoni C, Gilardi V, Bianchetti MG, Treglia G, Far\u00e9 PB (2019) Selective \u00df2-adrenoceptor agonists and relevant hyperlactatemia: systematic review and meta-analysis. J Clin Med 9(1):71. https:\/\/doi.org\/10.3390\/jcm9010071","journal-title":"J Clin Med"},{"issue":"4","key":"679_CR288","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF00265855","volume":"40","author":"K Liippo","year":"1991","unstructured":"Liippo K, Silvasti M, Tukiainen H (1991) Inhaled procaterol versus salbutamol in bronchial asthma. Eur J Clin Pharmacol 40(4):417\u2013418. https:\/\/doi.org\/10.1007\/BF00265855","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"679_CR289","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/thx.48.5.547","volume":"48","author":"A Lind\u00e9n","year":"1993","unstructured":"Lind\u00e9n A, Bergendal A, Ullman A, Skoogh BE, L\u00f6fdahl CG (1993) Salmeterol, formoterol, and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism. Thorax 48(5):547\u2013553. https:\/\/doi.org\/10.1136\/thx.48.5.547","journal-title":"Thorax"},{"issue":"18","key":"679_CR290","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","volume":"378","author":"DA Lipson","year":"2018","unstructured":"Lipson DA, Barnhart F, Brealey N, Brooks J, Criner GJ, Day NC, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lomas DA, Martinez FJ, Singh D, Tabberer M, Wise RA, Pascoe SJ, Investigators IMPACT (2018) Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med 378(18):1671\u20131680. https:\/\/doi.org\/10.1056\/NEJMoa1713901","journal-title":"N Engl J Med"},{"issue":"12","key":"679_CR291","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1164\/rccm.201911-2207OC","volume":"201","author":"DA Lipson","year":"2020","unstructured":"Lipson DA, Crim C, Criner GJ, Day NC, Dransfield MT, Halpin DMG, Han MK, Jones CE, Kilbride S, Lange P, Lomas DA, Lettis S, Manchester P, Martin N, Midwinter D, Morris A, Pascoe SJ, Singh D, Wise RA, Martinez FJ (2020) Reduction in all-cause mortality with fluticasone furoate\/umeclidinium\/vilanterol in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 201(12):1508\u20131516. https:\/\/doi.org\/10.1164\/rccm.201911-2207OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"679_CR292","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/pulp.1996.0002","volume":"9","author":"BJ Lipworth","year":"1996","unstructured":"Lipworth BJ (1996) Airway and systemic effects of inhaled corticosteroids in asthma: dose response relationship. Pulm Pharmacol 9(1):19\u201327. https:\/\/doi.org\/10.1006\/pulp.1996.0002","journal-title":"Pulm Pharmacol"},{"issue":"1","key":"679_CR293","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2125.1997.tb00025.x","volume":"43","author":"BJ Lipworth","year":"1997","unstructured":"Lipworth BJ, Grove A (1997) Evaluation of partial beta-adrenoceptor agonist activity. Br J Clin Pharmacol 43(1):9\u201314. https:\/\/doi.org\/10.1111\/j.1365-2125.1997.tb00025.x","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"679_CR294","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/BF00562546","volume":"37","author":"BJ Lipworth","year":"1989","unstructured":"Lipworth BJ, Clark RA, Dhillon DP, Moreland TA, Struthers AD, Clark GA, McDevitt DG (1989) Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma. Eur J Clin Pharmacol 37(6):567\u2013571. https:\/\/doi.org\/10.1007\/BF00562546","journal-title":"Eur J Clin Pharmacol"},{"issue":"7403","key":"679_CR295","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/s0140-6736(65)92221-x","volume":"2","author":"MF Lockett","year":"1965","unstructured":"Lockett MF (1965) Dangerous effects of isoprenaline in myocardial failure. Lancet 2(7403):104\u2013106. https:\/\/doi.org\/10.1016\/s0140-6736(65)92221-x","journal-title":"Lancet"},{"issue":"Suppl 5(II)","key":"679_CR296","first-page":"A1358","volume":"229","author":"CG L\u00f6fdahl","year":"1986","unstructured":"L\u00f6fdahl CG, Svedmyr N (1986) Effect duration of inhaled formoterol, a new\u03b2 2-adrenoceptor agonist, compared to salbutamol in asthmatic patients. Acta Pharmacol Toxicol 229(Suppl 5(II)):A1358","journal-title":"Acta Pharmacol Toxicol"},{"key":"679_CR297","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1398-9995.1989.tb01068.x","volume":"44","author":"CG L\u00f6fdahl","year":"1989","unstructured":"L\u00f6fdahl CG, Svedmyr N (1989) Formoterol fumarate, a new\u03b22-adrenoceptor agonist. Acute studies of selectivity and duration of effect after inhaled and oral administration. Allergy 44:264\u2013271","journal-title":"Allergy"},{"issue":"Suppl 2","key":"679_CR298","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000195765","volume":"55","author":"CG L\u00f6fdahl","year":"1989","unstructured":"L\u00f6fdahl CG, Sigvaldasson A, Skoogh BE, Svedmyr N (1989) Broxaterol, a new beta 2-adrenoceptor agonist compared to salbutamol in asthmatics, oral and inhalation treatment. Respiration 55(Suppl 2):15\u201319. https:\/\/doi.org\/10.1159\/000195765","journal-title":"Respiration"},{"issue":"Suppl B","key":"679_CR299","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1053\/rmed.2001.1139","volume":"95","author":"J L\u00f6tvall","year":"2001","unstructured":"L\u00f6tvall J (2001) Pharmacological similarities and differences between beta2-agonists. Respir Med 95(Suppl B):S7\u2013S11. https:\/\/doi.org\/10.1053\/rmed.2001.1139","journal-title":"Respir Med"},{"issue":"5","key":"679_CR300","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/j.1398-9995.1992.tb00668.x","volume":"47","author":"J L\u00f6tvall","year":"1992","unstructured":"L\u00f6tvall J, Lunde H, Ullman A, T\u00f6rnqvist H, Svedmyr N (1992) Twelve months, treatment with inhaled salmeterol in asthmatic patients. Effects on beta 2-receptor function and inflammatory cells. Allergy 47(5):477\u2013483. https:\/\/doi.org\/10.1111\/j.1398-9995.1992.tb00668.x","journal-title":"Allergy"},{"issue":"2","key":"679_CR301","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pupt.2004.10.007","volume":"18","author":"J L\u00f6tvall","year":"2005","unstructured":"L\u00f6tvall J, Palmqvist M, Ankerst J, Persson G, Rosenborg J, Bengtsson T, Rott Z, Poczi M, Devai A, Waldeck B (2005) The effect of formoterol over 24 h in patients with asthma: the role of enantiomers. Pulm Pharmacol Ther 18(2):109\u2013113. https:\/\/doi.org\/10.1016\/j.pupt.2004.10.007","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"679_CR302","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1183\/09031936.00121411","volume":"40","author":"J L\u00f6tvall","year":"2012","unstructured":"L\u00f6tvall J, Bateman ED, Bleecker ER, Busse WW, Woodcock A, Follows R, Lim J, Stone S, Jacques L, Haumann B (2012) 24-h duration of the novel LABA vilanterol trifenatate in asthma patients treated with inhaled corticosteroids. Eur Respir J 40(3):570\u2013579. https:\/\/doi.org\/10.1183\/09031936.00121411","journal-title":"Eur Respir J"},{"issue":"2-3","key":"679_CR303","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/s0014-2999(99)00019-9","volume":"367","author":"SN Louis","year":"1999","unstructured":"Louis SN, Nero TL, Iakovidis D, Jackman GP, Louis WJ (1999) LK 204-545, a highly selective beta1-adrenoceptor antagonist at human beta-adrenoceptors. Eur J Pharmacol 367(2-3):431\u2013435. https:\/\/doi.org\/10.1016\/s0014-2999(99)00019-9","journal-title":"Eur J Pharmacol"},{"issue":"9","key":"679_CR304","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/thoraxjnl-2015-208138","volume":"71","author":"RJ Loymans","year":"2016","unstructured":"Loymans RJ, Honkoop PJ, Termeer EH, Snoeck-Stroband JB, Assendelft WJ, Schermer TR, Chung KF, Sousa AR, Sterk PJ, Reddel HK, Sont JK, Ter Riet G (2016) Identifying patients at risk for severe exacerbations of asthma: development and external validation of a multivariable prediction model. Thorax 71(9):838\u2013846. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-208138","journal-title":"Thorax"},{"key":"679_CR305","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/COPD.S1516","volume":"3","author":"C Macie","year":"2008","unstructured":"Macie C, Wooldrage K, Manfreda J, Anthonisen N (2008) Cardiovascular morbidity and the use of inhaled bronchodilators. Int J Chron Obstruct Pulmon Dis 3:163\u2013169","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"679_CR306","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1183\/09031936.00120609","volume":"35","author":"PT Macklem","year":"2010","unstructured":"Macklem PT (2010) Therapeutic implications of the pathophysiology of COPD. Eur Respir J 35(3):676\u2013680. https:\/\/doi.org\/10.1183\/09031936.00120609","journal-title":"Eur Respir J"},{"issue":"2","key":"679_CR307","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1378\/chest.121.2.329","volume":"121","author":"R Magadle","year":"2002","unstructured":"Magadle R, Berar-Yanay N, Weiner P (2002) The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea. Chest 121(2):329\u2013333. https:\/\/doi.org\/10.1378\/chest.121.2.329","journal-title":"Chest"},{"issue":"6","key":"679_CR308","doi-asserted-by":"publisher","first-page":"487","DOI":"10.7326\/0003-4819-130-6-199903160-00005","volume":"130","author":"K Malmstrom","year":"1999","unstructured":"Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pi\u00f1eiro A, Wei LX, Seidenberg BC, Reiss TF (1999) Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast\/Beclomethasone Study Group. Ann Intern Med 130(6):487\u2013495. https:\/\/doi.org\/10.7326\/0003-4819-130-6-199903160-00005","journal-title":"Ann Intern Med"},{"issue":"12","key":"679_CR309","first-page":"60","volume":"27","author":"A M\u00e1ndi","year":"1977","unstructured":"M\u00e1ndi A, Galf\u00f3czy G, Galambos E (1977a) On the bronchodilatory effect of reproterol. Arzneimittelforschung 27(12):60\u201363","journal-title":"Arzneimittelforschung"},{"issue":"12","key":"679_CR310","first-page":"64","volume":"27","author":"A M\u00e1ndi","year":"1977","unstructured":"M\u00e1ndi A, Wilde W, Galg\u00f3czy G, Aurich R, Galambos E (1977b) Studies on the onset of effect of reproterol following inhalation from a metered aerosol. Arzneimittelforschung 27(12):64\u201366","journal-title":"Arzneimittelforschung"},{"issue":"10","key":"679_CR311","doi-asserted-by":"publisher","first-page":"614","DOI":"10.5414\/cp201513","volume":"49","author":"H Mangunnegoro","year":"2011","unstructured":"Mangunnegoro H, Novariska F, Wiyono WH, Setiawati A, Louisa M (2011) The efficacy of nebulized procaterol versus nebulized salbutamol for the treatment of moderate acute asthma: a randomized, double-blind, parallel group study. Int J Clin Pharmacol Ther 49(10):614\u2013621. https:\/\/doi.org\/10.5414\/cp201513","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"5973","key":"679_CR312","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1136\/bmj.2.5973.715","volume":"2","author":"GE Marlin","year":"1975","unstructured":"Marlin GE, Turner P (1975) Intravenous treatment with rimiterol and salbutamol in asthma. Br Med J 2(5973):715\u2013719. https:\/\/doi.org\/10.1136\/bmj.2.5973.715","journal-title":"Br Med J"},{"issue":"7","key":"679_CR313","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1136\/thx.53.7.558","volume":"53","author":"RM Martin","year":"1998","unstructured":"Martin RM, Dunn NR, Freemantle SN, Mann RD (1998) Risk of non-fatal cardiac failure and ischaemic heart disease with long acting beta 2 agonists. Thorax 53(7):558\u2013562. https:\/\/doi.org\/10.1136\/thx.53.7.558","journal-title":"Thorax"},{"issue":"5","key":"679_CR314","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1164\/rccm.202006-2618OC","volume":"203","author":"FJ Martinez","year":"2021","unstructured":"Martinez FJ, Rabe KF, Ferguson GT, Wedzicha JA, Singh D, Wang C, Rossman K, St Rose E, Trivedi R, Ballal S, Darken P, Aurivillius M, Reisner C, Dorinsky P (2021) Reduced all-cause mortality in the ETHOS trial of budesonide\/glycopyrrolate\/formoterol for chronic obstructive pulmonary disease. A randomized, double-blind, multicenter, parallel-group study. Am J Respir Crit Care Med 203(5):553\u2013564. https:\/\/doi.org\/10.1164\/rccm.202006-2618OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"8726","key":"679_CR315","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/0140-6736(90)92990-y","volume":"336","author":"JF Mart\u00ednez-Navarro","year":"1990","unstructured":"Mart\u00ednez-Navarro JF (1990) Food poisoning related to consumption of illicit beta-agonist in liver. Lancet 336(8726):1311. https:\/\/doi.org\/10.1016\/0140-6736(90)92990-y","journal-title":"Lancet"},{"issue":"11","key":"679_CR316","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41589-018-0145-x","volume":"14","author":"M Masureel","year":"2018","unstructured":"Masureel M, Zou Y, Picard LP, van der Westhuizen E, Mahoney JP, Rodrigues JPGLM, Mildorf TJ, Dror RO, Shaw DE, Bouvier M, Pardon E, Steyaert J, Sunahara RK, Weis WI, Zhang C, Kobilka BK (2018) Structural insights into binding specificity, efficacy and bias of a \u03b22AR partial agonist. Nat Chem Biol 14(11):1059\u20131066. https:\/\/doi.org\/10.1038\/s41589-018-0145-x","journal-title":"Nat Chem Biol"},{"issue":"4","key":"679_CR317","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2165\/00003495-200767040-00002","volume":"67","author":"MG Matera","year":"2007","unstructured":"Matera MG, Cazzola M (2007) ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD? Drugs 67(4):503\u2013515. https:\/\/doi.org\/10.2165\/00003495-200767040-00002","journal-title":"Drugs"},{"issue":"4","key":"679_CR318","first-page":"298","volume":"47","author":"MJ Mattila","year":"1969","unstructured":"Mattila MJ, Muittari A (1969) Effect of bronchodilator drugs on the peak expiratory flow rate of asthmatic patients: oral orciprenaline and terbutaline (KWD 2019). Ann Med Exp Biol Fenn 47(4):298\u2013302","journal-title":"Ann Med Exp Biol Fenn"},{"issue":"3","key":"679_CR319","first-page":"362","volume":"17","author":"MJ Mattila","year":"1967","unstructured":"Mattila MJ, Muittari A, Tiitinen H (1967) The effect of orciprenaline and its p-hydroxyphenyl derivative on the peak expiratory flow rate in asthmatic patients. Arzneimittelforschung 17(3):362\u2013364","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"679_CR320","first-page":"267","volume":"68","author":"JA Mazza","year":"1992","unstructured":"Mazza JA, Tashkin DP, Reed CE (1992) Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma. Ann Allergy 68(3):267\u2013273","journal-title":"Ann Allergy"},{"issue":"5","key":"679_CR321","first-page":"927","volume":"49","author":"KE McCrea","year":"1996","unstructured":"McCrea KE, Hill SJ (1996) Comparison of duration of agonist action at beta 1- and beta 2-adrenoceptors in C6 glioma cells: evidence that the long duration of action of salmeterol is specific to the beta 2-adrenoceptor. Mol Pharmacol 49(5):927\u2013937","journal-title":"Mol Pharmacol"},{"issue":"3","key":"679_CR322","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1476-5381.1974.tb09608.x","volume":"50","author":"DG McDevitt","year":"1974","unstructured":"McDevitt DG, Shanks RG, Swanton JG (1974) Further observations on the cardiotoxicity of isoprenaline during hypoxia. Br J Pharmacol 50(3):335\u2013344. https:\/\/doi.org\/10.1111\/j.1476-5381.1974.tb09608.x","journal-title":"Br J Pharmacol"},{"issue":"6","key":"679_CR323","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1378\/chest.13-0871","volume":"144","author":"T McKeever","year":"2013","unstructured":"McKeever T, Harrison TW, Hubbard R, Shaw D (2013) Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study. Chest 144(6):1788\u20131794. https:\/\/doi.org\/10.1378\/chest.13-0871","journal-title":"Chest"},{"issue":"8","key":"679_CR324","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/sj.bjp.0703506","volume":"130","author":"AJ McLean","year":"2000","unstructured":"McLean AJ, Milligan G (2000) Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors. Br J Pharmacol 130(8):1825\u20131832. https:\/\/doi.org\/10.1038\/sj.bjp.0703506","journal-title":"Br J Pharmacol"},{"key":"679_CR325","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(01)14446-6","volume":"175","author":"B Melland","year":"1910","unstructured":"Melland B (1910) The treatment of spasmodic asthma by the hypodermic injection of adrenalin. Lancet 175:1407\u20131411. https:\/\/doi.org\/10.1016\/S0140-6736(01)14446-6","journal-title":"Lancet"},{"key":"679_CR326","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.2147\/JAA.S324099","volume":"14","author":"F Menzella","year":"2021","unstructured":"Menzella F, Fontana M, Galeone C, D'Amato M, Canonica GW, Ghidoni G, Capobelli S, Scelfo C, Simonazzi A, Catellani C, Ruggiero P, Facciolongo N (2021) A real-world evaluation of clinical outcomes of biologicals and bronchial thermoplasty for severe refractory asthma (BIOTERM). J Asthma Allergy 14:1019\u20131031. https:\/\/doi.org\/10.2147\/JAA.S324099","journal-title":"J Asthma Allergy"},{"issue":"19","key":"679_CR327","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","volume":"384","author":"A Menzies-Gow","year":"2021","unstructured":"Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, Brightling CE, Griffiths JM, Hellqvist \u00c5, Bowen K, Kaur P, Almqvist G, Ponnarambil S, Colice G (2021) Tezepelumab in adults and adolescents with severe, uncontrolled asthma. N Engl J Med 384(19):1800\u20131809. https:\/\/doi.org\/10.1056\/NEJMoa2034975","journal-title":"N Engl J Med"},{"issue":"6","key":"679_CR328","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.rmed.2011.02.007","volume":"105","author":"T Meyer","year":"2011","unstructured":"Meyer T, Reitmeir P, Brand P, Herpich C, Sommerer K, Schulze A, Scheuch G, Newman S (2011) Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. Respir Med 105(6):900\u2013906. https:\/\/doi.org\/10.1016\/j.rmed.2011.02.007","journal-title":"Respir Med"},{"key":"679_CR329","unstructured":"MHRA Public Assessment Report (2009) Orciprenaline sulphate (Alupent): planned withdrawal from the UK market following a risk-benefit analysis. Available at https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/852403\/Orciprenaline_sulphate__Alupent__withdrawal_from_UK_market_after_a_risk-benefit_analysis.pdf"},{"key":"679_CR330","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/bja\/27.12.603","volume":"27","author":"RA Millar","year":"1955","unstructured":"Millar RA (1955) Adrenaline and noradrenaline. Br J Anaesth 27:603\u2013608","journal-title":"Br J Anaesth"},{"issue":"3","key":"679_CR331","first-page":"515","volume":"206","author":"H Minatoya","year":"1978","unstructured":"Minatoya H (1978) Studies on bitolterol, di-p-toluate ester of N-tert-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects. J Pharmacol Exp Ther 206(3):515\u2013527","journal-title":"J Pharmacol Exp Ther"},{"key":"679_CR332","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000192688","volume":"27","author":"A Minette","year":"1970","unstructured":"Minette A (1970) Spirometric study of the bronchodilating effects of hydroxyphenylorciprenaline (Th1165a) in various forms in a group of 124 coal miners suffering from bronchospasm. Respiration 27:276\u2013315","journal-title":"Respiration"},{"issue":"4","key":"679_CR333","first-page":"545","volume":"12","author":"A Minette","year":"1976","unstructured":"Minette A, Marcq M, Gepts L (1976) Carbuterol, fenoterol, orciprenaline, salbutamol and terbutaline per os in reversible obstructive chronic bronchitis. Bull Eur Physiopathol Respir 12(4):545\u2013553","journal-title":"Bull Eur Physiopathol Respir"},{"issue":"10","key":"679_CR334","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1021\/jm400348g","volume":"56","author":"SN Mistry","year":"2013","unstructured":"Mistry SN, Baker JG, Fischer PM, Hill SJ, Gardiner SM, Kellam B (2013) Synthesis and in vitro and in vivo characterization of highly \u03b21-selective \u03b2-adrenoceptor partial agonists. J Med Chem 56(10):3852\u20133865. https:\/\/doi.org\/10.1021\/jm400348g","journal-title":"J Med Chem"},{"issue":"2","key":"679_CR335","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/j.1447-0594.2012.00916.x","volume":"13","author":"H Mochizuki","year":"2013","unstructured":"Mochizuki H, Nanjo Y, Takahashi H (2013) Better adherence to a transdermal tulobuterol patch than inhaled salmeterol in elderly chronic obstructive pulmonary disease patients. Geriatr Gerontol Int 13(2):398\u2013404. https:\/\/doi.org\/10.1111\/j.1447-0594.2012.00916.x","journal-title":"Geriatr Gerontol Int"},{"issue":"5","key":"679_CR336","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ajem.2018.10.024","volume":"37","author":"E Montassier","year":"2019","unstructured":"Montassier E, Legrand M, Rossignol P, Potel G (2019) Hyperkalemia in the emergency department: consider the use of nebulized salbutamol. Am J Emerg Med 37(5):1004. https:\/\/doi.org\/10.1016\/j.ajem.2018.10.024","journal-title":"Am J Emerg Med"},{"issue":"2","key":"679_CR337","first-page":"410","volume":"207","author":"PF Moore","year":"1978","unstructured":"Moore PF, Constantine JW, Barth WE (1978) Pirbuterol, a selecttve beta2 adrenergic bronchodilator. J Pharmacol Exp Ther 207(2):410\u2013418","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"679_CR338","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1378\/chest.113.4.1095","volume":"113","author":"RH Moore","year":"1998","unstructured":"Moore RH, Khan A, Dickey BF (1998) Long-acting inhaled beta2-agonists in asthma therapy. Chest 113(4):1095\u20131108. https:\/\/doi.org\/10.1378\/chest.113.4.1095","journal-title":"Chest"},{"issue":"2","key":"679_CR339","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1165\/rcmb.2006-0158OC","volume":"36","author":"RH Moore","year":"2007","unstructured":"Moore RH, Millman EE, Godines V, Hanania NA, Tran TM, Peng H, Dickey BF, Knoll BJ, Clark RB (2007) Salmeterol stimulation dissociates beta2-adrenergic receptor phosphorylation and internalization. Am J Respir Cell Mol Biol 36(2):254\u2013261. https:\/\/doi.org\/10.1165\/rcmb.2006-0158OC","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"679_CR340","doi-asserted-by":"publisher","first-page":"2102865","DOI":"10.1183\/13993003.02865-2021","volume":"60","author":"K Mortimer","year":"2022","unstructured":"Mortimer K, Lesosky M, Garc\u00eda-Marcos L, Asher MI, Pearce N, Ellwood E, Bissell K, El Sony A, Ellwood P, Marks GB, Mart\u00ednez-Torres A, Morales E, Perez-Fernandez V, Robertson S, Rutter CE, Silverwood RJ, Strachan DP, Chiang CY, Global Asthma Network Phase I Study Group (2022) The burden of asthma, hay fever and eczema in adults in 17 countries: GAN phase I study. Eur Respir J 60(3):2102865. https:\/\/doi.org\/10.1183\/13993003.02865-2021","journal-title":"Eur Respir J"},{"issue":"3","key":"679_CR341","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jaci.2014.03.019","volume":"134","author":"H Mosbech","year":"2014","unstructured":"Mosbech H, Deckelmann R, de Blay F, Pastorello EA, Trebas-Pietras E, Andres LP, Malcus I, Lj\u00f8rring C, Canonica GW (2014) Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 134(3):568\u2013575.e7. https:\/\/doi.org\/10.1016\/j.jaci.2014.03.019","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"679_CR342","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1378\/chest.98.3.651","volume":"98","author":"RD Mountain","year":"1990","unstructured":"Mountain RD, Heffner JE, Brackett NC Jr, Sahn SA (1990) Acid-base disturbances in acute asthma. Chest 98(3):651\u2013655. https:\/\/doi.org\/10.1378\/chest.98.3.651","journal-title":"Chest"},{"issue":"15","key":"679_CR343","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.1993.03510150076033","volume":"270","author":"M Mullen","year":"1993","unstructured":"Mullen M, Mullen B, Carey M (1993) The association between beta-agonist use and death from asthma. A meta-analytic integration of case-control studies. JAMA 270(15):1842\u20131845","journal-title":"JAMA"},{"issue":"1","key":"679_CR344","first-page":"78","volume":"21","author":"A Munro","year":"2004","unstructured":"Munro A, Jacobs M (2004) Best evidence topic reports. Is intravenous aminophylline better than intravenous salbutamol in the treatment of moderate to severe asthma? Emerg Med J 21(1):78\u201380","journal-title":"Emerg Med J"},{"issue":"11A","key":"679_CR345","first-page":"1633","volume":"34","author":"T Murai","year":"1984","unstructured":"Murai T, Maejima T, Sanai K, Osada E (1984) Pharmacological studies of mabuterol, a new selective beta 2-stimulant. I: bronchodilating effect. Arzneimittelforschung 34(11A):1633\u20131640","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"679_CR346","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12890-021-01403-y","volume":"21","author":"M Muraki","year":"2021","unstructured":"Muraki M, Kunita Y, Shirahase K, Yamazaki R, Hanada S, Sawaguchi H, Tohda Y (2021) A randomized controlled trial of long-acting muscarinic antagonist and long-acting \u03b22 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease. BMC Pulm Med 21(1):26. https:\/\/doi.org\/10.1186\/s12890-021-01403-y","journal-title":"BMC Pulm Med"},{"issue":"6","key":"679_CR347","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1248\/cpb.25.1368","volume":"25","author":"K Murase","year":"1977","unstructured":"Murase K, Mase T, Ida H, Takahashi K, Murakami M (1977) New beta-adrenoreceptor stimulants. Studies on 3-acylamino-4-hydroxy-alpha-(N-substituted aminomethyl)benzyl alcohols. Chem Pharm Bull (Tokyo) 25(6):1368\u20131377. https:\/\/doi.org\/10.1248\/cpb.25.1368","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"14","key":"679_CR348","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s40265-014-0284-7","volume":"74","author":"L Murphy","year":"2014","unstructured":"Murphy L, Rennard S, Donohue J, Molimard M, Dahl R, Beeh KM, Dederichs J, F\u00fclle HJ, Higgins M, Young D (2014) Turning a molecule into a medicine: the development of indacaterol as a novel once-daily bronchodilator treatment for patients with COPD. Drugs 74(14):1635\u20131657. https:\/\/doi.org\/10.1007\/s40265-014-0284-7","journal-title":"Drugs"},{"issue":"5","key":"679_CR349","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S2213-2600(21)00023-0","volume":"9","author":"P Nair","year":"2021","unstructured":"Nair P, Surette MG, Virchow JC (2021) Neutrophilic asthma: misconception or misnomer? Lancet Respir Med 9(5):441\u2013443. https:\/\/doi.org\/10.1016\/S2213-2600(21)00023-0","journal-title":"Lancet Respir Med"},{"issue":"5","key":"679_CR350","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1183\/09031936.94.07050914","volume":"7","author":"E Naline","year":"1994","unstructured":"Naline E, Zhang Y, Qian Y, Mairon N, Anderson GP, Grandordy B, Advenier C (1994) Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus. Eur Respir J 7(5):914\u2013920","journal-title":"Eur Respir J"},{"issue":"1","key":"679_CR351","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2005.10.013","volume":"117","author":"HS Nelson","year":"2006","unstructured":"Nelson HS (2006a) Is there a problem with inhaled long-acting beta-adrenergic agonists? J Allergy Clin Immunol 117(1):3\u201316.; quiz 17. https:\/\/doi.org\/10.1016\/j.jaci.2005.10.013","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"679_CR352","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.pcrj.2006.08.006","volume":"15","author":"HS Nelson","year":"2006","unstructured":"Nelson HS (2006b) Long-acting beta-agonists in adult asthma: evidence that these drugs are safe. Prim Care Respir J 15(5):271\u2013277. https:\/\/doi.org\/10.1016\/j.pcrj.2006.08.006","journal-title":"Prim Care Respir J"},{"issue":"1","key":"679_CR353","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1378\/chest.129.1.15","volume":"129","author":"HS Nelson","year":"2006","unstructured":"Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM, SMART Study Group (2006) The salmeterol multicenter asthma research trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129(1):15\u201326. https:\/\/doi.org\/10.1378\/chest.129.1.15","journal-title":"Chest"},{"issue":"1","key":"679_CR354","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1081-1206(10)60101-9","volume":"102","author":"HS Nelson","year":"2009","unstructured":"Nelson HS, Carr W, Nathan R, Portnoy JM (2009) Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma. Ann Allergy Asthma Immunol 102(1):11\u201315. https:\/\/doi.org\/10.1016\/S1081-1206(10)60101-9","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"679_CR355","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea MG, Dom\u00ednguez-Andr\u00e9s J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, Joosten LAB, van der Meer JWM, Mhlanga MM, Mulder WJM, Riksen NP, Schlitzer A, Schultze JL, Stabell Benn C, Sun JC, Xavier RJ, Latz E (2020) Defining trained immunity and its role in health and disease. Nat Rev Immunol 20(6):375\u2013388. https:\/\/doi.org\/10.1038\/s41577-020-0285-6","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"679_CR356","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1378\/chest.110.3.595","volume":"110","author":"MT Newhouse","year":"1996","unstructured":"Newhouse MT, Chapman KR, McCallum AL, Abboud RT, Bowie DM, Hodder RV, Par\u00e9 PD, Mesic-Fuchs H, Molfino NA (1996) Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Chest 110(3):595\u2013603. https:\/\/doi.org\/10.1378\/chest.110.3.595","journal-title":"Chest"},{"issue":"5","key":"679_CR357","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1365-2125.1993.tb00393.x","volume":"36","author":"DM Newnham","year":"1993","unstructured":"Newnham DM, McDevitt DG, Lipworth BJ (1993) Comparison of the extrapulmonary beta2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered dose-inhaler and modified actuator device. Br J Clin Pharmacol 36(5):445\u2013450. https:\/\/doi.org\/10.1111\/j.1365-2125.1993.tb00393.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"679_CR358","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/j.1476-5381.1993.tb12833.x","volume":"108","author":"AT Nials","year":"1993","unstructured":"Nials AT, Sumner MJ, Johnson M, Coleman RA (1993a) Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol. Br J Pharmacol 108(2):507\u2013515. https:\/\/doi.org\/10.1111\/j.1476-5381.1993.tb12833.x","journal-title":"Br J Pharmacol"},{"issue":"3","key":"679_CR359","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1476-5381.1993.tb13929.x","volume":"110","author":"AT Nials","year":"1993","unstructured":"Nials AT, Coleman RA, Johnson M, Magnussen H, Rabe KF, Vardey CJ (1993b) Effects of beta-adrenoceptor agonists in human bronchial smooth muscle. Br J Pharmacol 110(3):1112\u20131116. https:\/\/doi.org\/10.1111\/j.1476-5381.1993.tb13929.x","journal-title":"Br J Pharmacol"},{"issue":"2\u20133","key":"679_CR360","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0014-2999(94)90392-1","volume":"251","author":"AT Nials","year":"1994","unstructured":"Nials AT, Ball DI, Butchers PR, Coleman RA, Humbles AA, Johnson M, Vardey CJ (1994) Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol. Eur J Pharmacol 251(2\u20133):127\u2013135. https:\/\/doi.org\/10.1016\/0014-2999(94)90392-1","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"679_CR361","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1254\/fpj.98.1_7","volume":"98","author":"M Nishimura","year":"1991","unstructured":"Nishimura M, Okiyama M, Fujiwara H, Kudo M, Simizu M, Maeda M, Yamada M, Toshimitsu Y (1991) Pharmacological action of SN-408, a novel long-acting selective beta 2-adrenoceptor agonist. Nihon Yakurigaku Zasshi 98(1):7\u201321. https:\/\/doi.org\/10.1254\/fpj.98.1_7","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"11","key":"679_CR362","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/j.1440-1681.2006.04480.x","volume":"33","author":"O Nishiyama","year":"2006","unstructured":"Nishiyama O, Taniguchi H, Kondoh Y, Kimura T, Kato K, Kume H, Shimokata K (2006) Comparison of the effects of tulobuterol patch and salmeterol in moderate to severe asthma. Clin Exp Pharmacol Physiol 33(11):1016\u20131021. https:\/\/doi.org\/10.1111\/j.1440-1681.2006.04480.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"679_CR363","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1513\/AnnalsATS.201703-259OC","volume":"15","author":"T Nurmagambetov","year":"2018","unstructured":"Nurmagambetov T, Kuwahara R, Garbe P (2018) The economic burden of asthma in the United States, 2008-2013. Ann Am Thorac Soc 15(3):348\u2013356. https:\/\/doi.org\/10.1513\/AnnalsATS.201703-259OC","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"679_CR364","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jaci.2009.08.047","volume":"124","author":"PM O\u2019Byrne","year":"2009","unstructured":"O\u2019Byrne PM, van der Linde J, Cockcroft DW, Gauvreau GM, Brannan JD, Fitzgerald M, Watson RM, Milot J, Davis B, O\u2019Connor M, Hart L, Korducki L, Hamilton AL, Boulet L-P (2009) Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting beta(2)-agonist, in patients with mild asthma. J Allergy Clin Immunol 124(6):1217\u20131221. https:\/\/doi.org\/10.1016\/j.jaci.2009.08.047","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"679_CR365","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1056\/NEJM199210223271704","volume":"327","author":"BJ O\u2019Connor","year":"1992","unstructured":"O\u2019Connor BJ, Aikman SL, Barnes PJ (1992) Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med 327(17):1204\u20131208. https:\/\/doi.org\/10.1056\/NEJM199210223271704","journal-title":"N Engl J Med"},{"issue":"1","key":"679_CR366","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0014-2999(70)90026-9","volume":"2","author":"SR O\u2019Donnell","year":"1970","unstructured":"O\u2019Donnell SR (1970) A selective beta-adrenoreceptor stimulant (Th1165a) related to orciprenaline. Eur J Pharmacol 2(1):35\u201343. https:\/\/doi.org\/10.1016\/0014-2999(70)90026-9","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"679_CR367","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0014-2999(72)90104-5","volume":"19","author":"SR O\u2019Donnell","year":"1972","unstructured":"O\u2019Donnell SR (1972) An examination of some -adrenoreceptor stimulants for selectivity using the isolated trachea and atria of the guinea pig. Eur J Pharmacol 19(3):371\u2013379. https:\/\/doi.org\/10.1016\/0014-2999(72)90104-5","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"679_CR368","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/0014-2999(78)90241-8","volume":"47","author":"SR O\u2019Donnell","year":"1978","unstructured":"O\u2019Donnell SR, Wanstall JC (1978) Evidence that the efficacy (intrinsic activity) of fenoterol is higher than that of salbutamol on beta-adrenoceptors in guinea-pig trachea. Eur J Pharmacol 47(3):333\u2013340. https:\/\/doi.org\/10.1016\/0014-2999(78)90241-8","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"679_CR369","doi-asserted-by":"publisher","first-page":"CD007694","DOI":"10.1002\/14651858.CD007694.pub3","volume":"4","author":"O O\u2019Shea","year":"2021","unstructured":"O\u2019Shea O, Stovold E, Cates CJ (2021) Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev 4(4):CD007694. https:\/\/doi.org\/10.1002\/14651858.CD007694.pub3","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"679_CR370","first-page":"190","volume":"224","author":"SR O'Donnell","year":"1976","unstructured":"O'Donnell SR (1976) Selectivity of clenbuterol (NAB 365) in guinea-pig isolated tissues containing beta-adrenoceptors. Arch Int Pharmacodyn Ther 224(2):190\u2013198","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"679_CR371","first-page":"l","volume":"16","author":"G Oliver","year":"1894","unstructured":"Oliver G, Sch\u00e4fer EA (1894) On the physiological action of extracts of the suprarenal capsule. J Physiol 16:l\u20134","journal-title":"J Physiol"},{"issue":"3","key":"679_CR372","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1113\/jphysiol.1895.sp000564","volume":"18","author":"G Oliver","year":"1895","unstructured":"Oliver G, Sch\u00e4fer EA (1895) The physiological effects of extracts of the suprarenal capsules. J Physiol 18(3):230\u2013276. https:\/\/doi.org\/10.1113\/jphysiol.1895.sp000564","journal-title":"J Physiol"},{"issue":"1","key":"679_CR373","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1023\/A:1016322524471","volume":"1","author":"OA Olsson","year":"1984","unstructured":"Olsson OA, Svensson L\u00c5 (1984) New lipophilic terbutaline ester prodrugs with long effect duration. Pharm Res 1(1):19\u201323. https:\/\/doi.org\/10.1023\/A:1016322524471","journal-title":"Pharm Res"},{"issue":"8","key":"679_CR374","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/archdischild-2015-309141","volume":"100","author":"DA O'Reilly","year":"2015","unstructured":"O'Reilly DA, Awale A, Cartledge P (2015) Question 2: blast from the past: is oral salbutamol useful in resource-poor settings? Arch Dis Child 100(8):806\u2013809. https:\/\/doi.org\/10.1136\/archdischild-2015-309141","journal-title":"Arch Dis Child"},{"issue":"1 Pt 1","key":"679_CR375","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0091-6749(85)90012-0","volume":"75","author":"HA Orgel","year":"1985","unstructured":"Orgel HA, Kemp JP, Tinkelman DG, Webb DR Jr (1985) Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma. J Allergy Clin Immunol 75(1 Pt 1):55\u201362. https:\/\/doi.org\/10.1016\/0091-6749(85)90012-0","journal-title":"J Allergy Clin Immunol"},{"key":"679_CR376","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.coph.2010.04.009","volume":"3","author":"VE Ortega","year":"2010","unstructured":"Ortega VE, Peters SP (2010) Beta-2 adrenergic agonists: focus on safety and benefits versus risks. Curr Opin Pharmacol 3:246\u2013253. https:\/\/doi.org\/10.1016\/j.coph.2010.04.009","journal-title":"Curr Opin Pharmacol"},{"issue":"13","key":"679_CR377","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","volume":"371","author":"HG Ortega","year":"2014","unstructured":"Ortega HG, Liu MC, Pavord ID, Brusselle GG, FitzGerald JM, Chetta A, Humbert M, Katz LE, Keene ON, Yancey SW, Chanez P, MENSA Investigators (2014) Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med 371(13):1198\u20131207. https:\/\/doi.org\/10.1056\/NEJMoa1403290","journal-title":"N Engl J Med"},{"issue":"Suppl 5","key":"679_CR378","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1097\/00005344-198906145-00007","volume":"14","author":"M Packer","year":"1989","unstructured":"Packer M (1989) Is activation of the sympathetic nervous system beneficial or detrimental to the patient with chronic heart failure? Lessons learned from clinical trials with beta-adrenergic agonists and antagonists. J Cardiovasc Pharmacol 14(Suppl 5):S38\u2013S43","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5635","key":"679_CR379","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1136\/bmj.1.5635.31","volume":"1","author":"KN Palmer","year":"1969","unstructured":"Palmer KN, Diament ML (1969) Effect of salbutamol on spirometry and blood-gas tensions in bronchial asthma. Br Med J 1(5635):31\u201332. https:\/\/doi.org\/10.1136\/bmj.1.5635.31","journal-title":"Br Med J"},{"issue":"22","key":"679_CR380","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1056\/NEJMoa2203163","volume":"386","author":"A Papi","year":"2022","unstructured":"Papi A, Chipps BE, Beasley R, Panettieri RA Jr, Israel E, Cooper M, Dunsire L, Jeynes-Ellis A, Johnsson E, Rees R, Cappelletti C, Albers FC (2022) Albuterol-budesonide fixed-dose combination rescue inhaler for asthma. N Engl J Med 386(22):2071\u20132083. https:\/\/doi.org\/10.1056\/NEJMoa2203163","journal-title":"N Engl J Med"},{"issue":"4","key":"679_CR381","first-page":"176","volume":"17","author":"C Pasotti","year":"1979","unstructured":"Pasotti C, Capra A, Vibelli C (1979) NAB 365 (clenbuterol) and salbutamol in asthmatics: a double-blind clinical trial. Int J Clin Pharmacol Biopharm 17(4):176\u2013180","journal-title":"Int J Clin Pharmacol Biopharm"},{"issue":"4","key":"679_CR382","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2125.1985.tb05076.x","volume":"20","author":"P Patchett","year":"1985","unstructured":"Patchett P, Patchett SM, Burge PS (1985) Bronchial and cardiovascular responses to inhaled reproterol in asthmatics: a double-blind placebo controlled dose-response study. Br J Clin Pharmacol 20(4):349\u2013353. https:\/\/doi.org\/10.1111\/j.1365-2125.1985.tb05076.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"679_CR383","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1365-2125.1986.tb05182.x","volume":"21","author":"KR Patel","year":"1986","unstructured":"Patel KR (1986) Bronchodilator activity of a new inhaled beta 2-adrenoceptor agonist, tulobuterol and its protective effect in exercise-induced asthma. Br J Clin Pharmacol 21(2):234\u2013237. https:\/\/doi.org\/10.1111\/j.1365-2125.1986.tb05182.x","journal-title":"Br J Clin Pharmacol"},{"issue":"Suppl","key":"679_CR384","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/BF02718135","volume":"168","author":"KR Patel","year":"1990","unstructured":"Patel KR (1990) Prolonged treatment with oral and inhaled tulobuterol does not induce airways tachyphlaxis. Lung 168(Suppl):210\u2013218. https:\/\/doi.org\/10.1007\/BF02718135","journal-title":"Lung"},{"issue":"2","key":"679_CR385","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.pupt.2010.11.004","volume":"24","author":"S Patel","year":"2011","unstructured":"Patel S, Summerhill S, Stanley M, Perros-Huguet C, Trevethick MA (2011) The reassertion profiles of long acting \u03b22-adrenoceptor agonists in the guinea pig isolated trachea and human recombinant \u03b22-adrenoceptor. Pulm Pharmacol Ther 24(2):247\u2013255. https:\/\/doi.org\/10.1016\/j.pupt.2010.11.004","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"679_CR386","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jaip.2013.04.008","volume":"1","author":"M Patel","year":"2013","unstructured":"Patel M, Pilcher J, Munro C, Hosking A, Pritchard A, Shaw D, Black P, Weatherall M, Beasley R, SMART Study Group (2013) Short-acting \u03b2-agonist use as a marker of current asthma control. J Allergy Clin Immunol Pract 1(4):370\u2013377. https:\/\/doi.org\/10.1016\/j.jaip.2013.04.008","journal-title":"J Allergy Clin Immunol Pract"},{"key":"679_CR387","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/0007-0971(75)90095-9","volume":"69","author":"IC Paterson","year":"1975","unstructured":"Paterson IC, Willey RF, Shotter V, Grant IW, Crompton GK (1975) Objective and subjective comparisons of terbutaline and rimiterol bronchodilator aerosols. Br J Dis Chest 69:267\u2013272. https:\/\/doi.org\/10.1016\/0007-0971(75)90095-9","journal-title":"Br J Dis Chest"},{"issue":"20","key":"679_CR388","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1056\/NEJM199711133372001","volume":"337","author":"RA Pauwels","year":"1997","unstructured":"Pauwels RA, L\u00f6fdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A (1997) Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 337(20):1405\u20131411. https:\/\/doi.org\/10.1056\/NEJM199711133372001","journal-title":"N Engl J Med"},{"key":"679_CR389","volume-title":"Adverse reactions: the fenoterol story","author":"N Pearce","year":"2007","unstructured":"Pearce N (2007) Adverse reactions: the fenoterol story. Auckland University Press. ISBN: 9781869403744"},{"issue":"3","key":"679_CR390","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1136\/thx.45.3.170","volume":"45","author":"N Pearce","year":"1990","unstructured":"Pearce N, Grainger J, Atkinson M, Crane J, Burgess C, Culling C, Windom H, Beasley R (1990) Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax 45(3):170\u2013175. https:\/\/doi.org\/10.1136\/thx.45.3.170","journal-title":"Thorax"},{"issue":"8941","key":"679_CR391","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/s0140-6736(95)91159-6","volume":"345","author":"N Pearce","year":"1995","unstructured":"Pearce N, Beasley R, Crane J, Burgess C, Jackson R (1995) End of the New Zealand asthma mortality epidemic. Lancet 345(8941):41\u201344. https:\/\/doi.org\/10.1016\/s0140-6736(95)91159-6","journal-title":"Lancet"},{"issue":"4","key":"679_CR392","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/BF00613456","volume":"29","author":"BK Pedersen","year":"1985","unstructured":"Pedersen BK, Laursen LC, Gnosspelius Y, Faurschou P, Weeke B (1985) Bambuterol: effects of a new anti-asthmatic drug. Eur J Clin Pharmacol 29(4):425\u2013427. https:\/\/doi.org\/10.1007\/BF00613456","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"679_CR393","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1378\/chest.72.6.731","volume":"72","author":"BE Pennock","year":"1977","unstructured":"Pennock BE, Rogers RM, Ryan BR, Ayers LN (1977) Aerosol administration of fenoterol hydrobromide (Th 1165a) in subjects with reversible obstructive airway disease. Chest 72(6):731\u2013736. https:\/\/doi.org\/10.1378\/chest.72.6.731","journal-title":"Chest"},{"issue":"2","key":"679_CR394","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000195177","volume":"51","author":"AP Perruchoud","year":"1987","unstructured":"Perruchoud AP, Br\u00fcndler H, Godly R, Imhof E, Herzog H (1987) Broxaterol (Z.1170), a new oral beta 2-agonist compared with salbutamol. Respiration 51(2):113\u2013118. https:\/\/doi.org\/10.1159\/000195177","journal-title":"Respiration"},{"key":"679_CR395","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.0954-6820.1970.tb05284.x","volume":"512","author":"H Persson","year":"1970","unstructured":"Persson H, Olsson T (1970) Some pharmacological properties of terbutaline (INN), 1-(3,5-dihydroxyphenyl)-2-(T-butylamino)-ethanol. A new sympathomimetic beta-receptor-stimulating agent. Acta Med Scand Suppl 512:11\u201319. https:\/\/doi.org\/10.1111\/j.0954-6820.1970.tb05284.x","journal-title":"Acta Med Scand Suppl"},{"issue":"1","key":"679_CR396","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1183\/09031936.95.08010034","volume":"8","author":"G Persson","year":"1995","unstructured":"Persson G, Baas A, Knight A, Larsen B, Olsson H (1995) One month treatment with the once daily oral beta 2-agonist bambuterol in asthmatic patients. Eur Respir J 8(1):34\u201339. https:\/\/doi.org\/10.1183\/09031936.95.08010034","journal-title":"Eur Respir J"},{"issue":"5","key":"679_CR397","first-page":"299","volume":"10","author":"A Petraglia","year":"1990","unstructured":"Petraglia A, Scarpitta M, Ansalone D, Gurrieri G, Galzerano V, Calvanese RC, Federico S, Zinno A (1990) Negligible metabolic effects of long-term oral treatment with a new beta 2-agonist: broxaterol. Int J Clin Pharmacol Res 10(5):299\u2013304","journal-title":"Int J Clin Pharmacol Res"},{"issue":"8","key":"679_CR398","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/s0954-6111(05)80260-4","volume":"87","author":"GR Petrie","year":"1993","unstructured":"Petrie GR, Chookang JY, Hassan WU, Morrison JF, O'Reilly JF, Pearson SB, Shneerson JM, Tang OT, Ning AC, Turbitt ML (1993) Bambuterol: effective in nocturnal asthma. Respir Med 87(8):581\u2013585. https:\/\/doi.org\/10.1016\/s0954-6111(05)80260-4","journal-title":"Respir Med"},{"issue":"3","key":"679_CR399","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1378\/chest.86.3.404","volume":"86","author":"TL Petty","year":"1984","unstructured":"Petty TL, Scoggin CH, Rollins DR, Repsher LH (1984) Bitolterol compared to isoproterenol in advanced chronic obstructive pulmonary disease. Chest 86(3):404\u2013408. https:\/\/doi.org\/10.1378\/chest.86.3.404","journal-title":"Chest"},{"issue":"4","key":"679_CR400","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/j.1552-4604.1972.tb00045.x","volume":"12","author":"EM Phillips","year":"1972","unstructured":"Phillips EM, Woolnough M, Marinova VM, Turner P (1972) A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man. J Clin Pharmacol New Drugs 12(4):158\u2013168. https:\/\/doi.org\/10.1002\/j.1552-4604.1972.tb00045.x","journal-title":"J Clin Pharmacol New Drugs"},{"issue":"5","key":"679_CR401","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2125.1980.tb05844.x","volume":"9","author":"PJ Phillips","year":"1980","unstructured":"Phillips PJ, Vedig AE, Jones PL, Chapman MG, Collins M, Edwards JB, Smeaton TC, Duncan BM (1980) Metabolic and cardiovascular side effects of the beta 2-adrenoceptor agonists salbutamol and rimiterol. Br J Clin Pharmacol 9(5):483\u2013491. https:\/\/doi.org\/10.1111\/j.1365-2125.1980.tb05844.x","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"679_CR402","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.phrs.2004.07.006","volume":"51","author":"G Piatti","year":"2005","unstructured":"Piatti G, Ambrosetti U, Santus P, Allegra L (2005) Effects of salmeterol on cilia and mucus in COPD and pneumonia patients. Pharmacol Res 51(2):165\u2013168. https:\/\/doi.org\/10.1016\/j.phrs.2004.07.006","journal-title":"Pharmacol Res"},{"issue":"6 Suppl","key":"679_CR403","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1378\/chest.73.6.949","volume":"73","author":"AL Plummer","year":"1978","unstructured":"Plummer AL (1978) The development of drug tolerance to beta2 adrenergic agents. Chest 73(6 Suppl):949\u2013957. https:\/\/doi.org\/10.1378\/chest.73.6.949","journal-title":"Chest"},{"issue":"7","key":"679_CR404","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1055\/s-2007-996280","volume":"12","author":"DE Potter","year":"1980","unstructured":"Potter DE, Woodson LC, Kempen RR, Ellis S (1980) Comparative metabolic and cardiovascular effects of carbuterol, isoproterenol, metaproterenol and salbutamol in the baboon. Horm Metab Res 12(7):323\u2013327. https:\/\/doi.org\/10.1055\/s-2007-996280","journal-title":"Horm Metab Res"},{"issue":"8","key":"679_CR405","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1249\/00005768-199508000-00003","volume":"27","author":"ID Prather","year":"1995","unstructured":"Prather ID, Brown DE, North P, Wilson JR (1995) Clenbuterol: a substitute for anabolic steroids? Med Sci Sports Exerc 27(8):1118\u20131121","journal-title":"Med Sci Sports Exerc"},{"issue":"5","key":"679_CR406","doi-asserted-by":"publisher","first-page":"e01003","DOI":"10.1002\/prp2.1003","volume":"10","author":"RGW Proudman","year":"2022","unstructured":"Proudman RGW, Akinaga J, Baker JG (2022) The signaling and selectivity of \u03b1-adrenoceptor agonists for the human \u03b12A, \u03b12B and \u03b12C-adrenoceptors and comparison with human \u03b11 and \u03b2-adrenoceptors. Pharmacol Res Perspect 10(5):e01003. https:\/\/doi.org\/10.1002\/prp2.1003","journal-title":"Pharmacol Res Perspect"},{"issue":"9","key":"679_CR407","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/bcp.13295","volume":"83","author":"CJ Qian","year":"2017","unstructured":"Qian CJ, Coulombe J, Suissa S, Ernst P (2017) Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study. Br J Clin Pharmacol 83(9):2077\u20132086. https:\/\/doi.org\/10.1111\/bcp.13295","journal-title":"Br J Clin Pharmacol"},{"issue":"26","key":"679_CR408","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","volume":"378","author":"KF Rabe","year":"2018","unstructured":"Rabe KF, Nair P, Brusselle G, Maspero JF, Castro M, Sher L, Zhu H, Hamilton JD, Swanson BN, Khan A, Chao J, Staudinger H, Pirozzi G, Antoni C, Amin N, Ruddy M, Akinlade B, Graham NMH, Stahl N, Yancopoulos GD, Teper A (2018) Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma. N Engl J Med 378(26):2475\u20132485. https:\/\/doi.org\/10.1056\/NEJMoa1804093","journal-title":"N Engl J Med"},{"issue":"8","key":"679_CR409","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1164\/rccm.201210-1853PP","volume":"187","author":"HH Raissy","year":"2013","unstructured":"Raissy HH, Kelly HW, Harkins M, Szefler SJ (2013) Inhaled corticosteroids in lung diseases. Am J Respir Crit Care Med 187(8):798\u2013803. https:\/\/doi.org\/10.1164\/rccm.201210-1853PP","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"679_CR410","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000194786","volume":"47","author":"C Rampulla","year":"1985","unstructured":"Rampulla C, Corsico R, Majani U, Lodola E (1985) Broxaterol: a double-blind clinical trial comparing broxaterol and salbutamol. Respiration 47(4):299\u2013302. https:\/\/doi.org\/10.1159\/000194786","journal-title":"Respiration"},{"issue":"3","key":"679_CR411","first-page":"367","volume":"50","author":"JL Rau","year":"2005","unstructured":"Rau JL (2005) The inhalation of drugs: advantages and problems. Respir Care 50(3):367\u2013382","journal-title":"Respir Care"},{"issue":"5","key":"679_CR412","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/j.1875-9114.2012.01025.x","volume":"32","author":"SM Ray","year":"2012","unstructured":"Ray SM, McMillen JC, Treadway SA, Helmer RS, Franks SA (2012) Indacaterol: a novel long-acting \u03b2(2)-agonist. Pharmacotherapy 32(5):456\u2013474. https:\/\/doi.org\/10.1002\/j.1875-9114.2012.01025.x","journal-title":"Pharmacotherapy"},{"issue":"6","key":"679_CR413","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1378\/chest.110.6.1446","volume":"110","author":"HH Rea","year":"1996","unstructured":"Rea HH, Garrett JE, Lanes SF, Birmann BM, Kolbe J (1996) The association between asthma drugs and severe life-threatening attacks. Chest 110(6):1446\u20131451. https:\/\/doi.org\/10.1378\/chest.110.6.1446","journal-title":"Chest"},{"issue":"8","key":"679_CR414","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/pds.5432","volume":"31","author":"C Rebordosa","year":"2022","unstructured":"Rebordosa C, Farkas DK, Montonen J, Laugesen K, Voss F, Aguado J, Bothner U, Rothman KJ, Zint K, Mines D, Ehrenstein V (2022) Cardiovascular events and all-cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long-acting beta2-agonists. Pharmacoepidemiol Drug Saf 31(8):827\u2013839. https:\/\/doi.org\/10.1002\/pds.5432","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9150","key":"679_CR415","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(98)06128-5","volume":"353","author":"H Reddel","year":"1999","unstructured":"Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A (1999) Differences between asthma exacerbations and poor asthma control. Lancet 353(9150):364\u2013369. https:\/\/doi.org\/10.1016\/S0140-6736(98)06128-5","journal-title":"Lancet"},{"issue":"3","key":"679_CR416","first-page":"150","volume":"65","author":"A Reyes-Mondragon","year":"2016","unstructured":"Reyes-Mondragon A, Delgado-Garc\u00eda G, Pacheco-Cant\u00fa A, Contreras-Garza N, Galarza-Delgado D\u00c1, Gonz\u00e1lez-Aguirre J (2016) Atrial fibrillation in an asthmatic patient with albuterol-induced lactic acidosis. Pneumologia 65(3):150\u2013151","journal-title":"Pneumologia"},{"issue":"1","key":"679_CR417","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1164\/arrd.1976.114.1.79","volume":"114","author":"RB Rhoades","year":"1976","unstructured":"Rhoades RB, Leifer KN, Bloom FL, Wittig HJ (1976) Spirometric comparison of carbuterol and isoproterenol aerosol therapy in bronchial asthma. A double blind, matched-pair study of 28 adults and a double blind crossover study of 18 children. Am Rev Respir Dis 114(1):79\u201386. https:\/\/doi.org\/10.1164\/arrd.1976.114.1.79","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"679_CR418","first-page":"596","volume":"42","author":"DG Rhodes","year":"1992","unstructured":"Rhodes DG, Newton R, Butler R, Herbette L (1992) Equilibrium and kinetic studies of the interactions of salmeterol with membrane bilayers. Mol Pharmacol 42(4):596\u2013602","journal-title":"Mol Pharmacol"},{"issue":"1","key":"679_CR419","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2165\/00003495-198530010-00002","volume":"30","author":"DM Richards","year":"1985","unstructured":"Richards DM, Brogden RN (1985) Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease. Drugs 30(1):6\u201321. https:\/\/doi.org\/10.2165\/00003495-198530010-00002","journal-title":"Drugs"},{"issue":"5","key":"679_CR420","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.2527\/jas1984.5951247x","volume":"59","author":"CA Ricks","year":"1984","unstructured":"Ricks CA, Dalrymple RH, Baker PK, Ingle DL (1984) Use of a \u03b2-agonist to alter fat and muscle deposition in steers. J Anim Sci 59(5):1247\u20131255. https:\/\/doi.org\/10.2527\/jas1984.5951247x","journal-title":"J Anim Sci"},{"issue":"6","key":"679_CR421","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1378\/chest.101.6.1699","volume":"101","author":"ED Robin","year":"1992","unstructured":"Robin ED, McCauley R (1992) Sudden cardiac death in bronchial asthma, and inhaled beta-adrenergic agonists. Chest 101(6):1699\u20131702. https:\/\/doi.org\/10.1378\/chest.101.6.1699","journal-title":"Chest"},{"issue":"5","key":"679_CR422","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1378\/chest.69.5.593","volume":"69","author":"MA Sackner","year":"1976","unstructured":"Sackner MA, Epstein S, Wanner A (1976) Effect of beta-adrenergic agonists aerosolized by freon propellant on tracheal mucous velocity and cardiac output. Chest 69(5):593\u2013598. https:\/\/doi.org\/10.1378\/chest.69.5.593","journal-title":"Chest"},{"issue":"1","key":"679_CR423","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0014-2999(91)90785-o","volume":"203","author":"R Sala","year":"1991","unstructured":"Sala R, Moriggi E, Della Bella D, Carenzi A (1991) The specific binding of broxaterol, a new beta 2-selective agonist, to beta-adrenoceptors. Eur J Pharmacol 203(1):17\u201323. https:\/\/doi.org\/10.1016\/0014-2999(91)90785-o","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"679_CR424","first-page":"225","volume":"17","author":"PR Saleeby","year":"1975","unstructured":"Saleeby PR, Ziskind MM (1975) Clinical study on carbuterol (SKF 40383), a new selective bronchodilator agent aerosol: double blind comparison with isoproterenol aerosol. Curr Ther Res Clin Exp 17(3):225\u2013233","journal-title":"Curr Ther Res Clin Exp"},{"issue":"3\u20134","key":"679_CR425","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/BF00567113","volume":"8","author":"Y Salorinne","year":"1975","unstructured":"Salorinne Y, Stenius B, Tukiainen P, Poppius H (1975) Double-blind cross-over comparison of clenbuterol and salbutamol tablets in asthmatic out-patients. Eur J Clin Pharmacol 8(3\u20134):189\u2013195. https:\/\/doi.org\/10.1007\/BF00567113","journal-title":"Eur J Clin Pharmacol"},{"issue":"6","key":"679_CR426","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1378\/chest.125.6.2309","volume":"125","author":"SR Salpeter","year":"2004","unstructured":"Salpeter SR, Ormiston TM, Salpeter EE (2004) Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 125(6):2309\u20132321","journal-title":"Chest"},{"issue":"11","key":"679_CR427","doi-asserted-by":"publisher","first-page":"2874","DOI":"10.3390\/biomedicines10112874","volume":"10","author":"L Salvati","year":"2022","unstructured":"Salvati L, Liotta F, Annunziato F, Cosmi L (2022) Therapeutical targets in allergic inflammation. Biomedicine 10(11):2874. https:\/\/doi.org\/10.3390\/biomedicines10112874","journal-title":"Biomedicine"},{"issue":"4","key":"679_CR428","first-page":"279","volume":"8","author":"J Sanchez","year":"1988","unstructured":"Sanchez J, Rivero A, Dal-Re R, Azanza JR (1988) Open cross-over comparison of tulobuterol and fenoterol in asthmatic adult patients. Int J Clin Pharmacol Res 8(4):279\u2013285","journal-title":"Int J Clin Pharmacol Res"},{"issue":"3","key":"679_CR429","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/0091-6749(77)90121-x","volume":"60","author":"JP Sanders","year":"1977","unstructured":"Sanders JP, Potter DE, Ellis S, Bee DE, Grant JA (1977) Metabolic and cardiovascular effects of carbuterol and metaproterenol. J Allergy Clin Immunol 60(3):174\u2013179. https:\/\/doi.org\/10.1016\/0091-6749(77)90121-x","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"679_CR430","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000195393","volume":"53","author":"T Sandstr\u00f6m","year":"1988","unstructured":"Sandstr\u00f6m T, Asander L, Clemmensen IH, Eklund G, Gnosspelius Y, Klarlund Pedersen B, Persson G, Ravn S, Rosenhall L, Weeke B (1988) Bambuterol: clinical effects of different doses of a long-acting bronchodilator prodrug. Respiration 53(1):31\u201336. https:\/\/doi.org\/10.1159\/000195393","journal-title":"Respiration"},{"issue":"6","key":"679_CR431","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ejim.2015.05.001","volume":"26","author":"P Santus","year":"2015","unstructured":"Santus P, Radovanovic D, Paggiaro P, Papi A, Sanduzzi A, Scichilone N, Braido F (2015) Why use long acting bronchodilators in chronic obstructive lung diseases? An extensive review on formoterol and salmeterol. Eur J Intern Med 26(6):379\u2013384. https:\/\/doi.org\/10.1016\/j.ejim.2015.05.001","journal-title":"Eur J Intern Med"},{"issue":"6","key":"679_CR432","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1097\/PCC.0b013e31828a7677","volume":"14","author":"SM Sarnaik","year":"2013","unstructured":"Sarnaik SM, Saladino RA, Manole M, Pitetti RA, Arora G, Kuch BA, Orr RA, Felmet KA (2013) Diastolic hypotension is an unrecognized risk factor for \u03b2-agonist-associated myocardial injury in children with asthma. Pediatr Crit Care Med 14(6):e273\u2013e279. https:\/\/doi.org\/10.1097\/PCC.0b013e31828a7677","journal-title":"Pediatr Crit Care Med"},{"issue":"12","key":"679_CR433","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.2337\/db13-1860","volume":"63","author":"M Sato","year":"2014","unstructured":"Sato M, Dehvari N, Oberg AI, Dallner OS, Sandstr\u00f6m AL, Olsen JM, Csikasz RI, Summers RJ, Hutchinson DS, Bengtsson T (2014) Improving type 2 diabetes through a distinct adrenergic signaling pathway involving mTORC2 that mediates glucose uptake in skeletal muscle. Diabetes 63(12):4115\u20134129. https:\/\/doi.org\/10.2337\/db13-1860","journal-title":"Diabetes"},{"issue":"1","key":"679_CR434","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/j.1476-5381.2009.00224.x","volume":"158","author":"I Sayers","year":"2009","unstructured":"Sayers I, Hawley J, Stewart CE, Billington CK, Henry A, Leighton-Davies JR, Charlton SJ, Hall IP (2009) Pharmacogenetic characterization of indacaterol, a novel beta 2-adrenoceptor agonist. Br J Pharmacol 158(1):277\u2013286. https:\/\/doi.org\/10.1111\/j.1476-5381.2009.00224.x","journal-title":"Br J Pharmacol"},{"issue":"5","key":"679_CR435","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2125.1987.tb03224.x","volume":"24","author":"M Scheinin","year":"1987","unstructured":"Scheinin M, Koulu M, Laurikainen E, Allonen H (1987) Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol 24(5):645\u2013653. https:\/\/doi.org\/10.1111\/j.1365-2125.1987.tb03224.x","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"679_CR436","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/sj.bjp.0705905","volume":"143","author":"AM Scola","year":"2004","unstructured":"Scola AM, Chong LK, Chess-Williams R, Peachell PT (2004) Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells. Br J Pharmacol 143(1):71\u201380. https:\/\/doi.org\/10.1038\/sj.bjp.0705905","journal-title":"Br J Pharmacol"},{"key":"679_CR437","doi-asserted-by":"publisher","first-page":"106311","DOI":"10.1016\/j.rmed.2021.106311","volume":"180","author":"E Scosyrev","year":"2021","unstructured":"Scosyrev E, van Zyl-Smit R, Kerstjens H, Gessner C, Kornmann O, Jain D, Aubrun E, D'Andrea P, Hosoe M, Pethe A, Brittain D (2021) Cardiovascular safety of mometasone\/indacaterol and mometasone\/indacaterol\/glycopyrronium once-daily fixed-dose combinations in asthma: pooled analysis of phase 3 trials. Respir Med 180:106311. https:\/\/doi.org\/10.1016\/j.rmed.2021.106311","journal-title":"Respir Med"},{"issue":"6 Suppl","key":"679_CR438","doi-asserted-by":"publisher","first-page":"S322","DOI":"10.1067\/mai.2002.129966","volume":"110","author":"MR Sears","year":"2002","unstructured":"Sears MR (2002) Adverse effects of beta-agonists. J Allergy Clin Immunol 110(6 Suppl):S322\u2013S328. https:\/\/doi.org\/10.1067\/mai.2002.129966","journal-title":"J Allergy Clin Immunol"},{"issue":"8728","key":"679_CR439","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/0140-6736(90)93098-a","volume":"336","author":"MR Sears","year":"1990","unstructured":"Sears MR, Taylor DR, Print CG, Lake DC, Li QQ, Flannery EM, Yates DM, Lucas MK, Herbison GP (1990) Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 336(8728):1391\u20131396. https:\/\/doi.org\/10.1016\/0140-6736(90)93098-a","journal-title":"Lancet"},{"issue":"1","key":"679_CR440","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1183\/09031936.00145006","volume":"33","author":"MR Sears","year":"2009","unstructured":"Sears MR, Ottosson A, Radner F, Suissa S (2009) Long-acting beta-agonists: a review of formoterol safety data from asthma clinical trials. Eur Respir J 33(1):21\u201332. https:\/\/doi.org\/10.1183\/09031936.00145006","journal-title":"Eur Respir J"},{"issue":"5","key":"679_CR441","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1159\/000067474","volume":"67","author":"AJ Seco","year":"2000","unstructured":"Seco AJ, Salgueiro ME, Villanueva MA, Manso G (2000) Treatment with high doses of terbutaline induces beta-adrenergic desensitization of guinea pig trachea not prevented by the addition of dexamethasone. Respiration 67(5):559\u2013564. https:\/\/doi.org\/10.1159\/000067474","journal-title":"Respiration"},{"issue":"1","key":"679_CR442","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1378\/chest.75.1.1","volume":"75","author":"RM Senior","year":"1979","unstructured":"Senior RM, Lefrak SS, Kleiger RE (1979) The heart in chronic obstructive pulmonary disease: arrhythmias. Chest 75(1):1\u20132. https:\/\/doi.org\/10.1378\/chest.75.1.1","journal-title":"Chest"},{"issue":"7","key":"679_CR443","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S2213-2600(21)00021-7","volume":"9","author":"DE Shaw","year":"2021","unstructured":"Shaw DE, Heaney LG, Thomas M, Beasley R, Gibson PG, Pavord ID (2021) Balancing the needs of the many and the few: where next for adult asthma guidelines? Lancet Respir Med 9(7):786\u2013794. https:\/\/doi.org\/10.1016\/S2213-2600(21)00021-7","journal-title":"Lancet Respir Med"},{"issue":"6","key":"679_CR444","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/0091-6749(85)90096-x","volume":"75","author":"SC Siegel","year":"1985","unstructured":"Siegel SC, Katz RM, Rachelefsky GS, Brandon ML, Borgen LA (1985) A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma. J Allergy Clin Immunol 75(6):698\u2013705. https:\/\/doi.org\/10.1016\/0091-6749(85)90096-x","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"679_CR445","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/BF00316096","volume":"39","author":"P Simone","year":"1990","unstructured":"Simone P, Borgia M, Torre L, Ventresca GP (1990) Dose-response comparison of broxaterol and salbutamol pressurized aerosols. Eur J Clin Pharmacol 39(6):565\u2013568. https:\/\/doi.org\/10.1007\/BF00316096","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"679_CR446","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1378\/chest.103.3.771","volume":"103","author":"DS Sitar","year":"1993","unstructured":"Sitar DS, Aoki FY, Warren CP, Knight A, Grossman RF, Alexander M, Soliman S (1993) A placebo-controlled dose-finding study with bambuterol in elderly patients with asthma. Chest 103(3):771\u2013776. https:\/\/doi.org\/10.1378\/chest.103.3.771","journal-title":"Chest"},{"issue":"1","key":"679_CR447","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1124\/jpet.112.198481","volume":"344","author":"RJ Slack","year":"2013","unstructured":"Slack RJ, Barrett VJ, Morrison VS, Sturton RG, Emmons AJ, Ford AJ, Knowles RG (2013) In vitro pharmacological characterization of vilanterol, a novel long-acting \u03b22-adrenoceptor agonist with 24-hour duration of action. J Pharmacol Exp Ther 344(1):218\u2013230. https:\/\/doi.org\/10.1124\/jpet.112.198481","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"679_CR448","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/thoraxjnl-2013-204517","volume":"69","author":"M Slater","year":"2014","unstructured":"Slater M, Rivett DW, Williams L, Martin M, Harrison T, Sayers I, Bruce KD, Shaw D (2014) The impact of azithromycin therapy on the airway microbiota in asthma. Thorax 69(7):673\u2013674. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-204517","journal-title":"Thorax"},{"issue":"18","key":"679_CR449","doi-asserted-by":"publisher","first-page":"e12960","DOI":"10.14814\/phy2.12960","volume":"4","author":"M Slater","year":"2016","unstructured":"Slater M, Torr E, Harrison T, Forrester D, Knox A, Shaw D, Sayers I (2016) The differential effects of azithromycin on the airway epithelium in vitro and in vivo. Physiol Rep 4(18):e12960. https:\/\/doi.org\/10.14814\/phy2.12960","journal-title":"Physiol Rep"},{"key":"679_CR450","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/S0140-6736(66)90167-X","volume":"287","author":"JM Smith","year":"1966","unstructured":"Smith JM (1966) Deaths from asthma. Lancet 287:1042. https:\/\/doi.org\/10.1016\/S0140-6736(66)90167-X","journal-title":"Lancet"},{"issue":"6877","key":"679_CR451","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1136\/bmj.306.6877.543","volume":"306","author":"ET Smyth","year":"1993","unstructured":"Smyth ET, Pavord ID, Wong CS, Wisniewski AF, Williams J, Tattersfield AE (1993) Interaction and dose equivalence of salbutamol and salmeterol in patients with asthma. BMJ 306(6877):543\u2013545. https:\/\/doi.org\/10.1136\/bmj.306.6877.543","journal-title":"BMJ"},{"key":"679_CR452","first-page":"341","volume":"11","author":"S Solis-Cohen","year":"1898","unstructured":"Solis-Cohen S (1898) A preliminary note on the treatment of hay-fever with suprarenal substance: with a report of personal experience. Phil Med J 11:341\u2013343","journal-title":"Phil Med J"},{"key":"679_CR453","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1001\/jama.1900.24610190014001c","volume":"19","author":"S Solis-Cohen","year":"1900","unstructured":"Solis-Cohen S (1900) The use of adrenal substance in the treatment of asthma. JAMA 19:1164\u20131166","journal-title":"JAMA"},{"issue":"1","key":"679_CR454","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1177\/106002809502900114","volume":"29","author":"C Spann","year":"1995","unstructured":"Spann C, Winter ME (1995) Effect of clenbuterol on athletic performance. Ann Pharmacother 29(1):75\u201377","journal-title":"Ann Pharmacother"},{"issue":"5612","key":"679_CR455","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1136\/bmj.3.5612.245","volume":"3","author":"FE Speizer","year":"1968","unstructured":"Speizer FE, Doll R (1968) A century of asthma deaths in young people. Br Med J 3(5612):245\u2013246. https:\/\/doi.org\/10.1136\/bmj.3.5612.245","journal-title":"Br Med J"},{"issue":"5588","key":"679_CR456","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1136\/bmj.1.5588.335","volume":"1","author":"FE Speizer","year":"1968","unstructured":"Speizer FE, Doll R, Heaf P (1968a) Observations on recent increase in mortality from asthma. Br Med J 1(5588):335\u2013339. https:\/\/doi.org\/10.1136\/bmj.1.5588.335","journal-title":"Br Med J"},{"issue":"5588","key":"679_CR457","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/bmj.1.5588.339","volume":"1","author":"FE Speizer","year":"1968","unstructured":"Speizer FE, Doll R, Heaf P, Strang LB (1968b) Investigation into use of drugs preceding death from asthma. Br Med J 1(5588):339\u2013343. https:\/\/doi.org\/10.1136\/bmj.1.5588.339","journal-title":"Br Med J"},{"issue":"8","key":"679_CR458","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJM199202203260801","volume":"326","author":"WO Spitzer","year":"1992","unstructured":"Spitzer WO, Suissa S, Ernst P, Horwitz RI, Habbick B, Cockcroft D, Boivin JF, McNutt M, Buist AS, Rebuck AS (1992) The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 326(8):501\u2013506. https:\/\/doi.org\/10.1056\/NEJM199202203260801","journal-title":"N Engl J Med"},{"issue":"9","key":"679_CR459","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1136\/archdischild-2013-304467","volume":"99","author":"ES Starkey","year":"2014","unstructured":"Starkey ES, Mulla H, Sammons HM, Pandya HC (2014) Intravenous salbutamol for childhood asthma: evidence-based medicine? Arch Dis Child 99(9):873\u2013877. https:\/\/doi.org\/10.1136\/archdischild-2013-304467","journal-title":"Arch Dis Child"},{"issue":"7131","key":"679_CR460","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1136\/bmj.316.7131.567","volume":"316","author":"RP Steeds","year":"1998","unstructured":"Steeds RP, Channer KS (1998) Drug treatment in heart failure \u2013 lowering heart rate may reduce mortality. BMJ 316(7131):567\u2013568. https:\/\/doi.org\/10.1136\/bmj.316.7131.567","journal-title":"BMJ"},{"issue":"10","key":"679_CR461","first-page":"1077","volume":"16","author":"SN Steen","year":"1974","unstructured":"Steen SN, Ziment I, Thomas JS (1974) Pirbuterol: a new bronchodilator. Phase I-single dose study. Curr Ther Res Clin Exp 16(10):1077\u20131081","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6","key":"679_CR462","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1378\/chest.72.6.724","volume":"72","author":"SN Steen","year":"1977","unstructured":"Steen SN, Smith R, Kuo J, Ziment I, Beall GN (1977) Comparison of the bronchodilator effects of aerosol fenoterol and isoproterenol. Chest 72(6):724\u2013730. https:\/\/doi.org\/10.1378\/chest.72.6.724","journal-title":"Chest"},{"issue":"1","key":"679_CR463","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/jamp.2016.1297","volume":"30","author":"SW Stein","year":"2017","unstructured":"Stein SW, Thiel CG (2017) The history of therapeutic aerosols: a chronological review. J Aerosol Med Pulm Drug Deliv 30(1):20\u201341. https:\/\/doi.org\/10.1089\/jamp.2016.1297","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"1","key":"679_CR464","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00281-020-00785-1","volume":"42","author":"J Stern","year":"2020","unstructured":"Stern J, Pier J, Litonjua AA (2020) Asthma epidemiology and risk factors. Semin Immunopathol 42(1):5\u201315. https:\/\/doi.org\/10.1007\/s00281-020-00785-1","journal-title":"Semin Immunopathol"},{"key":"679_CR465","first-page":"4149","volume":"37","author":"F Stolz","year":"1904","unstructured":"Stolz F (1904) Uber adrenalin und alkylaminoacetobrenzcatechin. Ber Dtsch Chem Ges 37:4149\u20134154","journal-title":"Ber Dtsch Chem Ges"},{"key":"679_CR466","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/sj.bjp.0707672","volume":"153","author":"PG Strange","year":"2008","unstructured":"Strange PG (2008) Agonist binding, agonist affinity and agonist efficacy at G protein-coupled receptors. Br J Pharmacol 153:1353\u20131363","journal-title":"Br J Pharmacol"},{"issue":"1","key":"679_CR467","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12931-015-0184-8","volume":"16","author":"G Stynes","year":"2015","unstructured":"Stynes G, Svedsater H, Wex J, Lettis S, Leather D, Castelnuovo E, Detry M, Berry S (2015) Once-daily fluticasone furoate\/vilanterol 100\/25 mcg versus twice daily combination therapies in COPD \u2013 mixed treatment comparisons of clinical efficacy. Respir Res 16(1):25. https:\/\/doi.org\/10.1186\/s12931-015-0184-8","journal-title":"Respir Res"},{"issue":"5","key":"679_CR468","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1111\/j.1532-5415.2009.02230.x","volume":"57","author":"T Sugawara","year":"2009","unstructured":"Sugawara T, Nanjo Y, Yamazaki M, Higashihara K, Tsuda Y, Mochizuki H, Noguchi T, Takahashi H (2009) Comparison of adherence and efficacy between inhaled salmeterol and transdermal tulobuterol patch in elderly patients with chronic obstructive pulmonary disorder. J Am Geriatr Soc 57(5):919\u2013920. https:\/\/doi.org\/10.1111\/j.1532-5415.2009.02230.x","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"679_CR469","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S2213-2600(21)00238-1","volume":"9","author":"S Suissa","year":"2021","unstructured":"Suissa S (2021) Perplexing mortality data from triple therapy trials in COPD. Lancet Respir Med 9(7):684\u2013685. https:\/\/doi.org\/10.1016\/S2213-2600(21)00238-1","journal-title":"Lancet Respir Med"},{"issue":"10","key":"679_CR470","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/s0895-4356(97)00158-3","volume":"50","author":"S Suissa","year":"1997","unstructured":"Suissa S, Ernst P (1997) Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic. J Clin Epidemiol 50(10):1079\u20131088. https:\/\/doi.org\/10.1016\/s0895-4356(97)00158-3","journal-title":"J Clin Epidemiol"},{"issue":"3 Pt 1","key":"679_CR471","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1164\/ajrccm.149.3.8118625","volume":"149","author":"S Suissa","year":"1994","unstructured":"Suissa S, Ernst P, Boivin JF, Horwitz RI, Habbick B, Cockroft D, Blais L, McNutt M, Buist AS, Spitzer WO (1994) A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med 149(3 Pt 1):604\u2013610. https:\/\/doi.org\/10.1164\/ajrccm.149.3.8118625","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 Pt 1","key":"679_CR472","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1164\/ajrccm.154.6.8970341","volume":"154","author":"S Suissa","year":"1996","unstructured":"Suissa S, Hemmelgarn B, Blais L, Ernst P (1996) Bronchodilators and acute cardiac death. Am J Respir Crit Care Med 154(6 Pt 1):1598\u20131602. https:\/\/doi.org\/10.1164\/ajrccm.154.6.8970341","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"679_CR473","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1056\/NEJM200008033430504","volume":"343","author":"S Suissa","year":"2000","unstructured":"Suissa S, Ernst P, Benayoun S, Baltzan M, Cai B (2000) Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med 343(5):332\u2013336. https:\/\/doi.org\/10.1056\/NEJM200008033430504","journal-title":"N Engl J Med"},{"issue":"3","key":"679_CR474","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.vascn.2008.06.003","volume":"58","author":"S Summerhill","year":"2008","unstructured":"Summerhill S, Stroud T, Nagendra R, Perros-Huguet C, Trevethick M (2008) A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors. J Pharmacol Toxicol Methods 58(3):189\u2013197. https:\/\/doi.org\/10.1016\/j.vascn.2008.06.003","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"4","key":"679_CR475","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1378\/chest.69.4.479","volume":"69","author":"NL Svedmyr","year":"1976","unstructured":"Svedmyr NL, Larsson SA, Thiringer GK (1976) Development of \u201cresistance\u201d in beta-adrenergic receptors of asthmatic patients. Chest 69(4):479\u2013483. https:\/\/doi.org\/10.1378\/chest.69.4.479","journal-title":"Chest"},{"key":"679_CR476","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40733-015-0016-0","volume":"2","author":"H Svedsater","year":"2016","unstructured":"Svedsater H, Stynes G, Wex J, Frith L, Leather D, Castelnuovo E, Detry M, Berry S (2016) Once-daily fluticasone furoate\/vilanterol versus twice daily combination therapies in asthma-mixed treatment comparisons of clinical efficacy. Asthma Res Pract 2:4. https:\/\/doi.org\/10.1186\/s40733-015-0016-0","journal-title":"Asthma Res Pract"},{"key":"679_CR477","first-page":"71","volume":"34","author":"LA Svensson","year":"1991","unstructured":"Svensson LA (1991) Mechanism of action of bambuterol: a beta-agonist prodrug with sustained lung affinity. Agents Actions Suppl 34:71\u201378","journal-title":"Agents Actions Suppl"},{"issue":"4","key":"679_CR478","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s40265-015-0354-5","volume":"75","author":"YY Syed","year":"2015","unstructured":"Syed YY (2015) Fluticasone furoate\/vilanterol: a review of its use in patients with asthma. Drugs 75(4):407\u2013418. https:\/\/doi.org\/10.1007\/s40265-015-0354-5","journal-title":"Drugs"},{"key":"679_CR479","first-page":"379","volume":"25","author":"L Szymonowicz","year":"1895","unstructured":"Szymonowicz L, Cybulski N (1895) Jahres Bericht der Thier-Chemie 25:379","journal-title":"Jahres Bericht der Thier-Chemie"},{"issue":"12","key":"679_CR480","first-page":"55","volume":"27","author":"D Tabori","year":"1977","unstructured":"Tabori D, Conkic B, Todic V, Mijatovic M, Mirkovc S, Zecevi\u0107 D, Camprag D (1977) The bronchdilating action of reproterol in patients with bronchial asthma and chronic obstructive bronchitis. Arzneimittelforschung 27(12):55\u201360","journal-title":"Arzneimittelforschung"},{"issue":"9","key":"679_CR481","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1136\/thoraxjnl-2013-204815","volume":"69","author":"A Tai","year":"2014","unstructured":"Tai A, Tran H, Roberts M, Clarke N, Wilson J, Robertson CF (2014) The association between childhood asthma and adult chronic obstructive pulmonary disease. Thorax 69(9):805\u2013810. https:\/\/doi.org\/10.1136\/thoraxjnl-2013-204815","journal-title":"Thorax"},{"issue":"9","key":"679_CR482","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/j.rmed.2007.05.001","volume":"101","author":"G Tamura","year":"2007","unstructured":"Tamura G, Ohta K (2007) Adherence to treatment by patients with asthma or COPD: comparison between inhaled drugs and transdermal patch. Respir Med 101(9):1895\u20131902. https:\/\/doi.org\/10.1016\/j.rmed.2007.05.001","journal-title":"Respir Med"},{"issue":"2","key":"679_CR483","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2332\/allergolint.11-RA-0358","volume":"61","author":"G Tamura","year":"2012","unstructured":"Tamura G, Ichinose M, Fukuchi Y, Miyamoto T (2012) Transdermal tulobuterol patch, a long-acting\u03b2(2)-agonist. Allergol Int 61(2):219\u2013229. https:\/\/doi.org\/10.2332\/allergolint.11-RA-0358","journal-title":"Allergol Int"},{"issue":"1","key":"679_CR484","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1164\/ajrccm.156.1.9610113","volume":"156","author":"KS Tan","year":"1997","unstructured":"Tan KS, Grove A, McLean A, Gnosspelius Y, Hall IP, Lipworth BJ (1997) Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med 156(1):28\u201335. https:\/\/doi.org\/10.1164\/ajrccm.156.1.9610113","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"679_CR485","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1378\/chest.113.1.34","volume":"113","author":"KS Tan","year":"1998","unstructured":"Tan KS, McFarlane LC, Lipworth BJ (1998) Concomitant administration of low-dose prednisolone protects against in vivo beta2-adrenoceptor subsensitivity induced by regular formoterol. Chest 113(1):34\u201341. https:\/\/doi.org\/10.1378\/chest.113.1.34","journal-title":"Chest"},{"issue":"3","key":"679_CR486","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1378\/chest.77.3.429","volume":"77","author":"MK Tandon","year":"1980","unstructured":"Tandon MK (1980) Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest 77(3):429\u2013431. https:\/\/doi.org\/10.1378\/chest.77.3.429","journal-title":"Chest"},{"issue":"4","key":"679_CR487","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1017\/s0025727300060373","volume":"39","author":"EM Tansey","year":"1995","unstructured":"Tansey EM (1995) What's in a name? Henry Dale and adrenaline, 1906. Med Hist 39(4):459\u2013476. https:\/\/doi.org\/10.1017\/s0025727300060373","journal-title":"Med Hist"},{"issue":"3","key":"679_CR488","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2125.1981.tb01222.x","volume":"12","author":"RA Tarala","year":"1981","unstructured":"Tarala RA, Martyn V, Paterson JW (1981) Effect of intravenous injection of rimiterol in asthma. Br J Clin Pharmacol 12(3):333\u2013340. https:\/\/doi.org\/10.1111\/j.1365-2125.1981.tb01222.x","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"679_CR489","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2222.1992.tb00175.x","volume":"22","author":"AE Tattersfield","year":"1992","unstructured":"Tattersfield AE (1992) Long-acting beta 2-agonists. Clin Exp Allergy 22(6):600\u2013605. https:\/\/doi.org\/10.1111\/j.1365-2222.1992.tb00175.x","journal-title":"Clin Exp Allergy"},{"issue":"2\u20133","key":"679_CR490","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1385\/CRIAI:31:2:107","volume":"31","author":"AE Tattersfield","year":"2006","unstructured":"Tattersfield AE (2006) Current issues with beta2-adrenoceptor agonists: historical background. Clin Rev Allergy Immunol 31(2\u20133):107\u2013118. https:\/\/doi.org\/10.1385\/CRIAI:31:2:107","journal-title":"Clin Rev Allergy Immunol"},{"issue":"24","key":"679_CR491","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1056\/NEJM196912112812402","volume":"281","author":"AE Tattersfield","year":"1969","unstructured":"Tattersfield AE, McNicol MW (1969) Salbutamol and isoproterenol. A double-blind trial to compare bronchodilator and cardiovascular activity. N Engl J Med 281(24):1323\u20131326. https:\/\/doi.org\/10.1056\/NEJM196912112812402","journal-title":"N Engl J Med"},{"issue":"1","key":"679_CR492","first-page":"17","volume":"57","author":"G Thiringer","year":"1976","unstructured":"Thiringer G, Svedmyr N (1976) Comparison of infused and inhaled terbutaline in patients with asthma. Scand J Respir Dis 57(1):17\u201324","journal-title":"Scand J Respir Dis"},{"issue":"4","key":"679_CR493","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/0091-6749(90)90190-f","volume":"85","author":"DG Tinkelman","year":"1990","unstructured":"Tinkelman DG, DeJong R, Lutz C, Spangler DL (1990) Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma. J Allergy Clin Immunol 85(4):719\u2013728. https:\/\/doi.org\/10.1016\/0091-6749(90)90190-f","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"679_CR494","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJM198201213060301","volume":"306","author":"VG Tirlapur","year":"1982","unstructured":"Tirlapur VG, Mir MA (1982) Nocturnal hypoxemia and associated electrocardiographic changes in patients with chronic obstructive airways disease. N Engl J Med 306(3):125\u2013130. https:\/\/doi.org\/10.1056\/NEJM198201213060301","journal-title":"N Engl J Med"},{"key":"679_CR495","doi-asserted-by":"publisher","first-page":"585989","DOI":"10.1155\/2010\/585989","volume":"2010","author":"R Tkacova","year":"2010","unstructured":"Tkacova R (2010) Systemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectives. Mediators Inflamm 2010:585989. https:\/\/doi.org\/10.1155\/2010\/585989","journal-title":"Mediators Inflamm"},{"issue":"4","key":"679_CR496","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.jaci.2018.06.008","volume":"143","author":"O Tliba","year":"2019","unstructured":"Tliba O, Panettieri RA Jr (2019) Paucigranulocytic asthma: uncoupling of airway obstruction from inflammation. J Allergy Clin Immunol 143(4):1287\u20131294. https:\/\/doi.org\/10.1016\/j.jaci.2018.06.008","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"679_CR497","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1007\/s00134-007-0673-4","volume":"33","author":"D Trachsel","year":"2007","unstructured":"Trachsel D, Newth CJ, Hammer J (2007) Adenosine for salbutamol-induced supraventricular tachycardia. Intensive Care Med 33(9):1676. https:\/\/doi.org\/10.1007\/s00134-007-0673-4","journal-title":"Intensive Care Med"},{"issue":"4","key":"679_CR498","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1185\/03007998809114242","volume":"11","author":"H Tukiainen","year":"1988","unstructured":"Tukiainen H, Jaakkola J, Torkko M, Terho EO (1988) Comparison between oral procaterol and salbutamol in patients with bronchial asthma. Curr Med Res Opin 11(4):236\u2013241. https:\/\/doi.org\/10.1185\/03007998809114242","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"679_CR499","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1021\/jm00228a020","volume":"19","author":"BF Tullar","year":"1976","unstructured":"Tullar BF, Minatoya H, Lorenz RR (1976) Esters of N-tert-butylarterenol. Long-acting new bronchodilators with reduced cardiac effects. J Med Chem 19(6):834\u2013838. https:\/\/doi.org\/10.1021\/jm00228a020","journal-title":"J Med Chem"},{"issue":"9","key":"679_CR500","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/thx.43.9.674","volume":"43","author":"A Ullman","year":"1988","unstructured":"Ullman A, Svedmyr N (1988) Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 43(9):674\u2013678. https:\/\/doi.org\/10.1136\/thx.43.9.674","journal-title":"Thorax"},{"issue":"3","key":"679_CR501","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1164\/ajrccm\/142.3.571","volume":"142","author":"A Ullman","year":"1990","unstructured":"Ullman A, Hedner J, Svedmyr N (1990) Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis 142(3):571\u2013575. https:\/\/doi.org\/10.1164\/ajrccm\/142.3.571","journal-title":"Am Rev Respir Dis"},{"issue":"11A","key":"679_CR502","first-page":"1697","volume":"34","author":"WT Ulmer","year":"1984","unstructured":"Ulmer WT, Scholz HJ, Baines A (1984) Pilot clinical trial with a new beta 2-sympathomimetic bronchodilator, mabuterol. Arzneimittelforschung 34(11A):1697\u20131698","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"679_CR503","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1165\/rcmb.2011-0220OC","volume":"46","author":"HJ Unwalla","year":"2012","unstructured":"Unwalla HJ, Horvath G, Roth FD, Conner GE, Salathe M (2012) Albuterol modulates its own transepithelial flux via changes in paracellular permeability. Am J Respir Cell Mol Biol 46(4):551\u2013558. https:\/\/doi.org\/10.1165\/rcmb.2011-0220OC. Epub 2011 Dec 8","journal-title":"Am J Respir Cell Mol Biol"},{"key":"679_CR504","first-page":"90","volume":"133","author":"CG Van Arman","year":"1961","unstructured":"Van Arman CG, Miller LM, O'Malley MP (1961) SC-10049: a catecholamine bronchodilator and hyperglycemic agent. J Pharmacol Exp Ther 133:90\u201397","journal-title":"J Pharmacol Exp Ther"},{"key":"679_CR505","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1183\/09031936.96.09081684","volume":"8","author":"JA van Noord","year":"1996","unstructured":"van Noord JA, Smeets JJ, Raaijmakers JA, Bommer AM, Maesen FP (1996) Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 8:1684\u20131688. https:\/\/doi.org\/10.1183\/09031936.96.09081684","journal-title":"Eur Respir J"},{"issue":"5","key":"679_CR506","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/s0091-6749(05)80185-x","volume":"86","author":"CP van Schayck","year":"1990","unstructured":"van Schayck CP, Graafsma SJ, Visch MB, Dompeling E, van Weel C, van Herwaarden CL (1990) Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol 86(5):793\u2013800. https:\/\/doi.org\/10.1016\/s0091-6749(05)80185-x","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"679_CR507","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/all.12448","volume":"69","author":"O Vandenplas","year":"2014","unstructured":"Vandenplas O, Wiszniewska M, Raulf M, de Blay F, Gerth van Wijk R, Moscato G, Nemery B, Pala G, Quirce S, Sastre J, Schl\u00fcnssen V, Sigsgaard T, Siracusa A, Tarlo SM, van Kampen V, Zock JP, Walusiak-Skorupa J, European Academy of Allergy and Clinical Immunology (2014) EAACI position paper: irritant-induced asthma. Allergy 69(9):1141\u20131153. https:\/\/doi.org\/10.1111\/all.12448","journal-title":"Allergy"},{"issue":"1","key":"679_CR508","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S2213-2600(22)00494-5","volume":"11","author":"P Venkatesan","year":"2023","unstructured":"Venkatesan P (2023) GOLD COPD report: 2023 update. Lancet Respir Med 11(1):18. https:\/\/doi.org\/10.1016\/S2213-2600(22)00494-5","journal-title":"Lancet Respir Med"},{"issue":"5","key":"679_CR509","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1152\/jappl.1980.48.5.868","volume":"48","author":"P Verdugo","year":"1980","unstructured":"Verdugo P, Johnson NT, Tam PY (1980) beta-Adrenergic stimulation of respiratory ciliary activity. J Appl Physiol Respir Environ Exerc Physiol 48(5):868\u2013871. https:\/\/doi.org\/10.1152\/jappl.1980.48.5.868","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"issue":"3","key":"679_CR510","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1159\/000029379","volume":"66","author":"JC Virchow Jr","year":"1999","unstructured":"Virchow JC Jr (1999) Reproterol: beta-2-agonist, theophylline, or both? Respiration 66(3):210\u2013211. https:\/\/doi.org\/10.1159\/000029379","journal-title":"Respiration"},{"issue":"16","key":"679_CR511","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1001\/jama.2016.3964","volume":"315","author":"JC Virchow","year":"2016","unstructured":"Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, Lj\u00f8rring C, Riis B, de Blay F (2016) Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: a randomized clinical trial. JAMA 315(16):1715\u20131725. https:\/\/doi.org\/10.1001\/jama.2016.3964","journal-title":"JAMA"},{"issue":"10210","key":"679_CR512","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/S0140-6736(19)32215-9","volume":"394","author":"JC Virchow","year":"2019","unstructured":"Virchow JC, Kuna P, Paggiaro P, Papi A, Singh D, Corre S, Zuccaro F, Vele A, Kots M, Georges G, Petruzzelli S, Canonica GW (2019) Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials. Lancet 394(10210):1737\u20131749. https:\/\/doi.org\/10.1016\/S0140-6736(19)32215-9","journal-title":"Lancet"},{"key":"679_CR513","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1515\/bchm2.1900.29.2.105","volume":"29","author":"O Von F\u00fcrth","year":"1900","unstructured":"Von F\u00fcrth O (1900) Zur Kenntniss der brenzcatechin\u00e4hnlichen Substanz der Nebennieren. III. Mittheilung. Z Physiol Chem 29:105\u2013123","journal-title":"Z Physiol Chem"},{"issue":"4","key":"679_CR514","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0306-3623(95)02052-7","volume":"27","author":"B Waldeck","year":"1996","unstructured":"Waldeck B (1996) Some pharmacodynamic aspects on long-acting beta-adrenoceptor agonists. Gen Pharmacol 27(4):575\u2013580. https:\/\/doi.org\/10.1016\/0306-3623(95)02052-7","journal-title":"Gen Pharmacol"},{"issue":"1\u20132","key":"679_CR515","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0014-2999(02)01728-4","volume":"445","author":"B Waldeck","year":"2002","unstructured":"Waldeck B (2002) Beta-adrenoceptor agonists and asthma \u2013 100 years of development. Eur J Pharmacol 445(1\u20132):1\u201312. https:\/\/doi.org\/10.1016\/s0014-2999(02)01728-4","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"679_CR516","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/j.1875-9114.1985.tb03410.x","volume":"5","author":"SB Walker","year":"1985","unstructured":"Walker SB, Kradjan WA, Bierman CW (1985) Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma. Pharmacotherapy 5(3):127\u2013137. https:\/\/doi.org\/10.1002\/j.1875-9114.1985.tb03410.x","journal-title":"Pharmacotherapy"},{"issue":"1","key":"679_CR517","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s0954-6111(99)90074-4","volume":"93","author":"B Wallaert","year":"1999","unstructured":"Wallaert B, Brun P, Ostinelli J, Murciano D, Champel F, Blaive B, Montan\u00e9 F, Godard P (1999) A comparison of two long-acting beta-agonists, oral bambuterol and inhaled salmeterol, in the treatment of moderate to severe asthmatic patients with nocturnal symptoms. The French Bambuterol Study Group. Respir Med 93(1):33\u201338. https:\/\/doi.org\/10.1016\/s0954-6111(99)90074-4","journal-title":"Respir Med"},{"issue":"7953","key":"679_CR518","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s0140-6736(76)91340-4","volume":"1","author":"P Wang","year":"1976","unstructured":"Wang P, Clausen T (1976) Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet 1(7953):221\u2013223. https:\/\/doi.org\/10.1016\/s0140-6736(76)91340-4","journal-title":"Lancet"},{"issue":"1","key":"679_CR519","first-page":"167","volume":"189","author":"JR Wardell","year":"1974","unstructured":"Wardell JR, Colella DF, Shetzline A, Fowler PJ (1974) Studies on carbuterol (SK & F 40383-A), a new selective bronchodilator agent. J Pharmacol Exp Ther 189(1):167\u2013184","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"679_CR520","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3109\/02770903.2012.724132","volume":"49","author":"MJ Warnier","year":"2012","unstructured":"Warnier MJ, Rutten FH, Kors JA, Lammers JW, de Boer A, Hoes AW, de Bruin ML (2012) Cardiac arrhythmias in adult patients with asthma. J Asthma 49(9):942\u2013946. https:\/\/doi.org\/10.3109\/02770903.2012.724132","journal-title":"J Asthma"},{"issue":"5688","key":"679_CR521","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1136\/bmj.1.5688.65","volume":"1","author":"DA Warrell","year":"1970","unstructured":"Warrell DA, Robertson DG, Howes JN, Conolly ME, Paterson JW, Beilin LJ, Dollery CT (1970) Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma. Br Med J 1(5688):65\u201370","journal-title":"Br Med J"},{"issue":"Suppl","key":"679_CR522","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1007\/BF02718134","volume":"168","author":"K Werdermann","year":"1990","unstructured":"Werdermann K (1990) Two-month comparative study of tulobuterol aerosol versus fenoterol aerosol in patients with chronic obstructive lung disease. Lung 168(Suppl):202\u2013209. https:\/\/doi.org\/10.1007\/BF02718134","journal-title":"Lung"},{"key":"679_CR523","unstructured":"Wetterlin KIL, Svensson LA (1968) Belgium patent No. 704932"},{"key":"679_CR524","unstructured":"WHO (2019) World Health Organization model list of essential medicines: 21st list 2019. World Health Organization, Geneva"},{"issue":"7","key":"679_CR525","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1111\/bcp.15135","volume":"88","author":"A Wilkinson","year":"2022","unstructured":"Wilkinson A, Woodcock A (2022) The environmental impact of inhalers for asthma: a green challenge and a golden opportunity. Br J Clin Pharmacol 88(7):3016\u20133022. https:\/\/doi.org\/10.1111\/bcp.15135","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"679_CR526","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1365-2125.1976.tb04881.x","volume":"3","author":"RF Willey","year":"1976","unstructured":"Willey RF, Grant IW, Pocock SJ (1976) Effects of oral salbutamol and pirbuterol on FEV1, heart rate and blood pressure in asthmatics. Br J Clin Pharmacol 3(4):595\u2013600. https:\/\/doi.org\/10.1111\/j.1365-2125.1976.tb04881.x","journal-title":"Br J Clin Pharmacol"},{"issue":"8232","key":"679_CR527","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/s0140-6736(81)92403-x","volume":"1","author":"JD Wilson","year":"1981","unstructured":"Wilson JD, Sutherland DC, Thomas AC (1981) Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? Lancet 1(8232):1235\u20131237. https:\/\/doi.org\/10.1016\/s0140-6736(81)92403-x","journal-title":"Lancet"},{"issue":"8728","key":"679_CR528","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/0140-6736(90)93099-b","volume":"336","author":"CS Wong","year":"1990","unstructured":"Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE (1990) Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet 336(8728):1396\u20131399. https:\/\/doi.org\/10.1016\/0140-6736(90)93099-b","journal-title":"Lancet"},{"issue":"4","key":"679_CR529","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1378\/chest.13-0178","volume":"144","author":"A Woodcock","year":"2013","unstructured":"Woodcock A, Bleecker ER, L\u00f6tvall J, O'Byrne PM, Bateman ED, Medley H, Ellsworth A, Jacques L, Busse WW (2013) Efficacy and safety of fluticasone furoate\/vilanterol compared with fluticasone propionate\/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial. Chest 144(4):1222\u20131229. https:\/\/doi.org\/10.1378\/chest.13-0178","journal-title":"Chest"},{"issue":"4","key":"679_CR530","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/02770903.2019.1709867","volume":"58","author":"S Woodward","year":"2021","unstructured":"Woodward S, Mundorff M, Weng C, Gamboa DG, Johnson MD (2021) Incidence of supraventricular tachycardia after inhaled short-acting beta agonist treatment in children. J Asthma 58(4):471\u2013480. https:\/\/doi.org\/10.1080\/02770903.2019.1709867","journal-title":"J Asthma"},{"issue":"4","key":"679_CR531","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1476-5381.1977.tb07543.x","volume":"61","author":"Y Yabuuchi","year":"1977","unstructured":"Yabuuchi Y (1977) The beta-adrenoceptor stimulant properties of OPC-2009 on guinea-pig isolated tracheal, right atrial and left atrial preparations. Br J Pharmacol 61(4):513\u2013521. https:\/\/doi.org\/10.1111\/j.1476-5381.1977.tb07543.x","journal-title":"Br J Pharmacol"},{"issue":"2","key":"679_CR532","first-page":"326","volume":"202","author":"Y Yabuuchi","year":"1977","unstructured":"Yabuuchi Y, Yamashita S, Tei SS (1977) Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog. J Pharmacol Exp Ther 202(2):326\u2013336","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"679_CR533","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pupt.2007.05.004","volume":"21","author":"T Yamagata","year":"2008","unstructured":"Yamagata T, Hirano T, Sugiura H, Yanagisawa S, Ichikawa T, Ueshima K, Akamatsu K, Nakanishi M, Matsunaga K, Minakata Y, Ichinose M (2008) Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists. Pulm Pharmacol Ther 21(1):160\u2013165. https:\/\/doi.org\/10.1016\/j.pupt.2007.05.004","journal-title":"Pulm Pharmacol Ther"},{"key":"679_CR534","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/096777200301100211","volume":"11","author":"T Yamashima","year":"2003","unstructured":"Yamashima T (2003) Jokichi Takamine (1854-1922), the samurai chemist, and his work on adrenalin. J Med Biogr 11:95\u2013102","journal-title":"J Med Biogr"},{"issue":"5","key":"679_CR535","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.2042-7158.1978.tb13228.x","volume":"30","author":"S Yamashita","year":"1978","unstructured":"Yamashita S, Takai M, Yabuuchi Y (1978) Actions of procaterol (OPC-2009), a new beta2-adrenoceptor stimulant, on pulmonary resistance, contractions of the soleus muscle, and cardiovascular system of the anaesthetized cat. J Pharm Pharmacol 30(5):273\u2013279. https:\/\/doi.org\/10.1111\/j.2042-7158.1978.tb13228.x","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"679_CR536","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1021\/jm00231a011","volume":"19","author":"S Yoshizaki","year":"1976","unstructured":"Yoshizaki S, Tanimura K, Tamada S, Yabuuchi Y, Nakagawa K (1976) Sympathomimetic amines having a carbostyril nucleus. J Med Chem 19(9):1138\u20131142. https:\/\/doi.org\/10.1021\/jm00231a011","journal-title":"J Med Chem"},{"key":"679_CR537","volume-title":"Asthma \u2013 from childhood asthma to ACOS phenotypes","author":"M Youssef","year":"2016","unstructured":"Youssef M, Kanagaratham C, Saad MI, Radzioch D (2016) Genetics of allergic asthma and current perpectivs on therapeutic management. In: Pereira C (ed) Asthma \u2013 from childhood asthma to ACOS phenotypes. ISBN 978-953-51-2441-2"},{"issue":"5\u20136","key":"679_CR538","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/j.1552-4604.1982.tb02669.x","volume":"22","author":"CL Zanetti","year":"1982","unstructured":"Zanetti CL, Rotman HH, Dresner AJ (1982) Efficacy and duration of action of procaterol, a new bronchodilator. J Clin Pharmacol 22(5\u20136):250\u2013253. https:\/\/doi.org\/10.1002\/j.1552-4604.1982.tb02669.x","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 2","key":"679_CR539","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000195767","volume":"55","author":"I Ziment","year":"1989","unstructured":"Ziment I (1989) Broxaterol: therapeutic trials and safety profile. Respiration 55(Suppl 2):28\u201340. https:\/\/doi.org\/10.1159\/000195767","journal-title":"Respiration"}],"container-title":["Handbook of Experimental Pharmacology","Adrenoceptors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2023_679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T19:05:47Z","timestamp":1725390347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2023_679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9783031667756","9783031667763"],"references-count":539,"URL":"https:\/\/doi.org\/10.1007\/164_2023_679","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"type":"print","value":"0171-2004"},{"type":"electronic","value":"1865-0325"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"15 September 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}